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CHAPTER 1
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10 GENERAL INTRODUCTION
1.1 EUTROPHICATION AND PHYTOPLANKTON BLOOMS
Aquatic systems are the habitat of many species and provide important ecosystem services, 
such as provision of drinking water and food, and coast protection [1, 2]. However, in 
many regions in the world, aquatic systems suffer heavily from increasing human pressure 
[3] and as a consequence, ecosystem functioning and biodiversity have decreased [4, 
5]. Eutrophication, the pollution with nutrients, is one of the drivers of aquatic system 
degradation and is regarded as one of the most important water quality issues in both 
freshwater and marine systems [6, 7].
Eutrophication changes food webs, as primary producers, and mostly phytoplankton 
species, benefit from the high level of available nutrients. Zooplankton can control excessive 
phytoplankton growth by grazing and by doing so, they transfer nutrients and energy to 
higher trophic levels [8]. However, when zooplankton grazing is reduced, for instance because 
zooplankton is intensely preyed upon by fish [8], or because of the phytoplankton’s toxicity, 
hard to handle morphology or poor nutritional value [9], phytoplankton can proliferate. In 
this situation, the trophic coupling between phyto- and zooplankton is distorted [10], and 
phytoplankton may reach very  high densities. In freshwater systems, such phytoplankton 
blooms mainly consist of cyanobacteria, which can accumulate at water surfaces and lee-
side shores in thick scums [11], while in marine systems, diatoms and dinoflagellates are 
the main blooming species (Figure 1.1). Excessive phytoplankton growth can reduce water 
transparency, reduce macrophyte growth and may cause anoxia and fish kills at night or 
upon decay [6, 7, 12]. Moreover, as will be explained in the next paragraph, phytoplankton 
blooms can be dangerous to humans, pets and wildlife because some phytoplankton species 
can produce potent toxins. Blooms of toxic species and blooms that have other detrimental 
effects on aquatic systems or ecosystem services are therefore often referred to as harmful 
(algal or cyanobacterial) blooms [6, 13, 14].
1.2 PHYCOTOXINS
One of our main concerns with phytoplankton blooms, as outlined above, is that they can be 
toxic. A variety of marine and freshwater phytoplankton species are capable of producing so 
called phycotoxins. In marine systems, phycotoxins are mainly produced by dinoflagellates 
and diatoms whereas in freshwater ecosystems, most toxins are produced by cyanobacteria 
[13]. Phycotoxins differ greatly in their structure, mode of action and level of toxicity. For 
instance, some toxins are protein phosphatase inhibitors (microcystins [15], okadaic acid 
[16]), while others block sodium channels (saxitoxins [17]), inhibit acetyl-choline esterase 
(anatoxin-a(s) [18]) or bind to glutamate receptors (domoic acid [19]). Main targets of 
phycotoxins are the nervous system and organs like liver, kidney and skin [11, 19, 20] and 
some toxins are tumour promotors [20, 21]. The effects of algal toxin exposure can range 
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from mild - like nausea and local numbness - to severe, such as respiratory difficulties, 
paralysis and death [19, 21-23].
Many phycotoxins can be transferred from phytoplankton to higher trophic levels such 
as shellfish, zooplankton and fish. Humans are therefore not only exposed to phycotoxins 
through direct contact with toxic algal blooms, but ingestion of contaminated food can be 
a major exposure route as well [13, 24]. Yearly, phycotoxins are responsible for over 60.000 
human intoxications worldwide [25]. Moreover, phycotoxins can kill wildlife (e.g. [26, 27]) 
and pets (e.g. [28, 29]). Phytoplankton blooms also have a negative economic impact: in 
Europe, marine blooms alone are estimated to yearly cause a 813 M€ economic loss, mainly 
to recreation and tourism (637 M€) and commercial fisheries (147 M€) [30].
Although hundreds of algal toxins have been identified already, new compounds are still 
being discovered. One of the compounds that have recently been added to the list of known 
phycotoxins is the non-proteinogenic, neurotoxic amino acid β-N-methylamino-L-alanine 
(BMAA, Figure 1.2). BMAA was discovered in 1967 in a terrestrial ecosystem, in the seeds 
of the cycad Cycas micronesica on the island of Guam [31]. In 2003, BMAA was found in the 
cyanobacterium Nostoc living in symbiosis with this cycad [32]. This first report of BMAA in 
a cyanobacterium was followed by positive reports for BMAA in free living and symbiotic 
cyanobacteria, as well as in cyanobacteria dominated field samples [33-36]. Given the 
putative role of BMAA in neurodegenerative illnesses [37], these findings of widespread 
occurrence of BMAA in virtually all tested cyanobacteria at sometimes alarming high 
concentrations led to the assumption that BMAA may pose a worldwide significant risk to 
human health [34, 38, 39].
Figure 1.1. Two freshwater cyanobacteria (A, Planktothrix rubescens and Woronichinia 
naegeliana) and two marine blooming phytoplankton species, a raphidophyte and the 
dinoflagellate Karlodinium veneficum (B, preserved in Lugol’s solution). Credit: Miquel Lürling 
(A) and Nathan S. Hall (B).
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Figure 1.2. Chemical structure of BMAA.
1.3 THE ROLE OF BMAA IN THE AETIOLOGY OF NEURODEGENERATIVE 
DISEASES
BMAA research started on Guam [31], in search for a cause of the high incidence of 
amyotrophic lateral sclerosis-Parkinsonism dementia complex (ALS-PDC), a combination of 
amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD) and Alzheimer’s disease (AD), 
among the indigenous Chamorro people. ALS-PDC incidence among the Chamorro people 
was about 100 times higher than in the continental United States [40], and was related to 
the Chamorro traditional diet, of which cycad seeds were a main constituent [41]. BMAA 
was found in dietary items such as cycad flour that was prepared from washed seeds, and 
flying foxes, a bat species that foraged on cycad seeds and that was regarded as a delicacy 
by the Chamorro people [42, 43]. In subsequent studies, BMAA was shown to be neurotoxic 
(e.g. [31, 44]), and BMAA exposure is at present regarded as one of the possible causes of 
ALS/PDC on Guam [45].
BMAA research expanded beyond Guam when its presence was reported in free living 
cyanobacteria originating from all over the world [33]. This finding implied that human 
exposure to BMAA could occur globally, and not only in the few ALS/PDC hotspots in the 
western Pacific, where the use of cycads was integrated in the traditional way of living 
[46-48]. BMAA exposure was now suggested to (also) play a role in the globally occurring 
neurodegenerative diseases AD, PD and ALS [37].
AD, PD and ALS are fatal, age-related, progressive neurodegenerative diseases. AD and PD 
have a high incidence: in the United States, 4.5 million people were suffering from AD in 
2005, and AD incidence is expected to increase in the US to 11-16 million cases in 2050 
[49]. Approximately one million Americans were affected by PD in 2005, and this number is 
expected to increase to 4 million in 2040 [49]. AD is the most common form of dementia [50] 
and this disease is characterised by the loss of neurons and synapses in the brain, mainly in 
the cerebral cortex [51]. PD is the second most prevalent neurodegenerative disease (after 
AD), and patients show tremor at rest, rigidity, slowness or absence of voluntary movement, 
instability and freezing [52]. PD is characterised by loss of neurons in the substantia nigra, 
a part of the mid brain [52]. ALS, of which patients have a life expectancy of 3 to 5 years 
after diagnosis [53], is characterised by motor neuron degeneration, leading to spasticity, 
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hyperreflexia, weakness, muscle atrophy  and paralysis. ALS does not affect the heart muscle, 
and most patients die from respiratory muscle failure [54]. These three neurodegenerative 
diseases have in common that for most of the cases (> 99% in AD [50] and approximately 
95% in PD [52] and ALS [53]) the disease is not inherited and at present, it is still unknown 
what triggers the onset of disease in these sporadic cases. Another common feature is that 
in all three of these diseases, excitotoxicity (neural injury or death invoked by excessive 
activation of glutamate receptors [55]), oxidative stress and protein misfolding are involved 
[56, 57].
BMAA exposure is one of the possible environmental factors that could play a role in the 
aetiology of AD, PD and ALS. Possible human exposure routes to BMAA include exposure 
to BMAA-containing phytoplankton, or through ingestion of higher aquatic organisms that 
have been in contact with such blooms [58]. The neurotoxicity of BMAA has been recognized 
both in vitro and in vivo [59, 60], and BMAA-mediated excitotoxicity and oxidative stress have 
been experimentally demonstrated (e.g. [61-64]). Furthermore, there is some indication 
that BMAA incorporation leads to protein misfolding in vitro [65], but this area needs further 
research. But even though it is established that BMAA is a neurotoxin, an animal model for 
BMAA-induced neurodegenerative diseases is still lacking [60, 66]. Recently, some progress 
has been made with a rat [67] and an primate model [68], but further work in this field is 
still required.
The hypothesis that BMAA may trigger ALS, AD and PD is supported by the reports of BMAA 
in brains of deceased ALS/PDC and AD patients [69-71], but these results could not be 
reproduced by other research groups [72-74]. In a recent study on BMAA in cerebrospinal 
fluid, BMAA was detected in one ALS patient, but higher concentrations were found in two 
control patients [75]. Although the results of this study are not conclusive yet, this type of 
work is promising as biomarkers for BMAA exposure could be developed from ante mortem 
analyses. These biomarkers could be used in larger scale epidemiological studies with living 
patients, which could shed more light on the role of BMAA exposure in the aetiology of ALS, 
AD and PD.
1.4 CONTROVERSY REGARDING THE PRESENCE OF BMAA IN AQUATIC 
ECOSYSTEMS
The initial report of high BMAA levels (up to a few mg/g DW) in nearly all tested free living 
cyanobacteria from over the world [33] promoted considerable follow-up research. The 
first follow-up studies on cyanobacterial isolates and field samples confirmed the presence 
of BMAA in the majority of the tested samples, albeit at slightly lower concentrations 
than initially reported [34-36]. However, other laboratories could not detect BMAA in 
any cyanobacterial sample (e.g. [76-79]), although the analytical methods used were in 
most cases sensitive enough to enable reproduction of these first results. The claim that 
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BMAA was produced by symbiotic cyanobacteria in the cycad’s coralloid roots [32] was 
challenged when cycads devoid of symbiotic cyanobacteria were found to increase in BMAA 
concentrations [80, 81]. This finding, in combination with the negative reports for BMAA in 
cyanobacteria by some research groups, raised doubts on the hypothesis that BMAA was a 
common cyanobacterial product.
When BMAA research expanded from cyanobacteria to higher trophic levels, similar 
differences between studies were observed. As an example, BMAA concentrations reported 
for food webs in South Florida (high µg/g up to mg/g dry weight levels [82]) were orders of 
magnitude higher than those reported for the Baltic Sea (mostly ng/g dry weight [83]). The 
cause of these conflicting results was attributed to the different analytical methods used, 
although there was initially little consensus on what would be the most suitable method 
for BMAA analysis (e.g. [77, 84]). The crucial role that analytical chemistry has played in 
BMAA research was clearly described in a 2012 tutorial: “The BMAA hypothesis relies on 
analytical data at every twist and turn, but there are many deficiencies in the work that has 
been performed. The putative link between cycads and neurodegenerative disease remains 
highly controversial, in large part because of discrepancies in the analytical findings relating 
to pivotal elements of this theory” [85]. In order to generate reliable data on the presence 
of BMAA in aquatic systems and in neurodegenerative disease patients, sound analytical 
methods should be applied, and the development of these methods starts with a thorough 
understanding of the analyte of interest.
1.5 BMAA ANALYSIS
1.5.1 Chemical properties of BMAA
BMAA is a small, polar compound with a molecular weight of 118.1 Da. BMAA is a basic 
amino acid, with pK values of 2.1 (carboxyl group), 6.5 and 9.7 (both amino groups) and 
a pI of 8.1 [86]. At physiological pH (7.4), the main fraction of BMAA will be a zwitterion 
[86]. At physiological pH and in the presence of bicarbonate, BMAA forms a carbamate that 
structurally resembles the neurotransmitter glutamate, which might explain why BMAA can 
activate glutamate receptors under physiological conditions [61] (Figure 1.3). BMAA can 
form complexes with metals, metal complexation is most pronounced at pH > 5 [87, 88]. 
BMAA does not have a chromophore and is colourless in solution. 
In addition to the free molecule described above (“free BMAA”) BMAA can also be present 
in bound forms in natural samples (Figure 1.4). The precursors of these bound forms still 
need to be identified. The structure of soluble bound BMAA is unknown, but in mussels, it 
appears to be a low molecular weight (< 3000 Da) compound in which BMAA is not bound 
with covalent peptide bonds [89]. And although precipitated bound BMAA is often referred 
to as “protein-associated” BMAA, the exact nature of the association of BMAA with proteins 
in natural tissues also needs to be elucidated. In vitro, BMAA can be incorporated into 
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proteins [65, 90], but in vivo experiments with bacteria do not show protein incorporation 
[91]. Whether protein incorporation also occurs in vivo is therefore still to be determined.
Free BMAA is commonly extracted with aqueous solvents, typically 0.1 M trichloroacetic 
acid (TCA) [70]. When the dried extract is hydrolysed, total soluble BMAA is obtained [92]. 
Finally, precipitated bound BMAA can be extracted by acid hydrolysis of the precipitate [70]. 
Total BMAA content, irrespective of its original form, is usually obtained by hydrolysis of the 
total sample (e.g. [93, 94]).
1.5.2. Analytical methods for BMAA analysis
Detection methods for BMAA in human tissue and environmental samples have evolved over 
the years and have been heavily debated (e.g. [77, 84, 88, 95]). In the past ten years, most 
analytical methods employed relied either on optical detection or on mass spectrometry 
(MS) detection [58]. As BMAA does not contain a chromophore, most methods based on 
optical detection, such as liquid chromatography coupled to fluorescence detection (LC-
FLD), require pre-column derivatisation with a chromophore containing reagent such as 
6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC, e.g. [34, 96]). This pre-column 
derivatisation has an additional advantage: the derivatised molecule is bigger and more 
hydrophobic, which facilitates reversed phase LC separation. A disadvantage of optical 
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Figure 1.3. A carbamate adduct of BMAA resembles glutamate. Based on [61].
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detection methods is that they are non-selective for BMAA, and therefore risk BMAA 
misidentification and overestimation [93]. In Box 1.1, the principles of the LC-FLD method 
using AQC derivatisation are explained.
Another approach to BMAA detection is mass spectrometry, and within this technique, 
liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is mostly applied 
for BMAA analysis [58]. When properly applied, LC-MS/MS is more selective than optical 
detection techniques [58, 93]. Although pre-column derivatisation of BMAA is not required 
for LC-MS/MS analysis, it is often used to enhance reversed phase separation. Commonly 
used derivatisation techniques in combination with LC-MS/MS analysis are AQC (e.g. [34, 
97, 98]), propyl chloroformate (e.g. [91, 99]) and dansyl chloride [100, 101]), see Box 1.2 for 
explanation of AQC derivatised LC-MS/MS analysis. LC separation of underivatised BMAA 
under reversed phase conditions is difficult due to the molecule’s low weight and high 
polarity. In underivatised LC-MS/MS analysis, hydrophilic liquid interaction chromatography 
(HILIC) is therefore usually employed (e.g. [76, 102, 103]). Box 1.3 explains the principles of 
the underivatised LC-MS/MS method.
When using LC-MS/MS based methods, it is important to distinguish between BMAA and 
its structural isomers such as 2,4-diaminobutyric acid (2,4-DAB, mostly referred to as DAB), 
N-(2-aminoethyl) glycine (AEG), ß-amino-N-methylalanine (BAMA) and 3,4-diaminobutyric 
acid (3,4-DAB) [97, 104]. Mostly, BMAA is chromatographically resolved from its structural 
isomers, but additional selectivity can be obtained by more advanced techniques such as 
differential mobility spectrometry [104]. Isotope dilution, e.g. by addition of deuterated 
BMAA [76] or DAB [105], is an often applied technique to improve BMAA quantification by 
LC-MS/MS.
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Figure 1.4. Different BMAA fractions in an aqueous extract. Free and soluble bound BMAA are 
found in the extract. Hydrolysis of the dried extract yields total soluble BMAA. Precipitated bound BMAA is found in 
the pellet created during extraction and can be released by hydrolysis. Total BMAA is the sum of all fractions and is 
usually obtained by hydrolysis of the total sample.
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Methods such as LC-FLD and LC-MS/MS require expensive equipment and an extensive 
sample workup. Faster and cheaper screening of surface waters for BMAA can be done with 
a commercial enzyme linked immunosorbent assay (ELISA), released in 2012. The principles 
of this assay are described in Box 1.4. ELISA uses the specific binding between the analyte (in 
this case BMAA) and an enzyme-labelled antibody for quantification. If the antibody used in 
the assay does not only bind to the intended analyte, but also to other sample components, 
the assay will create false positives or will overestimate analyte concentrations. As this so 
called cross reactivity is a common concern in ELISA, this assay is usually used for screening 
purposes only, and more selective analytical methods are used to verify positive results.
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Box 1.1. Principles of LC-FLD detection of BMAA.
Liquid chromatography coupled to a fluorescence 
detector (LC-FLD) uses the fluorescent properties of 
analytes for detection.
First, BMAA (red triangle) is extracted to release it 
from the sample cells. As BMAA does not contain a 
chromophore, a fluorescent tag needs to be added 
after extraction, a process called derivatisation. 
In the work presented in this thesis, the reagent 
6-aminoquinolyl-N-hydroxysuccinimidyl carbamate 
(AQC) is used. AQC reacts with primary and 
secondary amino groups [106], and as BMAA 
contains two amino groups, it is double derivatised.
Derivatised BMAA is bigger and less polar than the 
original molecule and can therefore be separated 
from other matrix compounds by reversed phase 
liquid chromatography.
The fluorescence detector records the emission 
signal of the AQC tag at 395 nm after excitation at 250 
nm. The emission wavelength is the same for all AQC 
derivatised compounds, and the method therefore 
only has two criteria for analyte identification: the 
presence of amino groups (i.e. the ability to react 
with AQC) and retention time. This means that 
selectivity of this method is low and that the chance that BMAA is misidentified or its 
concentration is overestimated is substantial, especially in samples in which compounds 
with amino groups are abundant. The green and blue triangles in the figure would in this 
case give an overlapping signal with BMAA and should either be removed during extraction 
or separated from BMAA during LC.
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Box 1.2. Principles of LC-MS/MS detection of BMAA following AQC derivatisation.
Liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) is a selective analytical method 
based on the on the detection of fragmented ions.
First, BMAA (red triangle) is extracted to release it from the 
sample cells. BMAA is then derivatised to enable reversed 
phase separation. In the work presented in this thesis, 
the reagent 6-aminoquinolyl-N-hydroxysuccinimidyl 
carbamate (AQC) is used. AQC reacts with primary and 
secondary amino groups [106], and as BMAA contains 
two amino groups, it is double derivatised.
Derivatised BMAA is bigger and less polar than the 
original molecule and can therefore be separated from 
other matrix compounds by reversed phase liquid 
chromatography.
Upon entering the MS/MS, the molecules are protonated 
and become ions (precursor ions). In the first mass filter, 
only ions with the same mass-to-charge ratio (m/z, the 
mass of the molecule divided by the charge obtained 
after protonation) as BMAA (m/z 459) are selected.
The ions that pass the first mass filter are subjected 
to collision-induced dissociation. In the collision cell, 
the ions break into distinct fragments. Under the right 
settings, the fragmentation pattern is reproducible and 
unique for each compound.
In the second mass filter, only product ions (fragments) 
characteristic of the analytes of interest are selected 
based on their m/z, these are the fragments that are detected. In the work presented in 
this thesis, the product ions m/z 171, 119 and 258 or 145 are used for BMAA identification.
LC-MS/MS has four criteria for analyte detection: retention time, m/z of the precursor ion, 
m/z of the product ions and the ratio between these product ions. Compounds that have a 
precursor with the same m/z after derivatisation and that (partly) give similar product ions 
as BMAA (green triangle, e.g. DAB) can interfere with the BMAA signal. These compounds 
need to be removed during extraction or separated from BMAA by LC before entering the 
MS/MS. 
 
Collision induced dissociation 
Mass filter 2 
Derivatised extract 
Reversed phase separation 
Mass filter 1 
Extract 
20 GENERAL INTRODUCTION
Box 1.3: Principles of LC-MS/MS detection of BMAA without derivatisation.
Liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) is a selective analytical 
method based on the detection of fragmented ions.
First, BMAA (red triangle) is extracted to release 
it from the sample cells. BMAA can be separated 
by LC without derivatisation. As BMAA is a small, 
polar compound, separation by reversed phase 
chromatography is difficult. In the work presented 
in this thesis, separation of underivatised BMAA 
from other compounds is therefore performed by 
hydrophilic interaction liquid chromatography (HILIC).
Upon entering the MS/MS, the molecules are 
protonated and become ions (precursor ions). In the 
first mass filter, only ions with the mass-to-charge 
ratio (m/z, the mass of the molecule divided by the 
charge obtained after protonation) of BMAA (m/z 
119.1) are selected.
The ions that pass the first mass filter are subjected 
to collision induced dissociation. In the collision cell, 
the ions break into distinct fragments. Under the right 
settings, the fragmentation pattern is reproducible 
and unique for each compound.
In the second mass filter, only product ions (fragments) characteristic of the analytes 
of interest are selected based on their m/z, these are the ions that are detected. In the 
work presented in this thesis, the product ions m/z 102.1, 88 and 76 are used for BMAA 
identification.
LC-MS/MS has four criteria for analyte detection: retention time, m/z of the precursor ion, 
m/z of the product ions and the ratio between the product ions. Compounds that have a 
precursor with the same m/z and that (partly) give similar product ions as BMAA (green 
triangle, e.g. DAB) can interfere with the BMAA signal. These compounds need to be 
removed during extraction or separated from BMAA by LC before entering the MS/MS.
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Box 1.4. Principle of BMAA detection by ELISA.
Enzyme Linked Immunosorbent Assay (ELISA) is an in vitro 
test based on binding affinity of the analyte to an antibody.
In the ELISA used in this thesis, a water sample or extract 
is added to a well of a microtiter plate. The bottom of each 
well is covered with antibodies (antibody 1 in figure). 
After addition of the sample, an enzyme conjugate and a 
second antibody are added (antibody 2 in figure). Antibody 
2 has a binding affinity for BMAA (red triangle) and the 
enzyme conjugate. Moreover, it can bind to antibody 
1. During incubation, BMAA and the enzyme conjugate 
compete for binding sites on antibody 2, while antibody 
2 reacts with antibody 1 and gets fixed to the bottom of 
the well.
During subsequent wash steps, the dissolved sample 
components, enzyme conjugates and antibodies that 
did not react and are therefore not fixed to the well, are 
removed.
Next, a substrate is added that gives a colour reaction with 
the enzyme conjugate. 
After incubation, the absorbance of each well is read at 450 
nm. The intensity of the well colour is inversely related to 
the amount of BMAA added to the well. ELISAs are generally 
fast, sensitive and relatively cheap methods. However, 
there’s a risk that other components bind to antibody 2 
(green diamond in figure). This so called cross-reactivity 
can cause false positive signals or analyte overestimation. 
Therefore, ELISAs are often used for screening purposes, 
and positive samples are subsequently analysed by more 
selective techniques.
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1.6 OBJECTIVES AND OUTLINE OF THE THESIS
In 2008, when the work for this thesis was started, literature on the occurrence of BMAA in 
aquatic system was scarce and BMAA was assumed to be present in nearly all cyanobacteria 
[33-36]. The initial aims of this thesis therefore were to investigate the presence of BMAA 
in Dutch aquatic systems, to determine its production under different environmental 
conditions, to determine its toxicity to zooplankton and to determine whether BMAA could 
accumulate in the aquatic food web. However, shortly after the first experiments for this 
thesis were started, negative results on BMAA in cyanobacteria were published [76, 78] and 
a heated discussion started, which mostly focussed on the use of analytical techniques (e.g. 
[77, 84, 95]). It then seemed more important to find out what had caused the differences in 
published results, and to find out which data on the presence of BMAA in aquatic systems 
were reliable. The focus of this thesis therefore changed, and as outlined below, most work 
was devoted to developing and selecting suitable analytical methods for BMAA analysis and 
reviewing BMAA literature in search for reliable data on the presence of BMAA in aquatic 
systems.
This thesis starts with a screening of Dutch urban waters for the presence of BMAA and 
DAB by LC-MS/MS without derivatisation. As shown in Chapter 2, BMAA was found in nine 
out of the 21 cyanobacteria dominated samples tested, at a maximum concentration of 
42 µg/g DW. The objective of the work presented in Chapter 3 was to find the causes of 
the discrepancy in published results. Three analytical methods were developed, one based 
on optical detection (LC-FLD) using AQC derivatisation, one LC-MS/MS method using 
AQC derivatisation and one underivatised LC-MS/MS method. It was shown that the LC-
FLD method risks misidentification of BMAA and might therefore overestimate BMAA 
concentrations in cyanobacterial samples. In Chapter 4, a commercially available ELISA 
kit for the analysis of BMAA was tested and it was shown to be highly cross-reactive and 
therefore unsuitable for the analysis of BMAA in water samples. Given the knowledge that 
results obtained by optical detection techniques and ELISA might be unreliable, a literature 
review described in Chapter 5 was performed. The aim of this review was to find out what 
we really know about the presence of BMAA in aquatic systems. From all reports on BMAA 
detection in aquatic systems, the studies that used appropriate analytical techniques and 
that properly reported their work were selected. In the studies that met these criteria, 
BMAA was either found in phytoplankton and higher aquatic organisms in concentrations 
in the ng/g DW to low µg/g DW range, or was not detected in studies that used analytical 
methods with detection limits in the µg/g DW range. As there now was sufficient evidence 
to assume that BMAA could be present in phytoplankton, the effects of BMAA exposure on 
the grazer D. magna were determined. In Chapter 6, trans generational effects of BMAA 
exposure on D. magna were investigated and it was found that BMAA was transferred from 
mother to offspring, and that the experimental animals did not adapt to BMAA exposure. 
Instead, two generations exposure led to higher brood mortality and lower neonate weight 
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than single generation exposure. The final work for this thesis consisted of organising and 
instructing a CYANOCOST initiated workshop on BMAA analysis. During this workshop, 
analytical methods for BMAA determination in a variety of matrices were discussed and 
tested, the results of which are presented in Chapter 7. Chapter 8 describes a standard 
operating procedure for LC-MS/MS analysis of underivatised BMAA in cyanobacteria and in 
Chapter 9, the work performed in this thesis is integrated and discussed.
“Aaah Aaah Aaah 
There’s something in the water, something in the water”
Brooke Fraser, Something in the water
CHAPTER 2
Presence of BMAA in duTch urBAn wATers
This chapter is based on: Determination of the neurotoxins BMAA (β-N-methylamino-
L-alanine) and DAB (α-,γ-diaminobutyric acid) by LC-MSMS in Dutch urban waters with 
cyanobacterial blooms. Faassen, E.J., Gillissen, F. Zweers, H.A.J. and Lürling, M., 2009. 
Amyotrophic Lateral Sclerosis, 10: 79-84.
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ABSTRACT 
We aimed to determine concentrations of the neurotoxic amino acids β-N-methylamino-
L-alanine (BMAA) and α-,γ-diaminobutyric acid (DAB) in mixed species scum material from 
Dutch urban waters that suffer from cyanobacterial blooms. BMAA and DAB were analysed 
in scum material without derivatisation by LC-MS/MS (liquid chromatography coupled to 
tandem mass spectrometry) using hydrophilic interaction liquid chromatography (HILIC). Our 
method showed high selectivity, good recovery of added compounds after sample extraction 
(86% for BMAA and 85% for DAB), acceptable recovery after sample hydrolysation (70% for 
BMAA and 56% for DAB) and acceptable precision. BMAA and DAB could be detected at an 
injected amount of 0.34 pmol. Free BMAA was detected in 9 of the 21 sampled locations at 
a maximum concentration of 42 µg/g DW. Free DAB was detected in 1 location at 4 µg/g DW. 
No protein-associated forms were detected. This study is the first to detect underivatised 
BMAA in cyanobacterial scum material using LC-MS/MS. Ubiquity of BMAA in cyanobacteria 
scums of Dutch urban waters could not be confirmed, where BMAA and DAB concentrations 
were relatively low; however, their co-occurrence with other cyanobacterial neurotoxins 
might pose a serious health risk, including chronic effects from low-level doses.
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2.1 INTRODUCTION
The non-protein amino acid β-N-methylamino-L-alanine (BMAA) is a neurotoxin [62, 64] that 
was identified first in cycad seeds [31, 46]. BMAA has been linked to the high incidence of the 
neurodegenerative disease amyotrophic lateral sclerosis/Parkinson dementia complex (ALS/
PDC) among the indigenous Chamorro people on the islands of Guam and Rota in the 1950s 
[43, 70, 71]. In 2003, Cox and co-workers reported that BMAA was produced by a symbiotic 
cyanobacterium (Nostoc sp.) within specialized roots of the cycad Cycas micronesica [32]. 
Subsequent analysis of cyanobacterial strains from different origins revealed that nearly all 
tested cyanobacteria contained BMAA [33, 36].
Cyanobacteria are ubiquitous, often flourishing in surface waters that have been over-
enriched with nutrients, where they may build massive blooms and form surface scums. 
Hence, there is a potential for widespread human exposure to BMAA [33]. This seems to 
be confirmed by analysis of scum material from surface waters in the UK that are used for 
drinking water and recreation [35].
The presence of BMAA in cyanobacteria has been demonstrated by detection of pre-column 
derivatised BMAA with at least five different analytical techniques, i.e. HPLC-FLD, UPLC-UV, 
LC-MS, LC-MS/MS and GC-MS [32-36, 107], and with an amino acid analyser, which uses 
post-column derivatisation [34]. Despite the multitude of analytical confirmations of BMAA 
in cyanobacteria, the validity of these data has recently been questioned because some of 
the methods used are not very specific for BMAA [76]. One study has tried to overcome 
this drawback by using multiple techniques on one sample [34]. In that study, low levels of 
BMAA are found in the tested cyanobacterial strain.
During (post- or pre-column) derivatisation, compounds other than BMAA will be derivatised 
as well, producing derivatiseds with similar optical properties as the BMAA derivatised. 
When applying optical detection techniques, the use of a confirmatory method such as LC-
MS/MS is therefore very important. Our paper extends current BMAA research by including 
a LC-MS/MS method for the detection of underivatised BMAA in cyanobacteria.
Interestingly, in a recent study using underivatised LC-MS/MS analysis, BMAA was not 
detected in cyanobacterial samples, but its isomer, the neurotoxic amino acid α-,γ-
diaminobutyric acid (DAB) was [76]. DAB had previously been found in association with 
BMAA in cycad tissues [42]. DAB also occurs in several species of the legume Lathyrus [108], 
in polymixin antibiotics [109] and the cell walls of some plant pathogenic bacteria [110].
Hence, most studies point to a potential exposure to cyanobacterial neurotoxic amino acids 
(BMAA and/or DAB) of people recreating in surface waters with cyanobacterial blooms. 
Therefore, the objective of this study was to determine concentrations of BMAA and DAB in 
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scum material from urban waters in The Netherlands that suffer from cyanobacterial blooms. 
Analysis was performed on a LC-MS/MS without derivatisation to ensure high selectivity.
2.2 MATERIAL AND METHODS
2.2.1 Sampling
Samples were taken from 21 urban waters with cyanobacterial blooms in the Netherlands. 
Sampling took place in 2006 and 2007, locations were visited once. Cyanobacterial scums 
were collected and dominant species were qualitatively determined by light microscopy. 
Subsequently, samples were lyophilized and stored up to 1.5 year at -20°C until further 
analysis.
2.2.2 Sample preparation
Sample preparation for LC-MS/MS analysis was based on Murch et al., 2004 [70], BMAA and 
DAB were analysed as free fractions and protein-associated fractions. The free fractions of 
0.5 mg sample were extracted with 150 μl 0.1 M trichloroacetic acid (TCA) for 48 hours at 4 
°C. After incubation, the samples were vortexed and centrifuged for 5 minutes at 15,800 × g. 
The supernatant was transferred to an Eppendorf tube and 150 μl 0.1 M TCA was added to 
the pellet. The sample was vortexed again and centrifuged. The supernatant was transferred 
to the Eppendorf tube, where both supernatant fractions were mixed. The supernatant was 
used for LC-MS/MS analysis of the free fractions. To obtain the protein-associated fractions, 
the pellet was dissolved in 200 μl hot 6N HCl, flushed with nitrogen gas for 1 minute and 
brought into vacuum. The pellet was hydrolysed for 20 hours at 112 °C. After hydrolysation, 
the samples were lyophilized for 24 hours. Finally, 200 μl 20 mM HCl was added to the 
lyophilized samples after which the protein-associated fractions could be analysed by LC-
MS/MS. Samples were either analysed directly after preparation or stored at -20 °C (up to 
one year) until analysis.
2.2.3 LC-MS/MS analysis
LC-MS/MS analysis was based on the procedure described by Rosén and Hellenäs [76]. The 
instruments used were an Agilent 1200 LC and an Agilent G6410A QQQ. Chromatography 
was performed on a 2.1*150 mm, 5 μm diameter ZIC-HILIC column (SeQuant, Sweden) with 
a Direct-Connect Filter (Grace Alltech). The mobile phase consisted of 65% acetonitrile, 35% 
water and 0.1% (v/v) formic acid. HPLC flow was 0.4 ml/min, injection volume 5 μl, column 
temperature 40 °C. The LC-MS/MS was operated in positive mode with an ESI source. 
Nitrogen was used as the drying and the collision gas. Both quadrupoles were operated in 
unit mode, fragmentor voltage was 50 V. In MRM mode, quadrupole 1 selected ions with a 
mass-to-charge ratio (m/z) of 119 and quadrupole 2 recorded the abundance of the following 
product ions: m/z 101 and 102 at 4 V collision energy, m/z 74, 76 and 88 at 8 V, m/z 73 at 10 
V, m/z 56 at 12 V and m/z 44 at 24 V. Calibration standards of BMAA (BMAA Hydrochloride, 
Sigma-Aldrich) and DAB (DAB Dihydrochloride, Sigma-Aldrich) were prepared on the day of 
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analysis. Calibration standards were dissolved in 0.1 M TCA for analysis of the free fractions 
and in 20 mM HCl for analysis of the protein-associated fractions.
We tested recovery by adding known amounts of BMAA and DAB (0.046 μg BMAA and 
0.042 μg DAB, dissolved in 20 μl water) to either a blank sample (no matrix) or to 0.5 mg 
cyanobacterial sample that did not contain detectable amounts of both analytes. BMAA and 
DAB were added at one of the four stages of sample preparation: 1) before TCA extraction, 
2) after TCA extraction, 3) before hydrolysis or 4) after hydrolysis (Figure 2.1). Sample 
preparation and LC-MS/MS analysis were performed as described above. Each addition 
was replicated 5 times. Recovery (R) was calculated as R = 100 × (m/s), where m is the 
measured amount and s is the spiked amount. The measured amount was calculated against 
a standard curve.
Hydrolysis pellet 
TCA extraction Analysis supernatant 
Sample 
1 
2 
3 
4 
Analysis solution of hydrolysed compounds 
Figure 2.1. Design of the recovery experiment. Numbers in circles indicate moments of BMAA 
and DAB addition during sample preparation: 1) to sample before TCA extraction, 2) to supernatant after TCA 
extraction, 3) to pellet before hydrolysis and 4) to solution of hydrolysed compounds.
2.3 RESULTS
BMAA and DAB were both detected at m/z 119 in a MS2 scan. BMAA and DAB were 
separated by retention time; the retention time of BMAA was shorter than that of DAB 
(Figure 2.2). Retention times for both compounds differed with the solvent used, retention 
times were shorter with TCA than with HCl. Furthermore, in both solvents the retention 
time of cyanobacterial samples was shorter than the retention time of calibration standards. 
This shift in retention time coincided with an increase in column pressure. In cyanobacterial 
samples, more peaks of the ion m/z 119 were present in the chromatogram, but because 
these peaks had a very short retention time, they did not interfere with the peaks of BMAA 
and DAB.
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Figure 2.2. LC-MS/MS chromatogram of a calibration standard containing 772 μg/l BMAA 
and 420 μg/l DAB, dissolved in 20 mM HCl. Solid lines indicate ions used for BMAA determination, 
dashed lines indicate ions for DAB determination. Bold lines indicate quantifier ions, normal lines indicate qualifier 
ions. Grey bars indicate retention times of BMAA and DAB.
For BMAA, m/z 102 was chosen as quantifier ion because it was the most abundant product 
ion. The ion m/z 102 is not unique to BMAA, it also occurs in the DAB signal (Figure 2.2). 
Product ions m/z 88 and m/z 76 were chosen as qualifier ions for two reasons. First, both 
ions had a relatively high abundance in the BMAA signal and were not detected in the 
DAB signal. Second, the background signal of these ions was low, so their ratio to m/z 102 
was constant even at low concentrations of BMAA (8 μg/l). The relative abundance of the 
qualifier ions to m/z 102 was 26% for m/z 88 and 27% for m/z 76. 
For DAB, m/z 101 was chosen as quantifier ion because it was the most abundant product 
ion. Product ion m/z 74 was chosen as qualifier ion for two reasons. First, it had a relatively 
high abundance in the DAB signal and was not detected in the BMAA signal. Second, it gave 
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the most constant signal at low levels of DAB (8 μg/l). The relative abundance of m/z 74 to 
m/z 101 was 23%.
The detection limit of the method is defined as the level at which the ratio quantifier ion/
qualifier ion(s) was within a 20% relative range of the expected value. This criterion was mostly 
met at a signal to noise level for the quantifier ion of 3. The detection limit of this method for 
both BMAA and DAB is 0.34 pmol injected on column. When 0.5 mg cyanobacterial sample 
is used for preparation, this leads to detection limits of approximately 4 μg/g DW for BMAA 
and DAB in the free fractions, 6 μg/g DW for BMAA in the protein-associated fraction and 
8 μg/g DW for DAB in the protein-associated fraction. The detection limits for the protein-
associated fractions are already corrected for loss during sample preparation and analysis 
(see below).
In the recovery experiment nearly all of the added BMAA and DAB was recovered in 
the blank samples (Table 2.1). In spiked cyanobacterial samples recovery of the added 
compounds was lower. Approximately 30% of BMAA was not recovered after hydrolysis. 
For DAB, losses occurred during hydrolysis and analysis of the protein-associated fraction. 
44% of the DAB that was added before hydrolysis was not recovered after measurement. 
For most treatments, the variation between replicates was relatively large with a SD varying 
between 2 and 12 (Table 2.1).
Table 2.1. Recovery (R, %) of BMAA and DAB added to blank and cyanobacterial samples 
during sample preparation: 1) to sample before TCA extraction, 2) to supernatant after TCA extraction, 3) to 
pellet before hydrolysis and 4) to solution of hydrolysed compounds. Amounts of added compounds are 0.046 μg 
BMAA and 0.042 μg DAB, dissolved in 20 μl water.
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Table 2.1.  (R, %) of BMA  and DAB added to blank d cyanob cteri l samples during 
sample pre aration: 1) to sample before TCA extraction, 2) to supernatant ft r TCA extraction, 3) to 
pellet before hydrolysis and 4) to solution of hydrolysed compounds. Amounts of added compounds 
are 0.046 μg BMAA and 0.042 μg DAB, dissolved in 20 μl water. 
Blank samples 
  R added BMAA (%) R added DAB (%) 
Moment of addition n Average  SD Average SD 
1) Before TCA extraction  5 103 5 97 5 
2) After TCA extraction 5 93 11 89 9 
3) Before hydrolysis  3 98 6 100 2 
4) After hydrolysis 4 112 9 104 10 
Cyanobacterial samples 
  R added BMAA (%) R added DAB (%) 
Moment of addition n Average  SD Average SD 
1) Before TCA extraction  5 86 9 85 10 
2) After TCA extraction 5 92 12 85 10 
3) Before hydrolysis  5 70 10 56 9 
4) After hydrolysis 4 110 5 77 3 
 
BMAA was detected in cyanobacterial scums in 9 of the 21 locations. DAB was detected in 1 location, 
where it co-occurred with BMAA (Table 2.2 and Figure 2.3). The highest measured BMAA 
concentration was 42 μg/g DW, DAB was found at a concentration of 4 μg/g DW. BMAA and DAB 
were only detected as free fractions, no BMAA and DAB were detected as protein-associated 
fractions. In eight of the nine samples in which BMAA was detected, filamentous cyanobacteria 
(Aphanizomenon, Dolichospermum, Planktothrix) were dominant or subdominant (Table 2.2). 
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location, where it co-occurred with BMAA (Table 2.2 and Figure 2.3). The highest measured 
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BMAA concentration was 42 μg/g DW, DAB was found at a concentration of 4 μg/g DW. 
BMAA and DAB were only detected as free fractions, no BMAA and DAB were detected as 
protein-associated fractions. In eight of the nine samples in which BMAA was detected, 
filamentous cyanobacteria (Aphanizomenon, Dolichospermum, Planktothrix) were dominant 
or subdominant (Table 2.2).
Table 2.2. Concentrations of free BMAA and DAB in cyanobacterial scums in Dutch urban 
waters and dominant and subdominant cyanobacteria in the scums.
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Table 2.2. Concentrations of free BMAA and DAB in cyanobacterial scums in Dutch urban waters 
and dominant and subdominant cyanobacteria in the scums. 
Location Sampling date [BMAA]1 
µg/g DW 
[DAB]1 
µg/g DW  
Dominant 
species2 
Subdominant 
Species2 
Nijmegen 18-7-2006 8 n.d. Do Pa 
Boxtel 24-7-2006 n.d. n.d. Wo  Ma, Mf, Do 
Bergen-op-Zoom 25-7-2006 4 n.d. Pa  
Grave 25-7-2006 n.d. n.d. Mf  Af 
Schijndel 25-7-2006 7 n.d. Ma  Wo 
St-Michielsgestel 25-7-2006 n.d. n.d. Wo  Ma, Do 
Etten Leur 27-7-2006 6 n.d. Ma Pa, Do 
Budel 1-8-2006 42 n.d. Do  
Deurne 1-8-2006 n.d. n.d. Ma  
Eindhoven 1-8-2006 n.d. n.d. Ma  
Wageningen 4-8-2006 n.d. n.d. Ma  Mf 
St-Oedenrode 1 1-9-2006 37 n.d. Af  Pa, Do, Ma 
Berkel-Enschot 18-10-2006 n.d. n.d. Gl  
St-Oedenrode 2 20-10-2006 4 n.d. Pa  Wo, Ma 
Tilburg 1 21-12-2006 6 4 Pa Wo 
Heikant 12-4-2007 n.d. n.d. Ag  
Arnhem 9-5-2007 n.d. n.d. Wo  Ma, Mf 
Beek en Donk 1-8-2007 4 n.d. Ma  Do 
Tilburg 2 8-8-2007 n.d. n.d. Wo  Ma 
Almere 28-8-2007 n.d. n.d. Ma  
Huizen 28-8-2007 n.d. n.d. Ma  
1 n.d. = not detected; 2 Af = Aphanizomenon flos-aquae; Ag = Aphanizomenon gracile; Do = 
Dolichospermum sp.; Gl = Gloeotrichia; Ma = Microcystis aeruginosa; Mf = Microcystis flos-aquae; Pa 
= Planktothrix agardhii; Wo = Woronichinia naegeliana. 
 
 
1 n.d. = not detected; 2 Af = Aphanizomenon flos-aquae; Ag = Aphanizomenon gracile; Do = Dolichospermum sp.; 
Gl = Gloeotrichia; Ma = Microcystis aeruginosa; Mf = Microcystis flos-aquae; Pa = Planktothrix agardhii; Wo = 
Woronichinia naegeliana.
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Figure 2.3. LC-MS/MS chromatogram of the free fraction of sample ‘Tilburg 1’ in 0.1 M 
TCA. Solid lines indicate ions used for BMAA determination; dashed lines indicate ions for DAB determination. Bold 
lines indicate quantifier ions, normal lines indicate qualifier ions. Grey bars indicate retention times of BMAA and 
DAB.
2.4 DISCUSSION
The results of this study clearly show that it is possible to detect and quantify underivatised 
BMAA and DAB in cyanobacteria dominated samples using LC-MS/MS. All three criteria 
for identification of the analytes [34] were met as both compounds could be identified 
by 1) the retention time, 2) the mass-to-charge ratio and 3) the ratio of product ions. Our 
results do not support the few recent studies that could not detect BMAA in cyanobacteria 
using a method without derivatisation [76, 78, 111], but also differ from those that used 
derivatisation techniques and found BMAA in nearly all cyanobacterial samples [33-36, 
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107]. The latter studies revealed BMAA levels ranging from a few to 276 µg/g DW in bloom 
samples and up to a few thousand µg/g DW in laboratory cultures in both free and protein-
associated fractions. In the present study, measured BMAA levels in mixed species scum 
samples were maximally a few dozen µg/g DW and BMAA was only detected in the free 
fraction.
This difference in concentration ranges could be caused by an underestimation of the free 
BMAA levels in this study. Scum samples were stored at -20°C for a year after preparation, 
but were thawed for a few days during this storage period. Stability of BMAA in the samples 
during storage has not been tested. However, it can also not be ruled out that other authors 
have overestimated BMAA levels in cyanobacteria due to the possible interference of other 
compounds during analysis [76].
It is unclear why in this study no protein-associated BMAA and DAB were detected in mixed 
species cyanobacterial scums from the Netherlands. Studies that use derivatisation have 
reported protein-associated BMAA in nearly every cyanobacterial sample [33-36, 107], in 
cycads [70, 112] and flying foxes [113]. DAB has been detected in hydrolysed cyanobacterial 
samples without derivatisation [76]. During this study, the original BMAA and DAB 
calibration standards in 20 mM HCl had remained stable. To check whether the lack of 
detection of protein-associated BMAA could have been caused by instability during storage, 
two laboratory strains and two cyanobacterial scums were hydrolysed and measured 
directly without storage. No BMAA or DAB were detected in these samples either. Another 
explanation for the absence of BMAA and DAB in the hydrolysed fractions could, therefore, 
be that the compounds were not released during hydrolysis in a free state, but reacted with 
other compounds within the matrix or solvent and could not be detected at m/z 119. For 
instance, complexation of metal ions with BMAA has been reported [87]. This process is 
unlikely to cause the total absence of signal in the hydrolysed fractions however, as most 
of the spiked BMAA and DAB could be recovered. BMAA and DAB might also have been 
incorporated in smaller peptides that were extracted with TCA but were not precipitated 
during centrifuging. This sort of association of non-protein amino acids with peptides is 
not unusual in cyanobacteria. The cyanobacterial toxins microcystins for example are 
heptapeptides that contain three unusual amino acids [114, 115]. Subsequent research will 
therefore include hydrolysation of the extraction solution, which will reveal whether BMAA 
and DAB are present in such small, extractable peptides. Finally, it is also possible that no 
protein-associated BMAA or DAB were present in concentrations exceeding the detection 
limits of 6 μg/g DW BMAA and 8 μg/g DW DAB.
This is the first study that detected BMAA in cyanobacteria without derivatisation; in 
contrast, a few recent studies could not detect BMAA in cyanobacteria using a method 
without derivatisation [76, 78, 111]. Possible reasons for the unsuccessful detection of 
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BMAA in those studies are a low sensitivity [111] and only a small number of samples tested 
[78]. Another recent LC-MS/MS study [76], however, reported a relatively high sensitivity 
and a wide range of analysed cyanobacterial samples. Differences between the results of 
that study and our study are difficult to explain. This discrepancy and other unexplained 
issues on levels and analysis of BMAA in cyanobacteria urge a comparative study where 
cyanobacterial samples are tested by different laboratories using different methods.
From this study it appears that BMAA and to a lesser extent DAB are present in relatively 
low concentrations in Dutch urban waters which suffer from cyanobacterial blooms. Health 
risks involved in the presence of these compounds are unclear because exposure is not 
quantified and dose-effect relations are not yet available. However, elevated BMAA levels 
have not only been detected in brain biopsies of Chamorros that died from ALS/PDC, but 
also in brain tissue of Northern Americans that died from Alzheimer’s disease and ALS, 
while no to very low concentrations of BMAA were detected in patients who had died of 
a non-neurodegenerative cause [71, 116]. Those results point towards a potential role of 
BMAA in human neurodegenerative disease outside Guam, in which cyanobacteria might 
be important players [39].
It is known that low concentrations of BMAA can enhance the effect of other neurotoxins at 
cellular level [64]. Also, BMAA co-occurs with the cyanobacterial neurotoxins DAB, anatoxin 
and saxitoxin [35]. We, therefore, advise further research be carried out on the synergistic 
effects of BMAA and other cyanobacterial neurotoxins.
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“Since different investigators using different methods have analysed different materials, 
it is difficult to determine the comparability of differing results”
Banack et al, 2010 Toxicon
CHAPTER 3
coMPArinG Three AnAlyTicAl 
MeThods for BMAA quAnTificATion
This chapter has been published as: A Comparative Study on Three Analytical Methods for 
the Determination of the Neurotoxin BMAA in Cyanobacteria. Faassen, E.J., Gillissen, F. and 
Lürling, M., 2012. PLoS ONE 7 (5).
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ABSTRACT
The cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) has been considered a 
serious health threat because of its putative role in multiple neurodegenerative diseases. First 
reports on BMAA concentrations in cyanobacteria were alarming: nearly all cyanobacteria 
were assumed to contain high BMAA concentrations, implying ubiquitous exposure. Recent 
studies however question this presence of high BMAA concentrations in cyanobacteria. 
To assess the real risk of BMAA to human health, this discrepancy must be resolved. We 
therefore tested whether the differences found could be caused by the analytical methods 
used in different studies.
Eight cyanobacterial samples and two control samples were analysed by three commonly 
used methods: HPLC-FLD analysis and LC-MS/MS analysis of both derivatised and 
underivatised samples. In line with published results, HPLC-FLD detected relatively high 
BMAA concentrations in some cyanobacterial samples, while both LC-MS/MS methods only 
detected BMAA in the positive control (cycad seed sarcotesta). Because we could eliminate 
the use of different samples and treatments as causal factors, we demonstrate that the 
observed differences were caused by the analytical methods.
We conclude that HPLC-FLD overestimated BMAA concentrations in some cyanobacterial 
samples due to its low selectivity and propose that BMAA might be present in (some) 
cyanobacteria, but in the low μg/g or ng/g range instead of the high μg/g range as sometimes 
reported before. We therefore recommend to only use selective and sensitive analytical 
methods like LC-MS/MS for BMAA analysis. Although possibly present in low concentrations 
in cyanobacteria, BMAA can still form a health risk. Recent evidence on BMAA accumulation 
in aquatic food chains suggests human exposure through consumption of fish and shellfish 
which expectedly exceeds exposure through cyanobacteria.
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3.1 INTRODUCTION
The neurotoxic amino acid β-N-methylamino-L-alanine (BMAA) has been linked to 
neurodegenerative diseases as Alzheimer’s disease (AD), Parkinson’s disease (PD) and 
amyotrophic lateral sclerosis (ALS) [37]. BMAA was first identified in 1967 in the seeds of the 
cycad Cycas micronesica [31] in a survey on the cause of the high incidence of ALS, PD and 
dementia on Guam [117]. The possible etiological role of BMAA in this neurodegenerative 
disease was at first disputed [118], but was recently resurrected by the discovery of high 
concentrations of BMAA in the protein associated fraction of the cycad seeds and its 
biomagnification in the Guamanian food chain [32, 70, 113, 119]. Furthermore, the finding of 
BMAA in the brains of people who had died with AD, ALS or PD outside Guam pointed towards 
a wider occurrence of BMAA [69, 71]. The detection of BMAA in the cyanobacterium Nostoc 
sp. that lives in symbiosis with the cycads [32] prompted the screening of cyanobacteria 
from all over the world for BMAA [33, 35, 36, 76, 77, 83, 94, 102, 107, 111, 120-122].
First reports on BMAA concentrations in cyanobacteria were alarming: high concentrations 
of BMAA were detected in nearly all tested free living laboratory strains [33], field isolates 
[36], field samples [35] and symbiotic species [33] (Table 3.1). In contrast, all but one [121] 
later studies could not reproduce these first results; BMAA was either not detected in 
cyanobacteria (e.g. [76, 77]), detected in some, yet not all, samples [102] or detected in all 
samples, but at very low concentrations [83]. The suggestion that BMAA might have been 
confused with its structural isomer α,γ-diaminobutyric acid (DAB) in the early studies [77] 
could be refuted [84].
Table 3.1. Overview of studies that analysed more than eight samples of free living 
cyanobacteria for BMAA.
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acid (DAB) in the early studies [77] could be refuted [84]. 
Table 3.1. Overview of studies that analysed more than eight samples of free living cyanobacteria 
for BMAA. 
Tested 
samples 
Fraction 
samples 
positive for 
BMAA 
BMAA concentration in 
positive samples a 
Analytical 
quantification 
method 
Derivatisation 
method 
Reference 
(n) (-) (µg/g DW) 
8 1.00 402 (190-1110) CE None [121] 
30 0.97 968 (10-6721) HPLC-FLD AQC b [33] 
12 1.00 103 (8-287) HPLC-FLD AQC [35] 
27 0.96 129 (0.1-2757) GC-MS EZ:faast [36] 
21 1.00 6.6*10-3 (1*10-3-15*10-3) LC-MS/MS AQC [83] 
20 0.95 1.35 (0.05-10.7) LC-MS EZ:faast [122] 
21 0.42 13 (4-42) LC-MS/MS None [102] 
36 0.00 - LC-MS/MS None [76] 
30 0.00 - LC-MS/MS None [77] 
a BMAA concentration is the sum of the free and protein associated concentrations. Values are 
averages, followed by minimum and maximum concentrations between brackets. b AQC: 6-
aminoquinolyl-N-hydroxysuccinimidyl carbamate 
Nonetheless there is still little consensus on BMAA concentrations in cyanobacteria. Cyanobacteria 
are ubiquitous and multiple routes of human exposure to cyanobacteria and their toxins exist [123]. 
It is therefore very important for human risk assessment to find the cause of the discrepancy in 
published results on BMAA concentrations in cyanobacteria. 
Several factors underlie the different studies. Researchers have used different samples, different 
sample treatments and different analytical methods [84]. However, the differences in results seem to 
be related to the analytical method used. High BMAA concentrations and high percentages of 
positives samples were found only in those studies that had used high performance liquid 
chromatography with fluorescence detection (HPLC-FLD), gas chromatography with mass 
spectrometry detection (GC-MS) or capillary electrophoresis (CE) for quantification (Table 3.1). On 
the other hand, studies that had used high performance liquid chromatography with tandem mass 
spectrometry detection (LC-MS/MS) for quantification either did not detect BMAA, or reported lower 
BMAA concentrations (Table 3.1). Therefore, we hypothesized that different analytical methods for 
the determination of cyanobacterial BMAA deviate in their results. To test the hypothesis, we 
analysed a set of cyanobacterial and control samples with three analytical methods: HPLC-FLD, LC-
MS/MS of derivatised samples and LC-MS/MS of underivatised samples. The observed differences in 
our study were comparable to the observed differences in literature and were caused by 
overestimation of BMAA concentrations by HPLC-FLD. 
a BMA  concentration is the sum of the free and protein associated concentratio s. Values are averages, followed 
by minimum and maximum concentrations between brackets. b AQC: 6-aminoquinolyl-N-hydroxysuccinimidyl 
carbamate
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Nonetheless there is still little consensus on BMAA concentrations in cyanobacteria. 
Cyanobacteria are ubiquitous and multiple routes of human exposure to cyanobacteria and 
their toxins exist [123]. It is therefore very important for human risk assessment to find the 
cause of the discrepancy in published results on BMAA concentrations in cyanobacteria.
Several factors underlie the different studies. Researchers have used different samples, 
different sample treatments and different analytical methods [84]. However, the differences 
in results seem to be related to the analytical method used. High BMAA concentrations 
and high percentages of positives samples were found only in those studies that had used 
high performance liquid chromatography with fluorescence detection (HPLC-FLD), gas 
chromatography with mass spectrometry detection (GC-MS) or capillary electrophoresis (CE) 
for quantification (Table 3.1). On the other hand, studies that had used high performance 
liquid chromatography with tandem mass spectrometry detection (LC-MS/MS) for 
quantification either did not detect BMAA, or reported lower BMAA concentrations (Table 
3.1). Therefore, we hypothesized that different analytical methods for the determination 
of cyanobacterial BMAA deviate in their results. To test the hypothesis, we analysed a set 
of cyanobacterial and control samples with three analytical methods: HPLC-FLD, LC-MS/MS 
of derivatised samples and LC-MS/MS of underivatised samples. The observed differences 
in our study were comparable to the observed differences in literature and were caused by 
overestimation of BMAA concentrations by HPLC-FLD.
3.2 RESULTS
3.2.1 Method validation
Before sample analysis, all three methods were validated. Results of method validation are 
shown in Table 3.2. LC-MS/MS analysis of samples was performed with deuterium labelled 
BMAA (D
3
BMAA) as an internal standard. However, the validation of both LC-MS/MS 
methods was performed without correction for the internal standard to make comparison 
with the HPLC-FLD method possible. HPLC-FLD response was linear up to a concentration 
of 1000 µg/l, while both LC-MS/MS responses were linear up to 500 µg/l (Table 3.2). When 
corrected for the response of D
3
BMAA however, the LC-MS/MS methods showed a broader 
range of linearity (Figure A3.1). For all three methods, the fit of the regression line was good 
(r2 > 0.999).
Detection and quantification limits of calibration standards were within the same range for 
all three methods. For the LC-MS/MS methods, the limit of detection (LOD) often equalled 
the limit of quantification (LOQ). This is possible because for these methods, LOD is defined 
as the lowest concentration where the signal-to-noise (S/N) ratio of all product ions is at 
least 3:1 and the ratio of the qualifier ion(s) to the quantifier ion is within a 20% relative 
range. The conditions for the ratio of the qualifier ions to the quantifier ion or for the S/N 
of the qualifier ions are often only met at a S/N ratio of the quantifier ion of 10:1, in which 
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case the criteria for LOQ are also met. Chromatograms of LODs in samples are shown in 
Figure A3.2. Detection limits in samples are higher for both derivatised methods than for 
underivatised LC-MS/MS analysis. This is due to the dilution during derivatisation (both 
extracts and hydrolysed samples) and the extra dilution that is needed in the hydrolysed 
samples to ensure effective derivatisation [124, 125]. A single LOD or LOQ of free BMAA in 
samples could not be determined for the HPLC-FLD method. The extracts of cyanobacterial 
samples showed many low peaks around the retention time of BMAA, which made a good 
estimation of the position of the baseline difficult. For each sample, the pattern of these 
peaks was different, so no universal LOD or LOQ could be derived. This problem did not occur 
in the hydrolysed samples, these chromatograms all showed fewer but higher peaks, with 
a better definable baseline for BMAA. Because baseline variation was higher for HPLC-FLD 
analysis than for LC-MS/MS analysis of derivatised samples, detection and quantification 
limits of the latter method in samples were lower. Underivatised LC-MS/MS was the most 
sensitive method for analysis of both extracted and hydrolysed samples.
Interday and intraday precision was good for all three methods; underivatised LC-MS/MS 
analysis was most precise. Inter workup of hydrolysed samples analysed by HPLC-FLD 
Table 3.2. Validation results of the three used methods, both LC-MS/MS methods are 
validated without correction for the internal standard D3BMAA.
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3.2 Results 
 
3.2.1 Method validation 
 
Before sample analysis, all three methods were validated. Results of method validation are shown in 
Table 3.2. LC-MS/MS analysis of samples was performed with deuterium labelled BMAA (D3BMAA) as 
an internal standard. However, the validation of both LC-MS/MS methods was performed without 
correction for the internal standard to make comparison with the HPLC-FLD method possible. HPLC-
FLD response was linear up to a concentration of 1000 µg/l, while both LC-MS/MS responses were 
linear up to 500 µg/l (Table 3.2). When corrected for the response of D3BMAA however, the LC-
MS/MS methods showed a broader range of linearity (Figure A3.1). For all three methods, the fit of 
the regression line was good (r2 > 0.999). 
 
Table 3.2. Validation results of the three used methods, both LC-MS/MS methods are validated 
without correction for the internal standard D3BMAA. 
  HPLC-FLD LC-MS/MS 
derivatised 
LC-MS/MS 
underivatised 
Linearity a     
Lowest concentration µg/l 15 5 7.5 
Highest concentration µg/l 1000 500 500 
Number of concentrations in tested range - 6 8 9 
r2 - 0.999 0.999 0.999 
     
Detection and quantification limits     
LOD calibration standard fmole/injection 68 85 106 
LOQ calibration standard fmole/injection 102 85 317 
LOD sample extract µg/g * 1.0 0.4 
LOD sample hydrolysed µg/g 40 10.0 1.6 
LOQ sample extract µg/g * 1.0 0.4 
LOQ sample hydrolysed µg/g 120 10.0 1.6 
     
Precision     
Intraday precision (n=6), response Relative SD (%) 2.8 3.0 0.7 
Intraday precision (n=6), RT Relative SD (%) 0.0 0.1 0.1 
Interday precision (n=12), response Relative SD (%) 4.6 5.0 1.9 
Interday precision (n=12), RT Relative SD (%) 0.1 0.0 0.2 
Inter workup (n=12) extract, response Relative SD (%) 8.6 6.7 7.1 
Inter workup (n=12) extract, RT Relative SD (%) 0.1 0.0 0.4 
Inter workup (n=12) hydrolysed, response Relative SD (%) 17.0 10.6 b 6.1 
Inter workup (n=12) hydrolysed, RT Relative SD (%) 0.1 0.1 b 0.1 
LOD: limit of detection, LOQ: limit of quantification, RT: retention time, a each concentration is 
injected in triplicate, b n=11, * not determined (see text) 
 
Detection and quantification limits of calibration standards were within the same range for all three 
methods. For the LC-MS/MS methods, the limit of detection (LOD) often equalled the limit of 
quantification (LOQ). This is possible because for th se methods, LOD is defined as the low st 
concentration where the signal-to-noise (S/N) ratio of all product ions is at least 3:1 and the ratio of 
the qualifier ion(s) to the quantifier ion is within a 20% relative range. The conditions for the ratio of 
LOD: limit of detection, LOQ: limit of quantification, RT: retention time, a each concentration is injected in triplicate, 
b n=11, * not determined (see text)
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showed an unexplainable high variation. Retention times in HPLC-FLD analysis were sensitive 
to variations in the buffer solution. This resulted in retention time differences between runs 
of maximum 0.3 min. Within runs, retention times were stable (Table 3.2).
Of the samples that were spiked before extraction, between 83.6 and 86.8% of the expected 
signal was recovered. Samples that were spiked before hydrolysis showed a lower recovery: 
between 46.7 (HPLC-FLD) and 69.3% (underivatised LC-MS/MS, Table 3.3).
Table 3.3. Recovery (%) of extraction and hydrolysis, analysed by the three different 
methods.
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the qualifier ions to the quantifier ion or for the S/N of the qualifier ions are often only met at a S/N 
ratio of the quantifier ion of 10:1, in which case the criteria for LOQ are also met. Chromatograms of 
LODs in samples are shown in Figure A3.2. Detection limits in samples are higher for both derivatised 
methods than for underivatised LC-MS/MS analysis. This is due to the dilution during derivatization 
(both extracts and hydrolysed samples) and the extra dilution that is needed in the hydrolysed 
samples to ensure effective derivatization [124, 125]. A single LOD or LOQ of free BMAA in samples 
could not be determined for the HPLC-FLD method. The extracts of cyanobacterial samples showed 
many low peaks around the retention time of BMAA, which made a good estimation of the position 
of the baseline difficult. For each sample, the pattern of these peaks was different, so no universal 
LOD or LOQ could be derived. This problem did not occur in the hydrolysed samples, these 
chromatograms all showed fewer but higher peaks, with a better definable baseline for BMAA. 
Because baseline variation was higher for HPLC-FLD analysis than for LC-MS/MS analysis of 
derivatised samples, detection and quantification limits of the latter method in samples were lower. 
Underivatised LC-MS/MS was the most sensitive method for analysis of both extracted and 
hydrolysed samples. 
 
Interday and intraday precision was good for all three methods; underivatised LC-MS/MS analysis 
was most precise. Inter workup of hydrolysed samples analysed by HPLC-FLD showed an 
unexplainable high variation. Retention times in HPLC-FLD analysis were sensitive to variations in the 
buffer solution. This resulted in retention time differences between runs of maximum 0.3 min. 
Within runs, r tention tim s wer  stable (Table 3.2). 
 
Of the samples that were spiked before extraction, between 83.6 and 86.8% of the expected signal 
was recovered. Samples that were spiked before hydrolysis showed a lower recovery: between 46.7 
(HPLC-FLD) and 69.3% (underivatised LC-MS/MS, Table 3.3). 
 
Table 3.3. Recovery (%) of extraction and hydrolysis, analysed by the three different methods. 
 Extraction Hydrolysis 
 average SD n average SD n 
HPLC-FLD 86.8 10.1 12 46.7 8.5 12 
LC-MS/MS derivatised a 83.6 5.5 12 68.6 6.8 11 
LC-MS/MS underivatised a 85.5 5.9 12 69.3 4.2 12 
a recovery is calculated for D3BMAA 
 
All three methods separated BMAA from its isomer DAB (Figure 3.1).  
 
a recovery is cal ulated for D
3
BMAA
All three methods separated BMAA from its isomer DAB (Figure 3.1). 
Figure 3.1. Chromatograms of the three analytical methods showing calibration standards 
and an extracted cyanobacterial sample. Panels A - C show calibration standards, panels D - F show the 
extracted Dolichospermum field scum. The green line in panel D represents the unspiked cyanobacterial sample, 
the blue line indicates the same sample, but spiked with BMAA before extraction. Coloured lines in panels B and E 
represent the transitions of ions with a mass-to-charge ratio (m/z) of 459 to m/z 171 (blue), 119 (green), 145 (pink) 
and 315 (orange). Coloured lines in panels C and F represent the transitions of m/z 119.1 to m/z 102.1 (blue), 88 
(pink), 76 (green), 101 (grey) and 74 (orange). Transitions for D
3
BMAA are not shown.
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3.2.2 BMAA in samples
Analysis of the same samples by the three methods yielded different results (Table 3.4). 
Both LC-MS/MS methods only indicated BMAA in the positive control, the sarcotesta of the 
cycad seed. HPLC-FLD however indicated BMAA not only in the cycad seed, but also in three 
of the eight cyanobacterial samples.
Table 3.4. Free and total BMAA concentrations (µg/g DW, average and SD, n=3) in control 
and cyanobacterial samples as analysed by three different methods.
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Table 3.4. Free and total BMAA concentrations (µg/g DW, average and SD, n=3) in control and 
cyanobacterial samples as analysed by three different methods. 
 HPLC-FLD LC-MS/MS derivatised LC-MS/MS underivatised 
 Free Total Free Total Free Total 
Controls       
S. obliquus SAG 276/3a (neg) n.d. n.d. n.d. n.d. n.d. n.d. 
Cycad seed sarcotesta (pos) 18.2 (1.4) d. 8.8 (3.0) 104.9 (4.5) 10.7 (2.9) 75.0 (10.8) 
Field scums       
Dolichospermum  21.7 (3.1) n.d. n.d. n.d. n.d. n.d. 
P. rubescens 6.3 (0.8) n.d. n.d. n.d. n.d. n.d. 
Aphanizomenon n.d. n.d. n.d. n.d. n.d. n.d. 
Microcystis n.d. n.d. n.d. n.d. n.d. n.d. 
Lab strains       
C. raciborskii CS-1 n.d. n.d. n.d. n.d. n.d. n.d. 
A. flos-aquae CCAP 1401/7 56.2a d. n.d. n.d. n.d. n.d. 
D. flos-aquae CCAP 1409/2A n.d. n.d. n.d. n.d. n.d. n.d. 
M. aeruginosa NIVA CYA 228/1 n.d. n.d. n.d. n.d. n.d. n.d. 
n.d.: not detected, d.: detected but below limit of quantification, a n=2 
 
Of the three methods used, HPLC-FLD has the highest detection limit for BMAA in samples. All BMAA 
concentrations as determined by HPLC-FLD were therefore far above the detection limit of both LC-
MS/MS methods (Tables 3.2 and 3.4). If samples indeed contained BMAA concentrations as high as 
indicated by HPLC-FLD, both LC-MS/MS methods should have detected BMAA as well. 
 
Free BMAA concentrations in the cycad seed sarcotesta were in the same range for all three 
methods. Total BMAA was also detected in the cycad seed by all three methods, but was below the 
LOQ for HPLC-FLD (Table 3.4). 
 
3.3 Discussion 
 
We clearly showed that the determined BMAA concentrations in some cyanobacterial samples varied 
depending on the analytical method used. The three methods only indicated similar BMAA 
concentrations in the positive control, the sarcotesta of a cycad seed. Since we have used the same 
samples and employed identical sample treatments, sample origin and treatment could be 
eliminated as possible causal factors [84] of the observed differences. The differences in BMAA 
concentrations can therefore only be attributed to the analytical methods, and are roughly in line 
with the observed discrepancy in published results (Table 3.1). 
 
HPLC-FLD identified BMAA in three out of eight cyanobacterial samples, while both LC-MS/MS 
methods did not detect any BMAA in cyanobacteria. These differences are most likely due to the low 
selectivity of the HPLC-FLD. HPLC-FLD is less selective than both LC-MS/MS methods, it has only two 
selection criteria: retention time and fluorescence signal. Because BMAA does not have fluorescent 
properties, derivatization with the fluorescent AQC was necessary for detection by HPLC-FLD. Both 
retention time and fluorescence signal are properties of the derivative of an analyte, instead of the 
analyte itself and any compound that reacts with AQC gives the same fluorescence signal after 
derivatization. AQC reacts with primary and secondary amino groups [106, 126], which means that it 
reacts with all amino acids and other amino group containing compounds. There are hundreds of 
naturally occurring amino acids [127], so there is always a chance that a derivatised compound other 
n.d.: not det cted, .: detected but below limit of quantification, a n=2
Of the three methods used, HPLC-FLD has the highest detection limit for BMAA in samples. 
All BMAA concentrations as determined by HPLC-FLD were therefore far above the detection 
limit of both LC-MS/MS methods (Tables 3.2 and 3.4). If samples indeed contained BMAA 
concentrations as high as indicated by HPLC-FLD, both LC-MS/MS methods should have 
detected BMAA as well.
Free BMAA concentrations in the cycad seed sarcotesta were in the same range for all three 
methods. Total BMAA was also detected in the cycad seed by all three methods, but was 
below the LOQ for HPLC-FLD (Table 3.4).
3.3 DISCUSSION
We c arly showed tha  the dete mined BMAA concentrations i some cyanobacterial 
samples varied depending on the analytical method used. The three methods only indicated 
similar BMAA concentrations in the positive control, the sarcotesta of a cycad seed. Since we 
have used the same samples and employed identical sample treatments, sample origin and 
treatment could be eliminated as possible causal factors [84] of the observed differences. 
Th  differences in BMAA concentrations can therefore only b  attribute  to the analytical 
methods, and are roughly in line with the observed discrepancy in published results (Table 
3.1).
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HPLC-FLD identified BMAA in three out of eight cyanobacterial samples, while both 
LC-MS/MS methods did not detect any BMAA in cyanobacteria. These differences are 
most likely due to the low selectivity of the HPLC-FLD. HPLC-FLD is less selective than both 
LC-MS/MS methods, it has only two selection criteria: retention time and fluorescence signal. 
Because BMAA does not have fluorescent properties, derivatisation with the fluorescent 
AQC was necessary for detection by HPLC-FLD. Both retention time and fluorescence 
signal are properties of the derivatised of an analyte, instead of the analyte itself and any 
compound that reacts with AQC gives the same fluorescence signal after derivatisation. AQC 
reacts with primary and secondary amino groups [106, 126], which means that it reacts 
with all amino acids and other amino group containing compounds. There are hundreds 
of naturally occurring amino acids [127], so there is always a chance that a derivatised 
compound other than BMAA has the same or a similar retention time as the BMAA 
derivatised. If such a compound is present in a sample, it leads to misidentification and 
subsequent overestimation of BMAA concentrations in that sample. HPLC-FLD is therefore 
an uncertain method for amino acid analysis in complex biological matrices that contain 
non-protein amino acids or other compounds with an amino group [106], especially when 
the analyte is present in low concentrations. 
LC-MS/MS is a more selective method than HPLC-FLD because it has four selection criteria: 
retention time, mass-to-charge ratio (m/z) of the precursor ion (the charged ‘original’ 
molecule), m/z of the product ions after collision induced dissociation and the ratio 
between the abundance of the product ions. The chance of compound misidentification by 
LC-MS/MS is therefore much smaller than by HPLC-FLD. In our study, LC-MS/MS peaks were 
only identified as BMAA when all four criteria were met.
The discrepancy in the results could not be caused by other factors like method sensitivity 
or difference in sample treatment (derivatisation versus underivatised analysis). In our 
study, the least sensitive method (HPLC-FLD) gave more positive results than the more 
sensitive LC-MS/MS methods. Quantification by LC-MS/MS was reliable because we used 
D
3
BMAA as an internal standard in all samples [76], resulting in unbiased estimates of 
BMAA concentrations in samples, also in low concentrations (Figure A3.3). The observed 
differences in results can therefore not be explained by differences in method sensitivity. 
Also derivatisation cannot explain the differences in results, because both derivatised 
methods (HPLC-FLD and LC-MS/MS analysis of derivatised samples) varied in their outcome. 
It has been suggested that (underivatised) HILIC LC-MS/MS analysis is less suitable for BMAA 
detection than LC-MS/MS analysis after derivatisation [84], but our study does not support 
this hypothesis as underivatised LC-MS/MS analysis was in our case more precise and 
more sensitive for samples than derivatised LC-MS/MS analysis (Table 3.2). Furthermore, 
the warning that the signal of methionine methylsulphonium might interfere with that of 
BMAA in underivatised LC-MS/MS analysis [95] is unnecessary, because this compound has 
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a different molecular weight than BMAA and its signal will therefore not be picked up in 
MRM analysis. We conclude that the most likely cause of the differences in our experiment 
is that HPLC-FLD has misidentified another amino containing compound as BMAA in some 
samples and consequently has overestimated BMAA concentrations in these samples.
From our study, it cannot be determined which compound has mistakenly been identified 
as BMAA by HPLC-FLD analysis. While attempts have been made to exclude compounds 
from being possibly interfering in various methods of BMAA analysis [84, 95], these 
studies only focus on a few compounds, mostly diamino acids. The possible similarity of 
the fragmentation pattern of diamino acids with that of BMAA makes these compounds 
likely candidates for interference with mass spectrometry analyses. The compounds tested 
in these two studies did not interfere with the BMAA signal in most tested methods, only 
one compound co-eluted in an UHPLC-UV/MS method [95]. However, the list of possible 
interfering compounds in HPLC-FLD analysis is much larger and also includes compounds 
with only one amino group. These two studies can therefore not be used to identify possibly 
interfering compounds in previously performed HPLC-FLD analyses. Furthermore, different 
chromatographic conditions can result in different interfering compounds, which means that 
the compound that has mistakenly been identified in our study, can be another compound 
than the one that has interfered in other studies.
The average BMAA concentrations found by HPLC-FLD in this study are lower than 
concentrations found in free living cyanobacteria by previous studies that used HPLC-FLD 
for quantification [33, 35] (Table 3.1). Furthermore, in our study BMAA was identified in 
only three of the eight tested cyanobacterial samples, while the other HPLC-FLD studies 
report presence of BMAA in nearly all tested cyanobacteria. Again, this is most likely due 
to the differences in chromatographic conditions between the studies. Although presence 
of BMAA has been confirmed by LC-MS/MS in the early HPLC-FLD based studies, BMAA 
concentrations determined by these LC-MS/MS analyses have not been reported [33, 
35]. It is therefore unknown whether the concentrations found by HPLC-FLD matched the 
concentrations found by LC-MS/MS in these studies. Also in the only other study, so far, 
that compared different analytical methods, BMAA concentrations based on LC-MS(/MS) 
analyses were not reported [34]. 
Certainly, variations in BMAA concentrations found in different studies may not only be 
caused by the use of different analytical methods. BMAA concentrations may also differ 
as a result of the origin or growth conditions of the cyanobacteria, which is the case for 
most other cyanobacterial toxins [128]. An attempt has been made to determine conditions 
under which cyanobacteria produce BMAA [99], but much work is still needed to understand 
BMAA production. Origin and growth conditions cannot explain the incongruity observed in 
our study because we analysed the same material with different analytical methods. So, 
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although the high BMAA concentrations measured in the early studies may indeed have 
resulted from samples that contained high amounts of BMAA, it is more plausible that they 
are an artefact of the HPLC-FLD method. Our results suggest that BMAA is not present in 
high concentrations in cyanobacteria. Presence of lower concentrations of BMAA (low μg/g 
DW or ng/g DW) in (some) cyanobacteria is more likely and could also explain why BMAA 
is detected by some selective methods with high sensitivity [83, 94] and is not detected 
[76, 77, 111] or detected only in a number of samples [102] by studies that have a lower 
sensitivity.
Our study only focused on three analytical methods and can therefore not explain other 
discrepancies in published BMAA concentrations than those between HPLC-FLD and 
(derivatised or underivatised) LC-MS/MS analysis. More work is for instance needed to 
explain the differences in concentrations found in cyanobacterial field isolates from similar 
regions and grown under similar condition that were analysed by the same group by GC-MS 
and LC-MS [36, 122]. Also the high concentrations found by CE analysis [121] are interesting, 
even though the authors of this last manuscript acknowledge that the selectivity of their 
method is low. In general, comparison of the quantitative results of different studies is 
hampered by the absence of recovery and validation data in many publications.
Even if BMAA concentrations in cyanobacteria are low, BMAA can still pose a threat 
to human health. First, BMAA has the ability to accumulate in food chains. In the Baltic 
sea, BMAA concentrations in zooplankton, shellfish and bottom-dwelling fish species are 
up to 200 fold higher than in the local cyanobacteria [83]. Moreover, laboratory studies 
have shown that the zooplankton species Daphnia magna is able to take up BMAA from its 
surrounding medium, thereby bioconcentrating BMAA up to 3800 times [129]. Presence of 
BMAA in the aquatic food chain means that people are not only exposed to BMAA by direct 
contact with cyanobacteria, but also through food. Exposure through food may extent over 
a larger area and a larger period of time than exposure through cyanobacteria. The dose of 
BMAA obtained through food might therefore exceed the dose obtained directly through 
cyanobacteria. Second, in addition to its own neurotoxicity, BMAA can also enhance the 
effect of other neurotoxins [64]. The additive effect of BMAA with other cyanobacterial 
neurotoxins has not been evaluated yet, but BMAA sometimes occurs simultaneously with 
the neurotoxins DAB [102], anatoxin-a and saxitoxin [35] and synergistic toxicity cannot on 
forehand be excluded.
We conclude that in our study HPLC-FLD overestimated BMAA concentrations in some 
cyanobacterial samples due to its low selectivity. Cyanobacterial BMAA concentrations 
seem to be overestimated in some previous studies as well and are more likely to be in the 
low μg/g DW or even in the ng/g DW range than in the high μg/g DW range as sometimes 
reported. We therefore recommend to only use selective and sensitive analytical methods 
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like LC-MS/MS for BMAA analysis. Although possibly present in low concentrations in 
cyanobacteria, presence of BMAA in the aquatic food chain and possible synergistic effects 
with other cyanobacterial neurotoxins still urge for investigation on the risk of BMAA for 
human health.
3.4 MATERIALS AND METHODS
Eight cyanobacterial samples (four scum samples from the field and four laboratory strains), 
a negative control (a green alga) and a positive control (sarcotesta of a cycad seed) were 
prepared for analysis of free and total BMAA. The sample treatments were the ones that 
are most often applied: trichloroacetic acid extraction for analysis of free BMAA and acid 
hydrolysis for total BMAA. All sample treatments were performed in nine fold. Six replicates 
of each fraction were then derivatised using AQC and analysed by HPLC-FLD (n=3) or 
LC-MS/MS (n=3). The other three replicates were analysed by LC-MS/MS without 
derivatisation. Prior to extraction or hydrolysis, deuterium labelled BMAA was added to 
the samples that were analysed by LC-MS/MS as an internal standard. L-2-aminobutyric 
acid (AAbA) was added after extraction or hydrolysis to the samples that were analysed by 
HPLC-FLD and was used as retention time reference. Validation of all methods was based on 
FDA guidelines [130, 131].
3.4.1 Sample material
The control samples consisted of the green alga Scenedesmus obliquus SAG 276/3a (negative 
control) and the sarcotesta of a Cycas micronesica (Hill) seed (positive control). S. obliquus 
was cultured as in [129] and was harvested directly before sample preparation. The cycad 
seed was kindly provided by Chad Husby, Montgomery Botanical Centre, Miami, US and was 
stored at -20 °C after picking. The cyanobacterial scum samples were collected in various 
lakes in The Netherlands in 2008 and 2009 and were dominated by either Dolichospermum, 
Planktothrix rubescens, Aphanizomenon or Microcystis. The cyanobacterial laboratory 
strains used were Cylindrospermopsis raciborskii CS-1, Aphanizomenon flos-aquae CCAP 
1401/7, Dolichospermum flos-aquae CCAP 1409/2A and Microcystis aeruginosa NIVA CYA 
228/1. The first three strains were grown in batch cultures on a modified WC medium [132] 
at room temperature at normal daylight and were harvested after a growth period of 20 
to 25 days, while Microcystis was grown for 15 days at 20°C and in 45 µmol quanta m-2s-1 
light in a 16:8 h light:dark rhythm. All samples were lyophilized and stored at -20 °C until 
preparation.
3.4.2 Sample preparation
All lyophilized samples were homogenized and extracted or hydrolysed. 5 mg of sample (0.5 
mg for the cycad seed) was extracted for free BMAA at room temperature in the dark for 
two hours in 300 μl 0.1 N trichloroacetic acid (TCA). After the extraction, the sample was 
centrifuged and the supernatant was transferred. 300 μl 0.1 N TCA was then again added 
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to the pellet and after vortexing and centrifugation the supernatant was pooled with the 
first supernatant and lyophilized. The dried supernatants were derivatised after dissolving 
them in 500 μl hot 20 mM HCl. Samples were derivatised by adding 60 μl buffer and 20 
μl reagent (6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC), purchased as AccQ®-
Tag, Waters) to 20 μl sample [124]. Dried supernatants for underivatised LC-MS/MS analysis 
were dissolved in 500 µl 65% acetonitrile, 35% Millipore water and 0.1% formic acid (v:v:v).
For total BMAA, 1 mg of lyophilized sample (0.5 mg for the cycad seed) was hydrolysed 
in an hydrolysis/derivatisation workstation (Eldex), using 6 N HCl liquid hydrolysis for 20 
hours at 105 °C in the absence of oxygen. After hydrolysis, samples for derivatised analysis 
were dissolved in 500 μl hot 20 mM HCl and subsequently diluted ten times in 20mM HCl 
to obtain a protein concentration below 0.1 g/l ([124, 125], maximum protein content of 
cyanobacteria was estimated to be 50%). Derivatisation procedure was the same as for the 
free fraction. Hydrolysed samples for underivatised LC-MS/MS analysis were dissolved in 1 
ml 65% acetonitrile, 35% Millipore water and 0.1% formic acid (v:v:v).
Deuterium labelled BMAA (D
3
BMAA, kindly provided by Johan Rosén, National Food 
Administration, Uppsala, Sweden and synthesized as in [76]) was added to the samples that 
were analysed by LC-MS/MS prior to extraction or hydrolysis so the maximum concentration 
at the moment of analysis was 400 µg/l. L-2-aminobutyric acid (AAbA, Sigma-Aldrich) was 
added to the samples that were analysed by HPLC-FLD after extraction or hydrolysis at a 
maximum concentration of 500 µg/l.
3.4.3 Sample analysis
HPLC-FLD analysis was performed on an Agilent 1100 LC-FLD. Compounds were separated on 
a Nova-Pak C18 3.9×300 mm, 4 µm column (Waters). Eluent A consisted of 140 mM sodium 
acetate and 5.6 mM triethylamine in Millipore water, adjusted to pH 5.2 with phosphoric 
acid. Eluent B was acetonitrile and eluent C was Millipore water. The elution program was: 0 
min 100% A; 7 min 90% A and 5.2% B; 10-20 min 84% A and 8.3% B; 23 min 75% A and 13% 
B; 38 min 65% A and 18.2% B; 40 min 40% A and 31.2% B; 42.5-52 min 52% B and 48% C; 
55-65 min 100% A. Flow rate was 1 ml/min, injection volume 4 µl and column temperature 
37 °C. Excitation wavelength was 250 nm, emission wavelength was 395 nm.
LC-MS/MS analysis of the derivatised samples was performed on an Agilent 1200 LC and 
an Agilent 6410A QQQ. Compounds were separated on a Zorbax Eclipse AAA 4.6×75 mm, 
3.5 μm column (Agilent) with mobile phases acetonitrile with 0.1% formic acid (v:v, eluent 
A) and Millipore water with 0.1% formic acid (v:v, eluent B). The following gradient was 
applied: 0 min 1% A; 4 min 2% A; 8 min 5% A; 18 min 10% A; 20-24 min 50% A; 24-38 min 
0% A. Flow rate was 1 ml/min, injection volume 10 µl and column temperature 40 °C. The 
LC-MS/MS was operated in positive mode with an ESI source, fragmentor voltage was 140 V. 
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Nitrogen was used as the drying and collision gas. Quadrupole 1 was operated in unit mode 
and quadrupole 2 was operated in widest mode. BMAA was detected by the transitions 
mass-to-charge ratio (m/z) 459 to m/z 171 at 32 V collision energy, m/z 119 and m/z 145 
(both 16 V). Ratio of the peak area of qualifier m/z 119 to the peak area of quantifier m/z 
171 was 10%; ratio of the qualifier m/z 145 to m/z 171 was 14%. DAB was detected by 
the transitions m/z 459 to m/z 171 (28 V), m/z 145 and m/z 315 (both 12 V). Ratio of the 
qualifier m/z 145 to quantifier m/z 171 was 83% and ratio of the qualifier m/z 315 to m/z 
171 was 8%. D
3
BMAA was detected by the transitions m/z 462 to m/z 171 (32 V), m/z 145 
and m/z 122 (both 16 V). Ratio of the qualifier m/z 145 to quantifier m/z 171 was 13% and 
ratio of the qualifier m/z 122 to m/z 171 was 23%.
Underivatised samples were analysed on the same LC-MS/MS equipment and with the same 
mobile phases as the derivatised samples. Compounds were separated on a 2.1×150 mm, 5 
µm diameter ZIC-HILIC column (Sequant) with a Direct-Connect Filter (Grace Alltech). Flow 
rate was 0.4 ml/min, injection volume 5 µl and column temperature 40 °C. The following 
gradient was applied: 0-2 min 95% A; 4 min 65% A; 8-17 min 55% A; 17-23 min 95% A. 
Fragmentor voltage was 50 V and both quadrupoles were operated in unit mode. BMAA was 
detected by the transitions m/z 119.1 to m/z 102.1 (4 V), m/z 88 and m/z 76 (both 8 V). Ratio 
of both qualifiers m/z 88 and m/z 76 to quantifiers m/z 102.1 was 21%. DAB was detected 
by the transitions m/z 119.1 to m/z 101 (4 V) and m/z 74 (8 V). Ratio of the qualifier m/z 76 
to quantifier m/z 101 was 23%. D
3
BMAA was detected by the transitions m/z 122.1 to m/z 
105.1 (4 V), m/z 88 and m/z 76 (both 8 V). Ratio of qualifier m/z 88 to quantifier m/z 105.1 
was 22%; ratio of m/z 76 to m/z 105.1 was 37%.
Calibration standards for the derivatised samples were prepared in 20mM HCl and then 
derivatised, calibration standards for the underivatised samples were prepared in 65% 
acetonitrile, 35% Millipore water and 0.1% formic acid (v:v:v). Calibration standards for LC-
MS/MS analysis contained BMAA, DAB (DAB dihydrochloride, Sigma-Aldrich) and D
3
BMAA. 
Calibration standards for HPLC-FLD analysis contained BMAA, DAB, methionine (DL-
Methionine, Fluka) and AAbA. BMAA concentrations in LC-MS/MS samples were determined 
by correcting the response of BMAA for the response of D
3
BMAA. BMAA concentrations 
analysed by HPLC-FLD were calculated against the calibration curve and subsequently 
corrected for the recovery (see method validation).
3.4.4 Method validation
To make comparison of the HPLC-FLD method with both LC-MS/MS methods possible, 
validation of both LC-MS/MS methods was performed without correction for the response 
of D
3
BMAA.
Linearity was determined by injecting a range of calibration standards in triplicate. 
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For both LC-MS/MS methods, limit of detection (LOD) in calibration standards was 
determined as the lowest injected concentration with a signal-to-noise (S/N) ratio of all 
product ions of at least 3:1. Furthermore, the ratio of the qualifier ions to the quantifier ion 
should be within a 20% relative range of the expected value. Limit of quantification (LOQ) was 
defined as the lowest injected concentration with a S/N ratio of the quantifier ion of at least 
10:1. Furthermore, the ratio of the qualifier ions to the quantifier should again be within the 
accepted range, and the S/N ratio of the qualifier ions should at least be 3:1. For HPLC-FLD 
analysis, LOD in calibration standards was defined as the lowest concentration of which the 
peak was clearly distinguishable from the background signal. LOQ was defined as the lowest 
concentration that was linear on the calibration curve. Detection and quantitation limits in 
samples were defined in the same way as for calibration standards. Limits in samples were 
determined by spiking a Dolichospermum scum sample with different BMAA concentrations 
prior to extraction or hydrolysis.
Intraday precision of response and retention time was determined by injecting the highest 
calibration standard (1000 µg/l) in six fold. For interday precision, calibration standards 
were injected again in six fold on a different day and the variation of all twelve injections 
was considered. Inter workup precision was determined by spiking an Dolichospermum 
scum sample in six fold before extraction or hydrolysis with either D
3
BMAA (both 
LC-MS/MS methods, 200 ng for free BMAA, 400 ng for underivatised total BMAA and 2000 
ng for derivatised total BMAA) or BMAA (HPLC-FLD method, 750 ng for free BMAA and 
9950 ng for total BMAA). The same sample treatment was repeated in six fold on another 
day and response was compared. The inter workup samples were also used for calculation 
of recovery, which is in this study defined as the percentage of the original signal that was 
recovered after sample preparation and analysis.
Since no reference material is available for BMAA, accuracy was not tested. Instead, a positive 
control sample (cycad seed sarcotesta) was included. The mass of cycad seed sarcotesta 
used for extraction and hydrolysis was lower than for the cyanobacterial samples, so the 
signal of the cycad seed would be close to the detection limits of the methods. Furthermore, 
recovery of all sample treatments was determined. 
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APPendix A3
Figure A3.1. LC-MS/MS BMAA calibration curves for derivatised analysis and underivatised 
analysis, corrected for D3BMAA. Panel A shows the calibration curve for derivatised analysis, panel 
B for underivatised analysis. All concentrations are injected in triplicate, except 5 and 10 µg/l in panel A, these 
concentrations are injected once.
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Figure A3.2. Limits of detection (LODs) for BMAA in spiked Dolichospermum scum 
samples. Panel A and B show HPLC-FLD signals, panel C and D show LC-MS/MS signals of derivatised samples 
and panel E and F show LC-MS/MS signals of underivatised samples. Panels C and E represent samples that are 
spiked with BMAA before extraction, panels B, D and F represent samples that are spiked before hydrolysis. No LOD 
could be defined for BMAA in extracted samples for HPLC-FLD analysis (see results in main text), panel A therefore 
shows an unspiked extracted field sample of Planktothrix rubescens with a low response at the retention time of 
BMAA (see also Table 3.4 in main text). Coloured lines in panels C and D represent the transitions of ions with a 
mass-to-charge ratio (m/z) of 459 to m/z 171 (blue), 119 (green), 145 (pink) and 315 (orange). Coloured lines in 
panels E and F represent the transitions of m/z 119.1 to m/z 102.1 (blue), 88 (pink), 76 (green), 101 (grey) and 74 
(orange). Transitions for D
3
BMAA are not shown.
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Figure A3.3. Concentrations of BMAA in spiked Dolichospermum scum samples, analysed 
by LC-MS/MS and corrected for D3BMAA. Panel A shows extracted derivatised samples, panel B shows 
hydrolysed derivatised samples, panel C shows extracted underivatised samples and hydrolysed underivatised 
samples are shown in panel D. All samples are spiked before extraction or hydrolysis and are injected once. 
“Blauw, blauw, blauw, blauw, blauw”
The Scene, Blauw
CHAPTER 4
evAluATion of A coMMerciAlly AvAilABle 
elisA for BMAA deTerMinATion 
This chapter has been published as: Evaluation of a Commercial Enzyme Linked 
Immunosorbent Assay (ELISA) for the Determination of the Neurotoxin BMAA in Surface 
Waters. Faassen E.J., Beekman, W. and Lürling, M. 2013, PLoS ONE 8 (6).
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ABSTRACT
The neurotoxin β-N-methylamino-L-alanine (BMAA) is suspected to play a role in Alzheimer’s 
disease, Parkinson’s disease and amyotrophic lateral sclerosis. Because BMAA seems to 
be produced by cyanobacteria, surface waters are screened for BMAA. However, reliable 
analysis of BMAA requires specialized and expensive equipment. In 2012, a commercial 
enzyme-linked immunosorbent assay (ELISA) for determination of BMAA in surface waters 
was released. This kit could enable fast and relatively cheap screening of surface waters for 
BMAA.
The objective of this study was to determine whether the BMAA ELISA kit was suitable for 
the determination of BMAA concentrations in surface waters. We hypothesised that the 
recovery of spiked samples was close to 100% and that the results of unspiked sample 
analysis were comparable between ELISA and liquid chromatography tandem mass 
spectrometry (LC-MS/MS) analysis. However, we found that recovery was higher than 100% 
in most spiked samples; highest determined recovery was over 400%. Furthermore, the 
ELISA gave a positive signal for nearly each tested sample while no BMAA could be detected 
by LC-MS/MS. We therefore conclude that in its current state, the kit is not suitable for 
screening surface waters for BMAA.
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4.1 INTRODUCTION
The neurotoxin β-N-methylamino-L-alanine (BMAA) was discovered in 1967 in cycad seeds 
from the island of Guam [31] and is suspected to play a role in the neurodegenerative 
diseases Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis [37]. 
Although there is proof of the neurotoxic effect of BMAA on cellular and animal level, 
the role of BMAA in the aetiology of these neurodegenerative diseases still needs further 
establishment [59]. Nevertheless, possible pathways of human exposure to BMAA are at 
present being investigated. After it was reported that BMAA was present in the cyanobacteria 
that live in symbiosis with the cycads on Guam [32], free living cyanobacteria were screened 
for BMAA. Initially, BMAA was detected in nearly all tested cyanobacterial species [33, 35, 
36], while some later studies found lower concentrations of BMAA [83], found BMAA only 
in some samples [102] or did not detect BMAA at all (e.g. [76, 77]). At present, the cause 
of these differences in BMAA concentrations in cyanobacteria has not been identified yet, 
although it is very probable that studies that have used the unselective HPLC-FLD (e.g. [33, 
35, 133]) have misidentified BMAA and/or overestimated its concentrations [93].
The analytical methods used for unambiguous identification of BMAA in the aquatic 
ecosystem should be sensitive, selective and robust [93, 134]. Methods based on tandem 
mass spectrometry like liquid chromatography coupled to tandem mass-spectrometry 
(LC-MS/MS) meet these requirements, but these types of analysis require rather specialized 
and expensive equipment. In 2012, a commercial enzyme-linked immunosorbent assay 
(ELISA) was released. The advantage of such an assay is that a rapid screening of multiple 
samples can be performed at relatively low costs and with relatively inexpensive equipment. 
The samples that give a positive signal in the ELISA then need to be further analysed by a 
more selective analytical method, but if the ELISA works well, time and money can be saved 
because the amount of samples for more specialized analysis is reduced.
The objective of our study was to determine whether the BMAA ELISA kit was suitable for 
the determination of BMAA concentrations in surface waters. We performed some basic 
tests, determined recovery of the ELISA kit in five different samples that were spiked 
with BMAA and we analysed unspiked water samples from different origin by ELISA and a 
validated LC-MS/MS method [93]. Because to our knowledge no BMAA was yet detected in 
untreated (i.e. not extracted or hydrolysed) water, we also included cyanobacterial extracts 
and hydrolysates in the experiment. We hypothesised that the recovery of the ELISA 
kit was close to 100% for most tested samples and that the results of the ELISA and the 
LC-MS/MS analysis were comparable. However, ELISA showed unexplainable deviations in 
the calibration curve, recoveries were higher than 100% in most spiked samples and nearly 
each tested sample gave a positive signal in ELISA while no BMAA could be detected by 
LC-MS/MS. We therefore conclude that the kit is not suitable for screening of surface waters 
for BMAA.
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4.2 MATERIAL AND METHODS
The ELISA kits were purchased from Abraxis and are based on direct competition: BMAA 
competes with a BMAA-horseradish peroxidase analogue for binding sites of the rabbit anti-
BMAA antibodies in solution. The BMAA antibodies are bound by a goat anti-rabbit antibody 
that is immobilised on the wells of the plate. The addition of a substrate generates a colour 
reaction that is inversely proportional to the amount of BMAA present in the sample. 
In this study, we tested nine plates. First, the response of the calibration standards provided 
with the kit was compared to the response of calibration standards prepared in water 
and in sample diluent (also provided with the kit). Next, as no pH range was given in the 
manufacturer’s instructions, we determined the response of a BMAA standard at a pH range 
of pH 1 to 10. We then determined recovery by spiking samples. Finally, a range of unspiked 
samples was analysed by ELISA and a validated LC-MS/MS method. The experiment was 
performed in the period from August to December 2012.
4.2.1 Calibration curves and pH series
All water used for sample preparation and analysis was purified with a Q-Pod (Millipore). 
BMAA calibration standards (BMAA hydrochloride, Sigma Aldrich) were prepared in water 
and in sample diluent (provided with the kit) directly before analysis. A pH series with 250 
µg/l BMAA was constructed in a trichloroacetic acid (TCA) solution (pH range 1.4 - 3), HCl 
(pH range 1 - 5) and NaOH (pH range 7 - 10). The pH series was analysed in duplicate.
4.2.2 Sample collection, pre-treatment and storage
All samples except the tap water and the humic acid solutions were collected in various 
lakes and ponds in The Netherlands (Table 4.1). Tap water was collected in the laboratory 
and humic acid (Sigma Aldrich) solutions were prepared in Millipore water in the laboratory. 
Samples 4 and 7 were collected in a PE bottle and homogenized. A part of sample 4 was 
filtered over a GF/C filter (Whatman), resulting in sample 5. Sample 6 was collected by 
pushing a core in lake sediment. From this core, the organic top layer of the sediment was 
collected, centrifuged and the supernatant was filtered over a GF/C filter and collected. 
Samples 1-7 were stored at 4 °C. Samples 8-10 were taken from ponds and lakes with 
cyanobacterial blooms and were stored at -20 °C. Samples 11-14 were also taken from 
ponds and lakes with cyanobacterial blooms and were lyophilized before storage at 
-20 °C.
Dominant cyanobacterial species were identified by light microscopy. Chlorophyll-a was 
determined in sample 1-6 by Phyto-PAM (Walz), only sample 4 contained detectable 
amounts (13 µg/l) of cyanobacterial chlorophyll-a. All water samples were fresh, except for 
sample 7, which had an electric conductivity of 9.3 mS/cm.
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No permission was required for sample collection. Samples 4, 5, 6 and 11 were collected from 
ponds on the campus of Wageningen University, which is private property. As employees of 
this university, we were allowed to enter the campus freely and to take samples for scientific 
research. Samples 7-10 and 12-14 were collected from lakes and ponds that were publicly 
accessible, which is allowed in The Netherlands. Sampling did not involve endangered or 
protected species and was compliant with the Dutch Flora and Fauna Act.
Table 4.1. Sample origin, pre-treatment and storage conditions.
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Table 4.1. Sample origin, pre-treatment and storage conditions. 
Sample name Origin City Sampling 
date 
Cyanobacterial 
dominance 
Pre-treatment Storage 
1 Tap water Laboratory n.a. Nov 2012 n.a. None 4 °C 
2 Humic acid 10 mg/l Laboratory n.a. n.a. n.a. None 4 °C 
3 Humic acid 100 mg/l Laboratory n.a. n.a. n.a. None 4 °C 
4 No bloom unfiltered Campus pond 1 Wageningen Nov 2012 None None 4 °C 
5 No bloom filtered Campus pond 1 Wageningen Nov 2012 None Filtration 4 °C 
6 Sediment water Campus pond 2 Wageningen Nov 2012 None Centrifugation 
and filtration 
4 °C 
7 Brackish De Veste Breskens Nov 2012 None None 4 °C 
8 Pl. rub. bloom 1 Lake De Kuil Prinsenbeek Nov 2010 Planktothrix 
rubescens 
None -20 °C 
9 Glo. ech. bloom Kralingse Plas Rotterdam July 2012 Gloeotrichia 
echinulata 
None -20 °C 
10 Micr. bloom 1 Urban pond Dongen June 2010 Microcystis None -20 °C 
11 Do. bloom Campus pond 3 Wageningen June 2008 Dolichospermum Lyophilisation -20 °C 
12 Pl. rub. bloom 2 Wuurdse Plas Elst April 2009 Planktothrix 
rubescens 
Lyophilisation -20 °C 
13 Aph. bloom Lake De Kuil Prinsenbeek Oct 2009 Aphanizomenon Lyophilisation -20 °C 
14 Micr. bloom 2 Gooimeer Almere Sep 2009 Microcystis Lyophilisation -20 °C 
n.a.: not applicable 
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4.2.3 Sample preparation for ELISA analysis
Directly before analysis, particles were removed from sample 8 by centrifugation and 
subsequent filtration over a GF/C filter. Sample 10 was also filtered over a GF/C filter and 
sample 9 was filtered in a tube with a 0.2 µm cellulose acetate filter (Grace Davison Discovery 
Science) at 16000*g.
Samples 11-14 were extracted in triplicate to release free BMAA from the cyanobacterial 
cells. 5 mg of sample was extracted at room temperature in the dark for two hours in 
300 μl 0.1 N TCA. After the extraction, the sample was centrifuged and the supernatant 
was transferred. 300 μl 0.1 N TCA was then again added to the pellet and after vortexing 
and centrifugation the supernatant was pooled with the first supernatant. The pooled 
supernatant was lyophilized and then dissolved in 600 µl of water brought to pH 7 by NaOH.
The same samples were also hydrolysed in triplicate to determine total BMAA concentration. 
1 mg of sample was hydrolysed in a hydrolysis/derivatisation workstation (Eldex), using 6 N 
HCl liquid hydrolysis for 20 hours at 105 °C in the absence of oxygen. Hydrolysates were 
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dried under vacuum and subsequently dissolved in 500 µl water that was brought to pH 7 
with NaOH. Both fractions were diluted 5 and 10 times in water with pH 7.
pH of all prepared samples was determined with a paper indicator strip (pH-Fix 0-14, 
Machery-Nagel).
4.2.4. Recovery determination
Samples 1 and 4-6 were used for recovery determination. For this, they were spiked with 
BMAA to a concentration of 100 µg/l. Unspiked samples were also analysed and recovery 
(%) was determined as 
( )
( )BMAAaddedconc
sampleunspikedconcsamplespikedconc*erycovre −= 100
            
Equation 4.1
Extracts and hydrolysates of sample 11 were also used for recovery determination. Extracts 
and hydrolysates were prepared in six fold and were dissolved in sample diluent. Both 
fractions were diluted 5, 10, 100 and 1000 times in sample diluent. Of the undiluted extract/
hydrolysate and each dilution, three replicates were spiked to a BMAA concentration of 
250 µg/l, while the other three replicates remained unspiked. Recovery was calculated for 
each dilution with equation 4.1. As the use of sample diluent gave problems in the recovery 
determination of sample 11 (see Results), recovery was also determined as described above, 
but the samples were dissolved in and diluted with water of pH 7.
4.2.5 ELISA procedure
ELISA kits were stored at 6 °C before analysis and were used before the expiration date. The 
assay was initially performed according to the instructions of the manufacturer:
•	 100 µl of standard solution or sample was added to the wells
•	 50 µl of enzyme conjugate solution was added with a multichannel pipette
•	 50 µl of antibody solution was added with a multichannel pipette
•	 The plate was covered with parafilm and the plate was mixed by circular movements for 
30 s on the bench top
•	 The plate was incubated for 90 min at room temperature in the dark
•	 The plate was washed four times with diluted washing solution (applied with a spray 
flask) and tapped dry
•	 150 µl of substrate solution was added with a multichannel pipette
•	 The plate was covered with parafilm and the plate was mixed by circular movements for 
30 s on the bench top
•	 The plate was incubated for 30 min at room temperature in the dark
•	 100 µl stop solution was added with a multichannel pipette
e
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•	 Within 15 minutes after the addition of stop solution, absorbance was read at 450 nm on 
a MTP reader (Synergy HT, BIOTEK).
After the first tests, we added an extra washing step with deionized water after washing with 
buffer solution. Furthermore, after a few tests, we replaced the sample diluent provided 
with the kit with water that was brought to pH 7 with NaOH for dissolving and diluting 
samples. 
The calibration curve was constructed by fitting the equation 
( )
( )( ) dcconc
da
B
B
b ++
−
=
∧10             
Equation 4.2
in Sigmaplot 12.0 (Systat Software Inc.), where B is the absorption of the calibration standard, 
B0 is the average absorption of the blank (0 µg/l BMAA) and conc is the concentration of the 
calibration standard. Parameters a, b, c and d were estimated. Samples were quantified by 
comparing the absorption of the sample to the absorption of the calibration curve. Samples 
with a signal below the signal of the lowest calibration standard (5 µg/l) were reported as 
not detected.
All samples except the extracts and hydrolysates were analysed in triplicate. The extracts 
and hydrolysates were already prepared in triplicate, so each replicate was analysed once.
4.2.6 LC-MS/MS analysis
Three series of ELISA calibration standards from different lots and samples 1-10 were 
prepared for underivatised LC-MS/MS analysis. Samples 1-10 were prepared in triplicate. 
The samples were prepared by adding 10 µl of a 10 mg/l D
3
BMAA solution (internal standard) 
in 20 mM HCl and 640 µl acetonitrile with 0.15% formic acid to 350 µl sample.
LC-MS/MS analysis was performed according to Faassen et al. [93] on an Agilent 1200 LC 
and an Agilent 6410A QQQ. Compounds were separated on a 2.1×150 mm, 5 µm diameter 
ZIC-HILIC column (Sequant) with a Direct-Connect Filter (Grace Alltech). Mobile phases were 
acetonitrile with 0.1% formic acid (v:v, eluent A) and Millipore water with 0.1% formic acid 
(v:v, eluent B). Flow rate was 0.4 ml/min, injection volume 5 µl and column temperature 
40 °C. The following gradient was applied: 0-2 min 5% B; 2-4 min linear increase to 35% 
B; 4-8 min linear increase to 45% B; 8-17 min 45% B; 17-23 min 5% B. Fragmentor voltage 
was 50 V and both quadrupoles were operated in unit mode. BMAA was detected by the 
transitions m/z 119.1 to m/z 102.1 at 4 V collision energy, m/z 88 and m/z 76 (both 8 V). 
Ratio of both qualifiers m/z 88 and m/z 76 to quantifier m/z 102.1 was 21%. D
3
BMAA was 
detected by the transitions m/z 122.1 to m/z 105.1 (4 V), m/z 88 and m/z 76 (both 8 V). Ratio 
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of qualifier m/z 88 to quantifier m/z 105.1 was 22%; ratio of m/z 76 to m/z 105.1 was 37%. 
Calibration standards contained BMAA and D
3
BMAA and were prepared in 65% acetonitrile, 
35% Millipore water and 0.1% formic acid (v:v:v). BMAA concentrations in samples were 
determined by correcting the response of BMAA for the response of D
3
BMAA.
Samples 11-14 were not analysed by LC-MS/MS in this study because they had already been 
analysed by LC-MS/MS previously [93].
4.3 RESULTS
4.3.1 Assay adjustment
According to the manufacturer’s instructions, the plate needed to be washed with the 
provided washing buffer solution after the first incubation and then patted dry before the 
substrate solution was added. However, when this protocol was followed, lather remained 
in the wells, leading to large variation between replicates. We therefore added an extra 
washing step: after washing with buffer, the plates were washed four times with deionized 
water and then patted dry. When this procedure was followed, no lather remained on the 
plate.
4.3.2 Variation within replicates
Incidentally, a well gave a value that deviated strongly from the other two replicates without 
apparent reason. This happened both in the calibration curves and in the samples. Even 
when the person performing the test was continuously supervised by another person and 
no mistakes, bubbles or inaccuracies were observed while the test was carried out, these 
outliers kept occurring. In this study, obvious outliers were not used in the calculation of the 
calibration curves, but no outliers were omitted from the results.
4.3.3 Response standards
The calibration curve of the kit was S-shaped when the horizontal axis was plotted on a 
logarithmic scale. On three plates, the 25 µg/l standard provided with the kit showed large 
variation (e.g. Figures 4.1A and 4.1B). On three other plates, this standard gave an absorption 
close to that of the 100 µg/l standard (Figure 4.1C). The calibration standards used on one 
of these latter plates were analysed by LC-MS/MS and according to this analysis, the 25 µg/l 
standard contained the assigned concentration.
The response of the standards provided with the kit was similar to the response of calibration 
standards prepared in water and in sample diluent (Figures 4.1A and 4.1B). BMAA standards 
dissolved in acidic (TCA and HCl) and basic (NaOH) solutions ranging from pH 2.7 to 10 also 
gave similar results as the calibration standards provided with the kit. Below pH 2.7, their 
response was higher than that of the kit’s standards, irrespective of whether a TCA or HCl 
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solution was used. Therefore only samples with a pH higher than 3 were analysed in the 
following experiments.
4.3.4 Recovery spiked samples
Recovery was determined in four samples without cyanobacterial dominance by addition 
of BMAA. For all four samples, recovery was higher than 100%, recovery of the filtered 
sediment water was highest (408 %, Figure 4.2). pH of these samples was between 7 and 8.
Figure 4.2. Recovery of spiked samples without cyanobacterial blooms. Error bars represent 
one SD, n=3. 
Recovery of extracted and hydrolysed samples was determined in sample 11, a surface 
water with a Dolichospermum bloom. First, the extracts and hydrolysates were dissolved 
in and diluted with the sample diluent that was provided with the test. At low dilutions, 
recovery was higher than 100%. Only when diluted 100 and 1000 times, recovery was close 
Figure 4.1. Calibration curves of three of the ELISA plates used in this study. Calibration 
standards provided with the kit are shown in black circles and solid black lines, calibration standards in water are 
shown in white circles and dotted black lines and calibration standards in sample diluent are shown in grey circles 
and grey solid lines. Outliers that are omitted from the calibration curve are shown as black crosses; all outliers 
belong to the standards from the kit.
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to 100% (Figure 4.3A). The pH of the undiluted extract was lower than 2 and this sample 
could therefore not be analysed.
Figure 4.3. Recovery of spiked extracts (black bars) and hydrolysates (grey bars) of 
sample 11. In panel A, sample diluent was used as solvent and diluent, in panel B, water brought to pH 7 was 
used. Error bars represent one SD, n=3. *: sample not analysed due to too low pH, **: signal of all replicates above 
calibration curve, which corresponds to recovery >200%, ***: signal of one replicate above calibration curve, bar 
represents average of other two replicates.
The results of the unspiked samples that were used for the recovery determination showed 
inconsistencies between replicates and between different dilutions of the same replicate 
(Tables 4.2 and 4.3). As repetition of this part of the experiment (including renewed 
sample workup) did not give better results, we repeated the experiment again, but then 
we dissolved and diluted samples in water that was brought to pH 7 with NaOH instead of 
in sample diluent. Recovery of extracts that were dissolved in water with pH 7 was close to 
100% when diluted at least 10 times, while hydrolysates had to be diluted at least 5 times 
(Figure 4.3B). The unspiked samples now gave consistent results between replicates and 
between dilutions (Tables 4.2 and 4.3).
Table 4.2. BMAA concentration as determined by ELISA and LOD* (both expressed as µg/g 
DW) for unspiked extracts of sample 11 in two different solvents.
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100 60 n.d. n.d. 76.4 n.d. n.d. n.d. 
1000 600 n.d. n.d. n.d. n.d. n.d. n.d. 
* LOD: limit of detection, n.a.: not analysed, sample pH too low, a.c.: above calibration curve 
(equivalent to > 300 µg/g BMAA in sample), n.d.: not detected 
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  Solvent: sample diluent Solvent: water pH 7 
Dilution LOD Replicate G Replicate H Replicate I Replicate J Replicate K Replicate L 
1 2.5 35.6 32.8 39.9 37.8 33.7 32.8 
5 12.5 29.9 n.d. 78.2 35.3 40.9 39.4 
10 25 n.d. n.d. 99.4 39.7 30.5 49.3 
100 250 352.4 n.d. n.d. n.d. n.d. n.d. 
1000 2500 n.d. n.d. n.d. n.d. n.d. n.d. 
* LOD: limit of detection, n.d.: not detected 
 
4.3.5 Response in unspiked samples 
 
The response of the ELISA for unspiked water samples is shown in Table 4.4 (untreated and filtered 
water samples) and Table 4.5 (extracted and hydrolysed water samples). Nearly all samples tested 
positive for BMAA, the ELISA did only not detect BMAA in some replicates of the filtered ‘No bloom’ 
sample, the sediment water sample and the 10 mg/l humic acid solution. According to the ELISA, 
samples 9 and 10, which are filtered samples of lakes with a cyanobacterial bloom, contained over 
200 µg/l BMAA. Tap water and the humic acid solutions that were prepared in the lab also tested 
positive for BMAA. All cyanobacterial extracts and hydrolysates were positive for BMAA; in each 
sample the concentration of total BMAA was higher than that of free BMAA. No BMAA was detected 
by ELISA in the blanks (purified water and sample diluent). 
 
No BMAA was detected in any of the samples by LC-MS/MS analysis in this study, neither was it 
detected in samples 11-14 that had been analysed by LC-MS/MS previously (field scums in Table 4 of 
ref [93]). 
 
* LOD: limit of detection, n.a.: not analysed, sample pH too low, a.c.: above calibration curve (equival nt to > 300 
µg/g BMAA in sample), n.d.: not detected
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Table 4.3. BMAA concentration by ELISA and LOD* (both expressed as µg/g DW) for 
unspiked hydrolysates of sample 11 in two different solvents.
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Table 4.4. BMAA concentrations (µg/l) in untreated and filtered samples as determined by ELISA. 
Sample Treatment Average SD n 
None 12.5 6.1 3 
None 16.8 - 2*
None 11.8 10.7 3 
None 10.7 2.4 3 
Filtrated 10.8 - 1**
Filtrated 16.5 - 1**
None 19.9 8.4 3 
Filtrated 59.2 3.7 3 
Filtrated 228.9 14.8 3 
1 Tap water 
2 Humic acid 10 mg/l 
3 Humic acid 100 mg/l 
4 ‘No bloom’ 
5 ‘No bloom’ 
6 Sediment water 
7 Brackish 
8 Pl. rub. bloom 1 
9 Glo. ech. bloom 
10 Micr. bloom 1 Filtrated 298.2 42.5 3 
*: 1 replicate not detected, **: 2 replicates not detected. 
Table 4.5. BMAA concentrations (µg/g DW) in extracted and hydrolysed water samples with 
cyanobacterial blooms as determined by ELISA. Concentrations are calculated from the 10 times 
diluted samples. 
Sample Treatment Average SD n 
Extraction 19.1 0.7 3 
Hydrolysis 39.8 9.4 3 
Extraction 30.3 4.6 3 
Hydrolysis 50.1 3.0 3 
Extraction 10.5 3.7 3 
Hydrolysis 85.3 11.3 3 
Extraction 13.8 3.7 3 
11 Do. bloom 
11 Do. bloom 
12 Pl. rub. bloom 2 
12 Pl. rub. bloom 2 
13 Aph. bloom 
13 Aph. bloom 
14 Micr. bloom 2 
14 Micr. bloom 2 Hydrolysis 84.4 28.6 3 
4.4 Discussion 
4.4.1 Test procedure and application range 
Before starting the final experiments on samples, we adjusted the test protocol at two points: we 
added an extra washing step with deionized water and we used water brought to pH 7 for dilution of 
sample extracts and hydrolysates instead of the provided sample diluent. These adjustments made 
our results more reproducible and consistent. We expect that these changes in the protocol did not 
have a negative impact on the performance of the test. The plates were washed before the addition 
of colour substrate, the extra washing step with deionized water could therefore have influenced the 
colour reaction. However, if such an effect occurred, it has likely been equal for the calibration curves 
and the samples, so quantification of the samples would not be affected. We also do not expect a 
negative effect of the use of water for sample dilution as the kit is designed for testing water samples 
and because the response of calibration standards in water and sample diluents is similar (Figure 
4.1). It was however surprising that the use of Millipore water brought to pH 7 gave better results 
than the diluent provided with the kit, as the latter consisted of distilled water according to the 
manufacturer. 
The calibration curve of the ELISA is S-shaped, with the steepest part of the curve between 25 µg/l 
and 250 µg/l. Quantification in this part of the curve is most precise, below 25 µg/l and above 250 
*: 1 replicate not detected, **: 2 replicates not detected.
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Table 4.5. BMAA concentrations (µg/g DW) in extracted and hydrolysed water samples 
with cyanobacterial blooms as determined by ELISA. Concentrations are calculated from the 10 times 
diluted samples.
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Before starting the final experiments on samples, we adjusted the test protocol at two 
points: we added an extra washing step with deionized water and we used water brought 
to pH 7 for dilution of sample extracts and hydrolysates instead of the provided sample 
diluent. These adjustments made our results more reproducible and consistent. We expect 
that these changes in the protocol did not have a negative impact on the performance of 
the test. The plates were washed before the addition of colour substrate, the extra washing 
step with deionized water could therefore have influenced the colour reaction. However, if 
such an effect occurred, it has likely been equal for the calibration curves and th  samples, 
so quantificati n of th  samples would not be affected. We also do no  expect a negative
effect of th  use of wat r for sample dilution as the kit is esign d for testing water samples 
and because the response of calibration standards in water and sample diluents is similar 
(Figure 4.1). It was however surprising that the use of Millipore water brought to pH 7 gave 
better results than the diluent provided with the kit, as the latter consisted of distilled water 
according to the manufacturer.
The calibration curve of the ELISA is S-shaped, with the steepest part of the curve between 
25 µg/l and 250 µg/l. Quantification in this part of the curve is most precise, below 25 
µg/l and above 250 µg/l, small changes in absorbance result in relatively large variations in 
calculated concentrations. The manufacturer reports a level of quantification of 4 µg/l and 
an upper limit of 500 µg/l. Because the absorbance of the 5 µg/l standard sometimes was 
close to that of the blank (B/B0 close to 1.0, Figure 4.1), we used a more conservative limit 
of detection and quantification of 5 µg/l in this study. On three plates, the 25 µg/l standard 
gave a signal that strongly deviated from the expected calibration curve. This was not caused 
by a too high BMAA concentration in these standards, as LC-MS/MS analysis confirmed that 
the calibration standards used on one of these three plates indeed contained the expected 
concentration. We therefore expect that the problem lied in the wells of the plate, or in an 
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impurity in the calibration standard that interfered during ELISA but not during LC-MS/MS 
analysis.
4.4.2 Recovery of spiked samples
The recovery of the spiked samples without cyanobacterial blooms was between 137% 
and 403%. As the pH of these samples was clearly above the critical threshold of 2.7, this 
overestimation could not be attributed to acidity of the samples. Also the possible presence 
of BMAA in these samples could not have caused this overestimation, as the concentrations 
that were determined in the unspiked samples were subtracted from the concentrations 
in the spiked samples. The recoveries of extracts and hydrolysates of a pond with an 
Dolichospermum bloom were also higher than 100% at the lowest dilutions. However, the 
recoveries of the more diluted samples were close to 100%. The mechanism behind these 
overestimations in spiked samples will be discussed below.
4.4.3 BMAA concentration in unspiked samples
The ELISA detected BMAA in every tested sample, although in three cases not in every 
replicate. No BMAA was detected by underivatised LC-MS/MS analysis in any of the samples, 
even though nearly all the concentrations as determined by ELISA are above the detection 
limit of the LC-MS/MS method [93]. LC-MS/MS analysis is considered a reliable method for 
BMAA detection in surface water [93, 134], although some issues have been raised against 
underivatised LC-MS/MS analysis [88]. However, as we think that the arguments raised by 
this group are refutable because we used deuterated BMAA as an internal standard [135], 
we consider the results of LC-MS/MS analysis reliable and therefore assume the ELISA 
results to be false positives.
4.4.4 Interfering compounds in ELISA
As the ELISA gave false positive results and elevated recoveries for most samples, it is likely 
that components in the samples have interfered. Because purified water and sample diluent 
contained no BMAA according to ELISA and gave accurate results when BMAA was added 
(Figures 4.1A and 4.1B), the problems seemed not to be caused by these solvents. One 
mechanism that could cause false positives and overestimation in an ELISA test is cross-
reactivity: the antibody in the test does not only react with the analyte (in this case BMAA), 
but also with other molecules in the sample. According to the manufacturer, the BMAA 
ELISA shows cross-reactivity with L-cysteine hydrochloride, L-glutamic acid, L-aspartic acid 
(all 0.2% of BMAA signal), γ-aminobutyric acid (0.02%) and DL-2,4-diaminobutyric acid 
dihydrochloride (0.01%). As all of these compounds can be present in cyanobacteria (e.g. 
[94, 102, 136, 137]), these compounds might indeed have increased the signal. However, 
cross-reactivity of only these five reported compounds is unlikely to be the only cause of 
the frequent occurrence of false positives with sometimes high concentrations. It is likely 
that the test shows cross-reactivity with more compounds. From our experiments we can 
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identify humic acids as likely being cross reactive: a 100 mg/l humic acid solution in purified 
water gave a BMAA signal corresponding to 11.8 µg/l BMAA (Table 4.4).
Besides cross-reactivity, other types of interferences seemed to have occurred in our 
experiments. The elevated recoveries of most spiked samples cannot be explained by 
cross-reactivity, as the recovery calculation was based on the differences in concentration 
between spiked and unspiked samples. According to the manufacturer, the kit can be used 
in a variety of inorganic solutions and in a 10% seawater solution. The electric conductivity 
of the brackish sample in this study was approximately 20% of that of the neighbouring 
seawater, so in this sample the seawater might have interfered. However, for the other 
samples we do not know which mechanisms are responsible for the observed overestimation 
as it happened in samples that varied greatly in origin and composition. Testing for possible 
interferences and identifying the underlying mechanisms is a laborious task that is normally 
carried out during test development and we therefore considered it beyond the scope of 
this study.
4.5 CONCLUSIONS
The objective of this study was to determine whether the evaluated ELISA kit is suitable 
for determination of BMAA concentrations in surface water. To our opinion, the kit (in its 
current state) should not be used for this purpose. One problem with the kit is that in one 
third of the tested cases, no decent calibration curve could be constructed because one 
standard strongly deviated from the expected line. On all tested plates, outliers occurred 
that could not be explained by obvious errors or inaccuracies. More importantly, the test 
gave elevated recoveries for a diversity of spiked samples and gave false positive results in 
nearly all tested samples. Although the manufacturer states that the test should be used for 
screening purposes and that additional analytical analysis should be performed to confirm 
positive results, a nearly 100% score of positives in samples that are unlikely to contain 
detectable amounts of BMAA makes the test unsuitable for its intended purposes. As a good 
screening method for BMAA in surface waters can be very useful, we recommend further 
development of the test.
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“I hope you’re not angry if I disagree”
Eddie Vedder, Society
CHAPTER 5
Presence of BMAA in AquATic sysTeMs: 
whAT do we reAlly know?
This chapter has been published as: Presence of the neurotoxin BMAA in aquatic ecosystems: 
what do we really know? Faassen, E.J., 2014. Toxins 6 (3).
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ABSTRACT
The neurotoxin β-N-methylamino-L-alanine (BMAA) is suspected to play a role in the 
neurological diseases amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s 
disease. BMAA production by cyanobacteria has been reported and contact with 
cyanobacteria infested waters or consumption of aquatic organisms are possible pathways 
to human exposure. However, there is little consensus regarding whether BMAA is present 
in cyanobacteria or not, and if so, at what concentrations. The aim of this review is to 
indicate the current state of knowledge on the presence of BMAA in aquatic ecosystems. 
Some studies have convincingly shown that BMAA can be present in aquatic samples at the 
µg/g dry weight level, which is around the detection limit of some equally credible studies 
in which no BMAA was detected. However, for the majority of the reviewed articles, it 
was unclear whether BMAA was correctly identified, either because inadequate analytical 
methods were used, or because poor reporting of analyses made it impossible to verify the 
results. Poor analysis, reporting and prolific errors have shaken the foundations of BMAA 
research. First steps towards estimation of human BMAA exposure are to develop and use 
selective, inter-laboratory validated methods and to correctly report the analytical work.
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5.1 INTRODUCTION
β-N-methylamino-L-alanine (BMAA) is a neurotoxin that has been linked to the progressive 
neurological diseases amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and 
Parkinson’s disease [37, 46, 59, 69]. BMAA was first discovered on the island of Guam in 
seeds of the cycad Cycas micronesica [31], which were used as food by the native Chamorro 
people [138]. As BMAA was shown to be neurotoxic [31], exposure to BMAA was considered 
as a possible cause of the high incidence of ALS/Parkinsonism-dementia complex (ALS/PDC) 
on this island [37]. However, the role of BMAA in the aetiology of ALS/PDC on Guam was 
heavily debated (e.g. [72, 139, 140]) and BMAA exposure is at present regarded as one of 
the possible causes of Western Pacific ALS-PDC [45].
BMAA research expanded beyond Guam after studies revealed the presence of BMAA beyond 
the seeds of the cycad, namely in the symbiotic cyanobacteria in the cycad’s coralloid roots 
[32, 42] as well as in free living cyanobacteria unrelated to the cycad [33]. The possibility of 
a global presence of BMAA, and thus of widespread human exposure to this neurotoxin led 
to the hypothesis that BMAA might be related to the global presence of neurodegenerative 
diseases [34]. The current state of knowledge recognizes the neurotoxicity of BMAA on 
cellular and in vivo level [59, 60] but an animal model for BMAA induced ALS is still lacking 
[60, 66]. Recently, additional toxicity mechanisms have been proposed that might better 
explain the relation between BMAA exposure and the chronic nature of ALS/PDC [45, 141]. 
Reports of BMAA in the brain of deceased patients suffering from ALS, PDC or Alzheimer’s 
disease support the BMAA ALS/PDC hypothesis [69-71], however, these results could not be 
replicated by another research group [72-74]. Some, but not all, of the differences between 
these studies might be tracked down to the analytical procedures applied [85]. 
A possible important pathway for human exposure to BMAA is through cyanobacterial blooms 
in water or through consumption of higher aquatic organisms exposed to such blooms [33, 
35, 83]. Recently, it was reported that also planktonic diatoms and dinoflagellates contain 
BMAA [98, 142]. Therefore, in addition to on-going research on the role of BMAA in causing 
human neurodegenerative diseases, studies also focus on estimating concentrations of 
BMAA in aquatic ecosystems. However, reported BMAA concentrations in aquatic systems 
vary widely between studies. Several studies have detected BMAA in all tested cyanobacteria 
samples, whereas others have not detected it in any sample (Table 5.1). Furthermore, 
cyanobacterial BMAA concentrations vary orders of magnitude between studies (Table 5.1). 
Likewise, several studies have found BMAA in higher trophic levels like molluscs and fish 
[82, 83, 94, 97, 100, 143-146], but others have not [147, 148]. Bioaccumulation of BMAA in 
higher aquatic organisms has been reported [83]. However, BMAA concentrations in the two 
food web studies performed so far differ greatly: those reported for the Baltic sea (mostly 
ng/g dry weight (DW), [83]) were a few orders of magnitude lower than those for Florida 
(high µg/g up to mg/g DW [82]).
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Table 5.1. Reported BMAA concentrations in free living cyanobacteria. Data from studies that 
have tested more than five independent samples are included, free and protein associated concentrations are 
summarized. Merged rows represent single studies. Method abbreviations are explained in Appendix A5.1.
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Publication Quantification n tested 
% 
positive 
[BMAA] in positive 
samples µg/g DW 
year method Derivatisation samples samples average median ref 
2005 LC-FLD AQC § 30 97 968 265 [33] 
2008 LC-FLD AQC 12 100 103 76 [35] 
2008 LC-FLD AQC 7 100 10 7.3 [107] 
2008 GC-MS EZ:faast 27 96 130 3.5 [36] 
2008 LC-MS/MS * none 34 0 - - [76] 
2009 LC-MS/MS none 21 43 13 6.0 [102] 
2010 LC-MS/MS ^ none 30 0 - - [77] 
2010 LC-MS/MS AQC 21 100 0.01 0.01 [83] 
2011 LC-MS EZ:faast 20 80 1.4 0.49 [122] 
2011 CE-UV none 8 100 402 277 [121] 
2012 LC-FLD AQC 18 100 14 9.0 [133] 
2012 LC-FLD AQC 16 100 0.29 0.24 [133] 
2012 LC-MS/MS # AQC 8 0 - - [93] 
2012 LC-MS/MS ~ none 8 0 - - [93] 
2012 LC-FLD AQC 8 38 28 22 [93] 
2014 LC-MS/MS AQC 10 100 4.4 3.2 [149] 
* Limit of detection (LOD) free < 1 µg/g DW, LOD total < 4 µg/g DW, ^ LOD 1.0 µg/g DW, # LOD free 1
µg/g DW, LOD total 10 µg/g DW, ~ LOD free 0.4 µg/g DW, LOD total 1.6 µg/g DW. § AQC: 6-
aminoquinolyl-N-hydroxysuccinimidyl carbamate
A possible explanation for the striking variations in BMAA concentrations (Table 5.1) could be that 
BMAA is produced in detectable amounts in some cyanobacteria and not in others. Concentrations of 
cyanobacterial secondary metabolites can vary within species, between species and between 
locations (e.g. [29, 128, 150]) but the variation within studies is usually larger than the variation 
between studies (e.g. [151, 152]) – though this is not the case for the BMAA results reported. Indeed, 
there is a strong bimodality in the absence/presence of BMAA in cyanobacteria samples, and analysis 
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A possible explanation for the striking variations in BMAA concentrations (Table 5.1) could 
be that BMAA is produced in detectable amounts in some cyanobacteria and not in others. 
Concentrations of cyanobacterial secondary metabolites can vary within species, between 
species and between locations (e.g. [29, 128, 150]) but the variation within studies is usually 
larg r than the vari tion between studies (e.g. [151, 152]) – though this is not the ca e for 
the BMAA results reported. Indeed, there is a strong bimodality in the absence/presence 
of BMAA in cyanobacteria samples, and analysis of similar [93, 133] or comparable samples 
[36, 122] with different methods yields different results (Table 5.1). This strongly suggests 
that additional factors to those influencing cyanobacterial metabolite production play a 
role in the reported divergences in cyanobacterial BMAA concentrations. In fact, the use 
of non-selective analytical methods likely is a major cause of the observed differences 
between studies [93], as is discussed in the next section. Additionally, even in cases where 
the appropriate analytical techniques are used, many research articles contain reporting 
errors such as an incomplete description of methods and results. In this setting, it is difficult 
to tell when BMAA has in fact been detected, as is shown in section 5.4. Furthermore, the 
absence of critical discussions in many studies hinders the comparison of data and findings, 
as is shown in section 5.5.
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The objective of this review is to elucidate the current state of knowledge on the presence 
of BMAA in aquatic ecosystems, based on studies in which appropriate analytical techniques 
have been employed and that were correctly reported. For this, I analysed primary research 
articles on the analysis, occurrence and production of BMAA in phytoplankton and higher 
aquatic organisms. Moreover, in the Appendices, I discuss some key articles on BMAA 
analysis, BMAA production by cyanobacteria and human exposure through cyanobacteria 
to illustrate the effect of reporting errors in their context (Appendices A5.2 to A5.6).
The main outcome of this review is that there is evidence for the presence of BMAA in 
aquatic organisms, but that this evidence is only based on a fraction of the published work. 
The assumed widespread occurrence of BMAA in aquatic ecosystems and its production 
by cyanobacteria could, therefore, not be verified. I find that unclear reporting and 
unsupported conclusions in key articles have shaken the foundations of BMAA research, an 
issue that needs to be tackled to determine human BMAA exposure routes and to provide a 
solid fundament for follow up studies.
5.2 THE ROLE OF ANALYTICAL METHODS IN THE BMAA CONTROVERSY
The use of different analytical methods in BMAA research has recently extensively been 
discussed [93, 134], and is summarized in this section, since it plays an important role in 
explaining observed differences in BMAA concentrations.
Figure 5.1. Analytical methods used for determination of BMAA concentrations in the 
aquatic ecosystem from 2005 up to 2013. Method abbreviations are explained in Appendix A5.1.
The most selective analytical methods used for BMAA analysis are 1H-NMR and LC-MS/MS. 
1H-NMR was only used in one study [111], but the sensitivity of this method is very low (LOD 
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5 mg/l). LC-MS/MS is the most frequently applied technique (Figure 5.1), and it is selective 
because it relies on four criteria for the identification of analytes (retention time, mass-to-
charge ratio (m/z) of the parent ion, m/z of product ions after collision induced dissociation 
and ratio between these product ions). Therefore, the chance of misidentification is 
minimized.
In LC-MS and GC-MS, no collision induced dissociation is used and these methods are, 
therefore, less selective than LC-MS/MS. In LC-FLD, LC- or CE-UV and AA analysis, analytes 
are identified by retention time and optical signal. As only two identification criteria are 
used by these methods, they are regarded as non-selective. An analytical technique that is 
based on different principles than the ones discussed before is ELISA, in which antibodies 
are used for identification. Recently, an ELISA for BMAA determination in environmental 
samples became commercially available. However, this test was shown to be unsuitable for 
its intended use [153].
A recent review on analytical techniques for BMAA research [134] recommends the use of 
MS/MS instead of optical methods (e.g. FLD) for detection. Indeed, there is a substantial 
chance of misidentification and overestimation of BMAA concentrations with optical 
detection based methods, as has experimentally been shown for one LC-FLD method [93]. 
In that study, FLD analyses resulted in overestimation or false positives in three out of eight 
tested samples. A group of scientist argued that BMAA could be successfully separated 
from its isomer α-,γ-diaminobutyric acid (DAB) [84] and other diamino acids [95] by a 
diversity of analytical methods, including those with optical detection. However, they do 
not properly answer the most important questions of possible misidentification by optical 
methods. It is unclear whether BMAA was separated from DAB in six of the ten investigated 
methods, because the chromatograms showing separation, or their legends are incomplete 
or incorrect (Appendix A5.2). Furthermore, only a narrow selection of possibly interfering 
compounds was tested, while in real samples many more compounds could possibly 
interfere (Appendix A5.3). Finally, it is not clear whether BMAA was correctly separated 
from the tested compounds in earlier studies by these authors, as it is not explicitly stated 
how the presented results relate to previous work (Appendices A5.2 and A5.3). 
MS/MS is currently generally accepted as the preferred detection technique for BMAA 
analysis, but when combined with LC separation, this technique also has its drawbacks. 
A main concern with LC-MS and LC-MS/MS analyses is the possible loss of signal by ion 
suppression [85, 88], when sample components other than the analyte decrease (and 
in some cases also enhance) the analyte signal [154]. The severity of this effect should, 
therefore, be estimated and reported for each LC-MS(/MS) method [85].
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To enhance its compatibility with different analytical methods, BMAA is sometimes 
derivatised. Derivatisation is used to change the properties of BMAA, e.g. to enhance its 
volatility for GC-MS analysis, to add chromophores for optical detection or to reduce polarity 
for reversed phase LC separation. While derivatisation adapts analytes to each technique, 
it does not necessarily influence the selectivity of each method. Therefore, the observed 
differences in cyanobacterial BMAA concentrations are not related to whether or not 
samples were derivatised (Table 5.1). The observed differences cannot either be explained 
by lack of sensitivity, as the detection limits of most methods with which no BMAA was 
detected were generally below the average concentrations found by others (Table 5.1).
Optical detection methods are still used in BMAA research (Figure 5.1). However, in the 
context of European guidelines for pesticide residue analysis, these techniques are only 
acceptable for frequently found residues – and always in conjunction with additional 
confirmatory methods – but more selective methods like MS/MS are preferred [155]. 
Identification by single MS is only regarded reliable when two or more diagnostic ions are 
used [155].
5.3 REVIEW OF REPORTED METHODS AND RESULTS
As detailed above, BMAA can only be reliably detected if the appropriate methods are 
used. Furthermore, for results to be clear and comparable, it is essential to report methods 
and results adequately. I here evaluate the methods and results sections of studies on 
BMAA detection in aquatic ecosystems. For each method, I checked if the following basic 
information was well reported: sample origin and storage, sample processing, sample 
analysis, method performance and BMAA identification.
Figure 5.2. Quality of reporting for analytical methods. Bars indicate: (nearly) correct and complete 
(green), incomplete or with errors (orange) and absent or with major errors (red). Data that have been published in 
previous method descriptions are shown in white, and ‘not applicable’ is shown in black. Results are summarized 
from Appendix A5.7.
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5.3.1 Sample origin and storage
Sample origin and storage conditions were well described in nearly half of the performed 
analyses (Figure 5.2). Most of the studies for which no data on sample origin and storage 
were provided focused on method development, but five studies focused on BMAA 
detection in cyanobacteria [33, 156-159]. Especially for these latter studies, information 
on sample origin and storage is required for the right interpretation of the detected BMAA 
concentrations, as cyanobacterial amino acid and toxin concentrations can change with 
changing growth conditions (e.g. [128, 150, 160, 161]). 
Incomplete description of sample origin in combination with incomplete data presentation 
can undermine the conclusions of a study. For instance, in a study on exposure of Gulf War 
veterans to BMAA [156], samples were taken from different locations in the Qatar desert. 
It is unclear how many samples were taken at each location, and which of these samples 
contained BMAA. The amount of BMAA in each sample was also not reported. As it unclear 
which locations of the Qatar desert contain which amount of BMAA, it is difficult to estimate 
the possible exposure of the veterans. The suggestion that BMAA exposure through desert 
dust may be linked to the increased incidence of ALS in Gulf War veterans is, therefore, not 
supported by the presented data (Appendix A5.4).
5.3.2 Sample processing
Essential information on sample processing was lacking for half of the analyses (Figure 
5.2), and it was impossible to estimate the workup efficiency for most of these analyses. 
Most details were lacking on volumes and weights during sample processing and on the 
derivatisation protocol (Appendix A5.7). Information on volumes and weights is required 
because volume-to-weight ratios partly determine extraction efficiencies, and the amount 
of sample injected in LC-MS(/MS) can influence the signal strength during analysis. 
Furthermore, derivatisation efficiency is also dependent on the sample/reagent ratio [125, 
134]. The derivatisation procedure was only sufficiently described sixteen times, while 
derivatisation was used in 49 analyses (Appendix A5.7). For some analyses, an estimation 
of the total sample processing efficiency (including the derivatisation step and/or clean-
up) could be derived from the use of internal standards and/or recovery data (e.g. [36, 
122, 135, 143, 162]). For most analyses, however, it remains unclear whether derivatisation 
was efficient and, therefore, whether BMAA concentrations were correctly determined or 
underestimated.
5.3.3 Sample analysis
In most studies the sample analysis was well described (Figure 5.2), but information on 
quantification was often missing (Appendix A5.7). For 18 out of the 43 analyses in which 
BMAA concentrations were determined, it was unclear how this was done. Quantification 
can be performed in different ways, e.g. against a calibration curve of pure standards or 
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spiked matrices, and with or without correction for internal standards or recoveries. 
Different methods of quantification can give different results, so this information is essential 
to allow comparison of studies.
When analytical methods are poorly described, they cannot be reproduced by other 
scientists and the results of the study cannot be validated by independent replication. For 
instance, some methods could not be reproduced because it was unclear how the elution 
programs was performed [96, 98] and for another study, it was even impossible to tell which 
analytical procedure had been followed [146].
5.3.4 Method performance
Method performance and validation data are used to show that the applied method 
is suitable for its intended purpose [130]. However, for most analyses these data were 
incomplete or missing (Figure 5.2). For instance, recovery was only correctly reported for 
one third of the methods (Appendix A5.7). Unless internal standards are used, recovery 
data should be used to correct the analysed BMAA concentration for possible losses during 
processing and/or analysis. One of the studies for which no recovery data are available is 
the study on BMAA concentrations in the Baltic food web [83]. The cyanobacterial BMAA 
concentrations found in this study are by far lower than those found in other studies (Table 
5.1). The validity of these results cannot be evaluated, because recovery data are neither 
given in the article in which the study is described [83], nor in the methodological article 
that preceded this study [94].
For sixteen methods, most data needed for method validation (detection limits, linear 
range, precision and recovery) were provided [34, 76, 79, 82, 93, 94, 100, 105, 111, 121, 
122, 135, 145, 148]. However, unvalidated methods (or methods for which no sufficient 
validation data were provided) were repeatedly referred to as ‘validated’. This was mainly 
the case for one LC-FLD method [34, 82, 84, 95, 107, 144, 158]. In addition, it was also stated 
that ‘the’ AQC based method for BMAA analysis has been validated by other methods [88]. 
However, it is unclear what ‘the’ AQC based method is, as AQC derivatisation has been used 
in combination with many different analytical methods (e.g. Table 5.1). In the only studies 
where multiple AQC methods were quantitatively compared, there was a discrepancy in 
results between the AQC LC-FLD and the AQC LC-MS/MS method [93] and between two 
AQC LC-FLD methods [133].
5.3.5 BMAA identification
Correct identification of BMAA can be shown by comparing a sample chromatogram (for 
methods using optical and mass spectrometry detection) or spectrum (mass spectrometry) 
to that of a BMAA standard or a sample spiked with BMAA. In 27 out of 65 methods, 
chromatograms or spectra provided enough information to prove that BMAA was correctly 
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identified (Appendix A5.7). For 21 methods, BMAA identification could not be verified 
because no (six methods) or only one chromatogram/spectrum was shown (fifteen methods, 
Appendix A5.7) and the response of a sample could not be compared to that of a standard. 
For other methods, chromatograms were incorrectly displayed.
For LC-MS/MS analysis, the four analyte identification criteria (retention time, m/z of the 
parent ion, m/z of product ions after collision induced dissociation and ratio between these 
product ions) should be shown to be the same between a BMAA standard and BMAA detected 
in a sample. However, for many LC-MS/MS analyses this was not correctly demonstrated: 
none of the studies that used LC-MS/MS to confirm positive findings by LC-FLD [34, 35, 82, 
107, 144, 156, 158, 159, 163] reported the LC-MS/MS identifications correctly. LC-MS/MS 
identification was only correctly presented in studies that used LC-MS/MS as their primary 
method [76, 77, 79, 93, 94, 97, 98, 100, 102, 135, 145, 164]. Examples of incorrectly displayed 
LC-MS/MS identifications are spectra of standards and samples acquired at different collision 
energies [82, 156], which makes them incomparable. Furthermore, the ratio of the product 
ions between the BMAA standard and the sample differed in two studies [142, 144], in 
other studies the integration method used for the different product ions was inconsistent 
[143, 163] and different BMAA retention times between spiked pure water and a spiked 
cyanobacterial extract were shown without explanation [105].
There are also problems with the proof of correct identification of BMAA in the only GC-MS 
study on cyanobacterial BMAA concentrations [36]. Chromatograms of standards, spiked 
and unspiked samples were provided, but the peaks in the unspiked samples that were 
attributed to BMAA did not exceed the noise level (Figures 5.3B and 5.3C). Furthermore, the 
spectrum of the standard differed from the spectra of the samples (Figure 5.3), so additional 
fragments could not be used to confirm presence of BMAA, as is required in single MS 
analysis [155].
5.4 BIAS THROUGH SELECTIVE LITERATURE REFERENCES AND LACK OF 
DISCUSSION
As described in the previous sections, it is for many studies unclear whether BMAA is 
correctly detected and quantified. In addition, literature interpretation is hindered by a lack 
of critical reflection on the quality and limitations of some studies. Also, certain studies 
selectively cited only literature on positive findings of BMAA, thereby creating a biased view 
on the subject.
5.4.1 Selective use of references
The selective use of references has in some studies resulted in a biased view towards positive 
findings of BMAA. For the first articles on BMAA in cyanobacteria [33, 35, 36], knowledge 
on presence of BMAA in cyanobacteria was limited and the results of these studies were in 
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agreement with each other. However, results started to differ when no BMAA was detected 
in subsequent studies [76, 78, 111]. As a consequence, a public discussion on the suitability 
of the applied analytical methods and the correctness of results started (e.g. [76, 77]). 
These conflicting data and/or methodological issues were mentioned in most articles from 
2009 and later, but were ignored by some (e.g. [82, 95, 144, 147, 157, 159, 163]). Especially 
in studies in which optical detection was used as the primary analytical method and in 
which high BMAA concentrations were found using these methods [96, 121, 133, 144]; no 
reference to the debate on concentrations and methods was made.
Also in an experimental study on method performance [88], a biased view was created by 
selective referring to previous research. In this study, adduct formation in underivatised 
LC-MS analysis was investigated and it was concluded that for this type of analysis, adduct 
and complex formation may lead to an extreme underestimation of BMAA concentrations. 
However, the authors do not adequately discuss the underivatised LC-MS or LC-MS/MS 
publications in which complex and adduct formation do not seem to play a major role. 
Neither do they refer to the only study in which underivatised and derivatised LC-MS/MS 
analyses were directly compared, and in which underivatised LC-MS/MS performance was 
slightly better than derivatised LC-MS/MS performance. Finally, the authors recommend 
using derivatised LC-MS analysis with LC-FLD as a confirmatory technique, but do not discuss 
the points raised against the use of LC-FLD for BMAA analysis in several other publications 
(Appendix A5.5).
5.4.2 Discussion of quality and limitations of the study
In most articles, presented work was not critically discussed and limitations of the study 
were rarely addressed, which contributes to uncertainty about the validity of some results. 
For instance, one group published an article on derivatisation optimization [125] which was 
followed by a methodological article on SPE and LC-MS/MS analysis of samples [94]. This 
method was subsequently used for a food web study [83]. In 2012, the same group published 
two more methodological articles, one on separation of BMAA from isomers [97] and one 
describing quantification by LC-MS/MS [135]. These articles have greatly contributed to 
aquatic BMAA research, but on the same time give rise to some questions. For instance, 
why was an optimum ratio between sample protein and derivatisation reagent advised in 
the first study [125], and this ratio by far exceeded in the second study [94]? Furthermore, 
the LC-MS/MS method was adjusted in 2012 because the ratio between product ions 
used for BMAA identification in samples did not always correspond to the ratio in a BMAA 
standard [97]. If these ratios do not correspond it is uncertain whether BMAA is present in 
the samples. It was concluded that the difference in ratios might have been caused by an 
interfering isomer, but the question regarding whether this interference was also present 
during the food web study [83] and, therefore, whether BMAA was correctly identified 
in this study was not addressed. Finally, a subsequent article by this group described an 
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optimized LC-MS/MS method that could be used for quantification [135]. Sensitivity was 
improved in comparison to the first published method when expressed as fmole/injection 
(70 in [94] and 4.2 in [135]), but it is not discussed why, when expressed in µg/g dry weight, 
this method was a hundred times less sensitive (LOD of 0.1 µg/g DW) than the first method 
[94] by which a concentration of 0.001 µg/g DW had been detected [83].
Similarly, another group published several articles on method development and sample 
testing [36, 122, 162] and one on BMAA production by cyanobacteria [99]. In two of 
these articles, BMAA concentrations were determined in multiple cyanobacterial isolates. 
Although the tested isolates were not identical, they were described in both articles as 
being representative for the region and they were cultured under similar conditions [36, 
122]. The average BMAA concentration determined by GC-MS in one study [36] was nearly 
a hundred times higher than the average concentration determined by LC-MS in the 
other study [122] (Table 5.1), but possible causes of this difference were not adequately 
discussed [122]. Furthermore, from the experimental study [99], the authors conclude that 
cyanobacteria produce BMAA in response to nitrogen starvation. The authors suggest that 
some other studies did not detect BMAA because only nutritionally replete cyanobacteria 
were analysed. However, the authors do not check this with their previous work, in which 
they frequently reported BMAA in cyanobacteria that were grown on BG11 [36, 122], a 
medium that is very rich in nitrogen [165, 166].
5.5 CONCLUSIONS
5.5.1 Presence of BMAA in aquatic ecosystems
There is evidence that BMAA can be present in cyanobacteria dominated samples [83, 
94, 102, 135, 164], while in some equally credible studies, BMAA has not been detected 
in cyanobacteria [76-79, 93, 97]. The evidence for presence of BMAA is generated by 
studies that have used LC-MS/MS, which is at present regarded as one of the most suitable 
techniques for BMAA analysis due to its high selectivity and sensitivity [93, 134]. In addition, 
these studies have correctly shown the appropriate chromatograms, so it is likely that BMAA 
has been correctly identified. The negative results are based on well reported LC-MS and LC-
MS/MS studies. LC-MS is less selective than LC-MS/MS, but this method is included because 
less selective methods do not have a higher risk of creating false negative results than more 
selective methods.
Based on studies in which the quantification method has also properly been reported, BMAA 
concentrations in positive cyanobacterial samples are 0.73 µg/g DW in a cyanobacteria 
culture [135] or range from 4 to 42 µg/g DW in field material dominated by, but not 
necessarily solely comprised of, cyanobacteria [102]. These concentrations are close to the 
detection limits of the previously mentioned LC-MS(/MS) studies in which no BMAA was 
detected, which range from 0.1 to 10 µg/g DW [76-78, 93, 97] (LOD in [79] is not included 
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because it is expressed per unit of wet weight). No BMAA was detected in cyanobacterial 
samples by 1H-NMR, another highly selective, but rather insensitive method (LOD of 5 mg/l) 
[111].
One LC-MS/MS based study has convincingly shown that axenic diatom cultures can contain 
BMAA at concentrations between 1.1 and 3.3 ng/g DW, the BMAA concentration in a 
cyanobacteria/diatom dominated field sample was 27.6 ng/g DW [98].
BMAA has also been detected in (some samples of) higher aquatic organisms [83, 94, 97, 
100, 145], at concentrations between 4.7 and 14.1 µg/g DW in crabs [145], 6.8 and 46.9 
µg/g DW in oysters [145] and 0.63 and 1.6 µg/g wet weight in mussels [100] by LC-MS/MS 
based studies. The two studies in which no BMAA was detected in higher aquatic organisms 
(fish and shrimp) have used LC-FLD analysis (LOD 0.21 µg/g DW for fish and 0.3 µg/g DW for 
shrimp [147, 148]).
Figure 5.4. Number of studies that have provided convincing evidence for correct BMAA 
analysis in aquatic samples (blue and green slices) and studies that have not provided 
conclusive evidence (grey and black slices). Classification is explained in Appendix A5.8.
Although it is shown that BMAA can be present in aquatic ecosystems, this conclusion is only 
based on a narrow selection of articles (Figure 5.4). There is too little evidence to conclude 
that BMAA is occurring worldwide in aquatic ecosystems. Independent confirmation from a 
number of different laboratories is needed to verify this hypothesis.
More work is also needed to identify the BMAA producers in aquatic systems. Only one 
study has confirmed presence of BMAA in an axenic cyanobacterial culture [94]. The only 
study so far on BMAA production by cyanobacteria [99] does not provide evidence as the 
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experimental setup is flawed, there is too little evidence for correct BMAA identification and 
not all results are presented (Appendix A5.6). Diatoms might also be BMAA producers, as 
one study has shown that axenic diatom cultures contain BMAA [98]. Taken together, only 
two studies have identified cyanobacteria and diatoms as possible BMAA producers, but 
their findings have not yet been confirmed by other, independent laboratories. The question 
whether other organisms than phytoplankton are capable of BMAA production has so far 
only been explored for cycads [80].
For the majority of the published work on BMAA in aquatic ecosystems, it is unclear 
whether the results were correct. The field of BMAA analysis is still developing, and lack of 
certified reference material and an inter-laboratory validated method has resulted in the 
use of different analytical techniques. Amongst these, non-selective analytical methods 
have frequently been used, which may have caused false positives or overestimations. In 
addition, the appropriateness of some selective analytical methods could not be verified 
because BMAA identification was insufficiently reported.
Nevertheless, the use and description of analytical techniques are not the only sources of 
confusion in aquatic BMAA research. It lacks a solid foundation as the conclusions drawn 
in some of the key articles on analysis [84, 88, 95], production by cyanobacteria [99] and 
human exposure through cyanobacteria [156] were either unclear or not supported by 
the presented data. Finally, literature interpretation is hindered by occasional selective 
referencing to positive findings and by lack of a critical evaluation of the presented work.
5.5.2 Improving the science 
The first steps to advance BMAA research in aquatic ecosystems have been made by the 
increased use and development of selective analytical methods. An inter-laboratory 
comparison and validation of these methods, preferably using certified reference material, 
would be a next step toward a more unified discussion on which analytical methods to 
use in BMAA research. However, the field can only move forward if the use of appropriate 
methods is combined with correct and complete description of research. Future studies 
should include an extensive and correct description of methods and results (see e.g. 
[85]), with special attention to recovery data, quantification procedure and identification. 
Furthermore, the work should be critically evaluated and should be put it in its scientific 
context.
A solid base of knowledge relies on good insight into past results. Most evidence for 
correct BMAA analysis is provided in sixteen studies [76-79, 83, 93, 94, 97, 98, 100, 102, 
135, 145, 147, 148, 164]. While it is well possible that BMAA has correctly been identified 
(and/or quantified) in other studies, there is no publicly available evidence for it. Full analysis 
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disclosure, or availability of sample material for comparative analyses is essential to improve 
the current state of knowledge in BMAA research.
In conclusion, the current knowledge on presence of BMAA in aquatic ecosystems is more 
limited than the literature suggests. The state of knowledge will increase if appropriate, 
inter-laboratory validated methods are developed and used, and if the analytical work is 
correctly reported. This progress is needed to establish to what extent humans are exposed 
to BMAA through for instance ingestion of surface water during recreation and consumption 
of seafood. 
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APPendix A5.1. 
MeThod ABBreviATions
AA (amino acid analyser):
liquid chromatography separation, detection by visible light absorption 
CE-UV:
capillary electrophoresis separation, ultra violet detection
ELISA (enzyme linked immunosorbent assay):
identification by antibodies, detection by visible light absorption 
GC-MS:
gas chromatography separation, mass spectrometry detection
1H-NMR:
proton nuclear magnetic resonance spectroscopy
LC-FLD:
Liquid chromatography separation, fluorescence detection
LC-MS:
Liquid chromatography separation, mass spectrometry detection
LC-MS/MS:
Liquid chromatography separation, tandem mass spectrometry detection
LC-UV:
Liquid chromatography separation, ultra violet detection
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APPendix A5.2. 
ArTicle discussion ‘disTinGuishinG The cyAnoBAcTeriAl 
neuroToxin β-N-MeThylAMino-l-AlAnine (BMAA) froM iTs 
sTrucTurAl isoMer 2,4-diAMinoBuTyric Acid (2,4-dAB) [84]’
From 2008 up to 2010, it was repeatedly suggested that DAB had by some methods possibly 
been misidentified as BMAA (e.g.[76, 77]). In this 2010 article, LC and GC based methods are 
reviewed and their ability to separate BMAA from DAB is discussed.
LC separation of BMAA and DAB
The LC section starts with an overview of methods that can distinguish DAB from BMAA, 
and chromatograms are shown to prove separation. However, the legends of six of the ten 
provided chromatograms are incomplete or incorrect, so it is unclear by which methods the 
chromatograms are produced:
•	 Fig 2A: Legend refers to a 60 min gradient in [43], but in this reference a 49 minute 
gradient was employed
•	 Fig 2C: Legend refers to studies in which no BMAA analysis was performed [167, 168]
•	 Fig 4: Sample used from [156], method unknown. Retention time of BMAA does not 
match the retention time in [156]. Figure shows BMAA and DAB, while in [156] only 
BMAA was shown in the LC-MS/MS chromatogram
•	 Fig 6: No method given, this seems to be a later published method [122]
•	 Fig 7: No method given
•	 Fig 8: DAB not shown, no methods given but figure is identical to Fig 1 in a later published 
study [162]. Legend states that samples have been derivatised according to [36], but [36] 
is not a LC-MS but a GC-MS study in which a different derivatisation procedure has been 
used. This is reflected by the different reported m/z for the BMAA derivatised: 130.2 in 
[36] and 333 in this figure.
The authors suggest that negative findings by underivatised Hydrophilic Liquid Interaction 
Chromatography (HILIC) MS/MS analysis are caused by inferior performance of this method. 
However, they did not compare method performance data like LODs and recoveries to 
verify whether the performance of underivatised methods was indeed worse than that of 
derivatised MS/MS methods. An example is given to support the claim that HILIC separation 
is less efficient and results in broad peaks, however the peak that is referred to (Figure 2A 
in [77]) is of equal width as one of the peaks shown for derivatised separation (Figure 2A 
in [84]). Furthermore, authors state that DAB was routinely used in sample queues for LC 
methods from the first article in 2003 on [42], but in many of the articles published after 
2003 by the authors, DAB is not mentioned (e.g. [33, 35, 107]). Furthermore, they state 
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that negative findings of another study [78] were confirmed by the author’s own LC-MS/MS 
methods, but no method details or references are provided.
GC separation of BMAA and DAB
The question whether BMAA and DAB are separated in GC based methods [36, 169] is not 
answered in this manuscript, although there is a paragraph dedicated to this subject. It 
is only stated (in the LC paragraph) that in one GC-MS method [36], BMAA is separated 
from alanine, sarcosine and trypotophan. However, the retention times of these three 
amino acids have not been reported in [36]. Instead, they are taken from another study 
in which different conditions are used [170]. As different chromatographic conditions can 
lead to differences in retention times, the results of [170] cannot be extrapolated to [36]. 
Furthermore, it was stated that a GC-MS method developed by another group [169] might 
be too insensitive for BMAA detection, however only the LOD for the protein-bound fraction 
is referred to, and not the LOD for free BMAA, which was 50 times lower [169].
Discussion
In the discussion, the authors recommend a comparative exercise between laboratories 
that should include a repetition of validated methods (for issues with the term validated, 
see Section 5.3.4 in this Chapter), a balanced view on whether HILIC chromatography is 
adequate for BMAA analysis and a check for unambiguous determination of BMAA. They 
hereby again question the suitability of HILIC based methods without providing fact based 
arguments against it.
In conclusion
This article suffers from many reporting deficiencies: not all addressed questions were 
answered, parts were suggestive and incorrect references were given. Methods that had not 
yet been published were included in this review, although it was stated that previous results 
were considered. Furthermore, separation of DAB and BMAA by GC-MS was not adequately 
discussed. As it is not made explicit which studies have and which have not separated BMAA 
from DAB, the conclusion that these compounds are “routinely and clearly distinguished by 
having different retention times during chromatographic separation” is not supported by 
the presented data.
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APPendix A5.3. 
ArTicle discussion ‘disTinGuishinG The cyAnoBAcTeriAl 
neuroToxin β-N-MeThylAMino-l-AlAnine (BMAA) 
froM oTher diAMino Acids [95]’
In this 2011 article, a group of scientists reports the separation of BMAA from other diamino 
acids. Five analytical techniques are described and chromatograms showing separation of 
BMAA from other compounds are presented.
Justification and research aim
It is unclear why this research has been performed, it lacks a description of the justification 
and aim. In the introduction, authors only state that it is important to distinguish BMAA 
from similar molecules. The method section does not provide clarity either. It consists of the 
description of five analytical techniques, all but one are not referred to, and are therefore 
assumed to be developed for this study. The one method referred to (LC-FLD, § 2.7.), should 
also be regarded as a newly developed method. Although the references [34, 42, 43] suggest 
it has already been used before, the elution program used in two of these studies differs 
from the one described in § 2.7. [34, 43]. In the other study [42] no elution program was 
reported, but a reference to yet another study [126] is made. The elution program in this 
reference does however also not correspond to the elution program described in § 2.7.
Relevance of the work
After having reached this point in the manuscript, it looks like new methods were developed 
to enable good separation of BMAA from other diamino acids. When placed in the context 
of the main debates in BMAA research from 2009 to 2011, some questions on the relevance 
of the work arise:
•	 The interference in methods based on optical detection is not limited to diamino acids, 
but to compounds with amino groups [76, 93]. Why are only a few diamino acids tested 
for these methods?
•	 Diamino acids with a different molecular weight from BMAA are not the most likely 
candidates to interfere in methods with mass-spectrometry detection [93]. Why are all 
but two tested diamino acids compounds with a different molecular weight?
Relation to previous and future work
In the results section, authors state that the methods have indeed been adapted in this study 
and show that BMAA can be distinguished from the tested diamino acids by these methods. 
It then, however, becomes confusing whether the subsequent conclusions are based on 
methods used in this study or on previously used methods. Authors state that standard 
LC-MS/MS methods distinguish BMAA from other amino acids, with a reference to previously 
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used methods [34, 94]. As these previous methods differ from the ones presented in this 
study, this statement would imply that the conclusion is based on previous methods, but 
this conclusion is not supported by data or chromatograms. Furthermore, it is mentioned 
that the BMAA isomer N-2(amino)ethylglycine coeluted with BMAA in the current 
LC-UV/MS method, but that in previous studies that included LC-UV or LC-MS analysis 
[34, 92, 107, 156], BMAA identification was correct because other methods were used 
for confirmation. Also in this case, three [34, 92, 107] of the four the methods referred 
to are different from the tested method so it is unclear whether N-2(amino)ethylglycine 
coelution had also occurred in these studies. In the discussion “standard methods” are 
mentioned without definition: “We found that standard methods of amino acid analysis 
clearly distinguish BMAA from the twelve amino acids tested”.
The repeated referring to “standard” and “previously used” methods implies that BMAA was 
already separated from other diamino acids in previous work. As it is neither discussed how 
the methods used in this study relate to previously used methods and nor whether, to the 
opinion of the authors, BMAA was correctly identified in previous studies, the implications 
of the study remain unclear.
In conclusion
It is unclear which questions are answered by this study. Five methods have been shown 
to separate BMAA from a selection of diamino acids, but the relevance of this selection is 
questionable and not discussed. As these methods have all been adapted in this study, no 
conclusion about separation of BMAA from the selected compounds in previous studies can 
be drawn. However, the repeated reference to “standard” and previously used methods 
could mistakenly make a reader think that it is shown in this article that BMAA was also 
separated from the selected compounds in previous work.
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APPendix A5.4. 
ArTicle discussion ‘cyAnoBAcTeriA And BMAA 
exPosure froM deserT dusT: A PossiBle link To 
sPorAdic Als AMonG Gulf wAr veTerAns [156]’
In this 2009 article, cyanobacteria crusts from the Qatar desert were collected and analysed 
for BMAA in order to assess whether veterans had been exposed to BMAA during the Gulf 
War. It was concluded that BMAA was present in the cyanobacteria crusts, which led to 
the suggestion that BMAA exposure through desert dust may be linked to the increased 
incidence of ALS in Gulf War veterans.
Incomplete description of methods
Cyanobacteria crust samples were taken from one location in 2007 and from three locations 
in 2008. It is unknown how many samples were taken from each location. After sampling, 
some crust samples were dried and analysed, while others were cultured and subsequently 
analysed. It is unclear how many samples were cultured and what the origin of this/these 
samples was.
Four different methods were used for BMAA analysis. It is unclear which samples were 
analysed by which methods. The only thing that is clear is that samples that were positive 
for BMAA in AA and/or LC-FLD analysis were reanalysed by LC-MS/MS and that the cultured 
samples were analysed by LC-MS and AA.
Incomplete description of results
Authors state in the Results section that BMAA was detected in desert crust samples from one 
location and that BMAA and DAB were detected in the cultured crust. It is unknown whether 
BMAA was detected in the samples from the other locations. The provided chromatograms 
do not provide more clarity as is not made clear to which samples they belong, it is only 
stated whether they represent dried or cultured samples. Furthermore, some samples 
were analysed by multiple methods, but the results of these analyses per sample are not 
presented, so it is unclear whether they are in agreement. BMAA concentrations are not 
reported.
Incorrect data visualisation
The provided LC-MS/MS chromatogram consists of three panels, one of which gives 
information on the sample and the other two give information on a BMAA standard. In 
two of these panels, product ions for a standard and for a sample are shown. However, the 
product ions of the standard were acquired at different settings than those of the sample. 
This results in different ratios of product ions between the standard and the sample (see 
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also Section 5.3.5 of this Chapter). It is unclear whether these ratios would have been the 
same when analysed under the same conditions and therefore whether BMAA has correctly 
been identified by LC-MS/MS.
In conclusion
The major problem of this article is that it is unclear how many samples were analysed and 
how much BMAA was present in each sample. As the presence of BMAA in cyanobacteria 
was linked to BMAA exposure of veterans, it is essential to know the BMAA concentrations 
and distribution in the sampled areas. Another problem is the confirmation by LC-MS/MS. 
The crust samples that tested positive for BMAA with the less selective methods LC-FLD 
and AA were reanalysed by the more selective method LC-MS/MS. However, the presented 
LC-MS/MS chromatograms do not provide enough information to prove that BMAA was 
correctly identified with this method.
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APPendix A5.5. 
ArTicle discussion ‘reAcTiviTy of β-MeThylAMino-l-AlAnine 
in coMPlex sAMPle MATrixes coMPlicATinG deTecTion And 
quAnTificATion By MAss sPecTroMeTry [88]’
This 2012 article explores a possible explanation for the frequent lack of detection of BMAA 
by underivatised LC-MS(/MS) analyses. For this, the effect of different solutions on the 
BMAA signal in LC-MS analysis is determined. The authors hypothesise that the formation 
of adducts and complexes hinders electrospray ionisation MS analysis and can distort 
chromatography.
Adduct and complex formation and the detection of mass-to charge ratio (m/z) 119
Adduct formation is determined by adding BMAA to different trichloroacetic acid (TCA)/salt 
solutions. These mixtures are scanned at different cone voltages and the intensity of the 
ion with a m/z of 119 (singly charged BMAA) and the m/z’s of BMAA adducts and dimers 
are recorded. As the response of m/z 119 is low in most solutions and for most settings, it 
is concluded that even under optimal circumstances, m/z 119 accounts for less than 10% of 
the total BMAA ions in solution. This is however contradicted by Figure 2A, which shows a 
70% presence of m/z 119 and by Figure 1, which shows a 30% presence. Furthermore, this 
conclusion implies that other MS settings are optimized for BMAA analysis at m/z 119 and 
that TCA is the optimal solution for BMAA detection. This is contradictory to earlier work, 
which is not discussed in the current article. In this earlier work, m/z 119 is found to be the 
main peak after infusion of an aqueous BMAA solution [76]. 
Complementary to the evaluation of adduct formation, the authors explore whether metal 
complexes of BMAA can form in sample matrixes by chemically synthesizing a BMAA-Zinc 
complex. However, chemical synthesis of a BMAA-Zinc complex does not prove that this 
complex will be formed in real samples. To prove this, real samples should be analysed for 
the presence of such a complex, but this is not done.
Implications for sample analysis
The authors conclude that signal suppression and alteration of chromatographic behaviour 
due to adduct and complex formation may lead to an extreme underestimation of BMAA 
concentrations in underivatised LC-MS sample analysis, especially when external calibration 
curves are used for quantification. However, nearly all underivatised MS(/MS) studies have 
anticipated this by determining recovery [77, 78, 93, 102, 120], by using matrix based 
calibration curves [79] or by using D
3
BMAA as an internal standard [76, 93]. In these studies, 
recovery rates generally exceed 80% and matrix based calibration curves have similar 
slopes as neat curves, so there is no indication that strong signal suppression indeed occurs 
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in real samples. The authors, however, suggest that the reaction time used for recovery 
determination is too short for complex formation, and that reported recoveries are therefore 
highly overestimated. This is an important suggestion, as it supports the main conclusion of 
the article. However, it is not grounded on arguments or data. In the method section, it is 
not mentioned that BMAA was allowed to react with TCA or salt solutions for a given period 
of time, nor are data on reaction time shown in the results section. Also in an older article 
that describes BMAA-metal complex formation [87], no reaction times are given.
Furthermore, the authors suggest that the solutions used in this study are representative 
for sample extracts, but they do not provide data on metal concentrations in cyanobacterial 
extracts. Trace element composition of marine phytoplankton [171], however, suggest that 
metal concentrations in cyanobacterial extracts will be much lower than the concentrated 
(9 mM salts and 10 mM TCA for each treatment) solutions used in this study. The authors 
conclude that BMAA reactivity may complicate analysis of many different types of samples, 
but have not verified this conclusion by analysing real samples.
Recommended analytical procedure
The article ends with the recommendation to use derivatisation combined with reversed 
phase chromatography for sample analysis, and to use at least two orthogonal detection 
methods such as FLD and MS. Finally, it is recommended to use multiple m/zs in BMAA 
analysis. This latter recommendation is supported by the presented work, but the other 
recommendations are not. Firstly, no adequate comparison between derivatised and 
underivatised MS analysis is carried out in this study. In the only study in which these 
methods have been compared, derivatised MS/MS analysis did not perform better than 
underivatised MS/MS analysis [93], but the authors do not refer to this study in their 
discussion. Furthermore, FLD detection is suggested as additional technique, without 
referring to recent articles that provide arguments against the use of this method [93, 134].
In conclusion
A possible weak point in MS analysis is pointed out in this article, which is valuable. However, 
the relevance of the experiments for real sample analysis is not shown and most conclusions 
are not supported by data. Finally, not all relevant publications are discussed, resulting in a 
biased view on the subject.
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APPendix A5.6. 
ArTicle discussion ‘niTroGen 
sTArvATion resulTs in The ProducTion of 
β-N-MeThylAMino-l-AlAnine [99]’
This 2011 article was the first to investigate conditions under which cyanobacteria produce 
BMAA. In this experimental study, two cyanobacterial strains are repeatedly subjected to 
nitrogen starvation. The presence of BMAA in the cultures is monitored throughout the 
experiments and authors conclude that nitrogen starvation results in the production of 
BMAA.
Flaws in experimental setup
One weak point of this work is that the design of this experiment is flawed. Nitrogen is 
supplied as labelled ammonium in the experimental treatment and as unlabelled nitrate in 
the control treatment. As cyanobacteria differ in their response to ammonium and nitrate 
as nitrogen source [172], the type of nitrogen source should be similar between treatments. 
Furthermore, in a nitrogen starvation experiment, the proper control treatment would be 
nitrogen repletion rather than nitrogen starvation.
Suboptimal analysis
Another problem with this study is the detection of BMAA. Samples were analysed by LC-
MS/MS, either as a Q1 scan without collision induced dissociation or in multiple reaction 
monitoring mode with collision induced dissociation and detection of product ions. This 
means that the LC-MS/MS was used as a less selective LC-MS for most of the analyses.
Presentation of raw data
The presented data are either too little or too much processed for good interpretation. 
Examples of too little data processing are the figures in which a BMAA decrease or 
increase is shown. In these figures (Figure 1 and 3), results are presented as LC-MS(/MS) 
peak areas instead of as cellular or biomass related toxin content or concentrations, which 
are more commonly used (e.g. [150, 173]). During the experiment, a fixed volume of 
sample was taken at each sampling event. It is not shown how the biomass concentration 
changed during the experiments, but as the experiment is performed in batch cultures, it 
is likely to have changed. Therefore, it is reasonable to assume that different amounts of 
cyanobacteria were present in the different samples. As only the intensity of the MS(/MS) 
signal is shown, no correction is made for these changes in biomass concentration. Figures 
1 and 3, therefore, only reflect the total amount of BMAA present in the sample and it 
cannot be derived whether the observed changes in these figures reflect changes in cellular 
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BMAA concentrations or merely result from changes in biomass concentration during the 
experiment.
Obscured data presentation
The changes in labelled amino acid abundance in the experimental cultures are too much 
processed to allow easy interpretation. The increases in labelled amino acids after nitrogen 
starvation are shown as ratios of the singly labelled to the unlabelled amino acids, which 
are subsequently normalized against control cultures. This use of ratios of ratios obscures 
the results. More importantly however, results do not represent a response to nitrogen 
starvation as the control treatment had also been nitrogen starved. The results represent 
the differences in cyanobacterial response to the nitrogen sources used and from the 
presented data it can again not be derived whether these differences are caused by changes 
in cellular composition and/or in biomass.
Incomplete data presentation
Not all essential data are presented. Data on biomass indicators and nutritional status of the 
cyanobacteria are lacking. The table that shows the increase in labelled amino acids, lacks 
data for some samples, but this is not explained. In addition, Figures 1 and 3 only show free 
unlabelled BMAA, the unlabelled protein associated fractions and both fractions of labelled 
BMAA are missing.
In conclusion
This study suffers from flaws in the experimental design and lack of data on cyanobacterial 
biomass, nutritional status and presence or absence of different BMAA fractions. It was 
for instance not checked whether the cyanobacteria were really nitrogen starved and the 
right control treatments were not included. Furthermore, the employed LC-MS/MS was 
mostly operated as a LC-MS without motivation. Too little data (e.g. chromatograms with 
product ions of standards and a samples) were provided to show that BMAA was correctly 
identified. Taken together the above mentioned flaws and omissions and either the lack of 
data processing or the expression of data as ratios of ratios instead, this article’s  conclusions 
cannot be verified by the presented data.
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APPendix A5.7. 
rePorTinG quAliTy of MeThods And resulTs
Table A5.7. Reporting quality of methods and results. Only methods with which environmental 
samples were tested are included. Symbols used are: + (nearly) correct and complete, ~ incomplete or with errors, 
- absent or with major errors, p shown in previous publication of the same method, x not applicable. Coloured 
columns summarize previous columns, colours correspond to the symbols + (green), ~ (orange), – (red) and x (white). 
Studies in which previously published method were used and referred to are indicated by: § [94], ^ [148], # [93] and 
% [98].
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[33] LC-MS Y ~ - - - - - - + - x - - - - - - - - - - - - 
[33] LC-FLD Y ~ - - - - - - ~ ~ ~ ~ - - + - - ~ ~ + + - + 
[35] LC-FLD Y + + + + - - - + + - ~ - - + - - - - + + + + 
[35] LC-MS/MS Y + + + + - - - + + x ~ - - - - - - - - ~ - - 
[34] AA N + - - ~ + x + + + - + - - - - - - - - + - ~ 
[34] LC-MS/MS Y + - - ~ - - - + ~ ~ ~ - - - - - - - - + - ~ 
[34] LC-MS Y + - - ~ ~ ~ ~ + + x + - - - - - - - - ~ ~ - 
[34] LC-UV Y + - - ~ + + + ~ + ~ + + - + - + - ~ - ~ - -
[34] LC-FLD Y + - - ~ + + + + + + + - - - - - - - ~ ~ ~ ~ 
[125] LC-FLD Y + + + + ~ - - + ~ + ~ ~ + ~ ~ - - ~ - - ~ -
[78] LC-MS N ~ - - - + x + + + + + + + + - - + + + - + + 
[107] LC-UV Y + + - ~ ~ - - ~ ~ - ~ - - - - - - - + + - + 
[107] LC-MS Y + + - ~ ~ - - + + x + - - - - - - - + + - + 
[107] LC-MS/MS Y + + - ~ - - - + + x + - - - - - - - - ~ - - 
[107] LC-FLD Y + + - ~ ~ - - + + ~ + - - + - - - ~ + + - + 
[36] GC-MS Y + + + + - - - + + + + + - + - - - ~ + ~ ~ ~ 
[76] LC-MS/MS N ~ - - - ~ x + + + + + + + - + + - + + + + + 
[111] 1H-NMR X ~ - - - ~ x ~ ~ + + + + + + - + + + + - + + 
[148] LC-FLD Y ~ - - - + + + + + x + + + + + - + + + + + + 
[102] LC-MS/MS N + + + + + x + + + + + - + + + - + + + + - + 
[157] LC-MS Y + - - - - - - ~ - ~ - - - + - - ~ ~ - - - - 
[158] LC-MS/MS N ~ - - - - x - + ~ - ~ - - - - - - - ~ ~ ~ ~ 
[158] LC-FLD Y ~ - - - + + + + + + + - - + - - - - - - - - 
[163] LC-MS/MS Y + + + + + - ~ + + x + - - - - - - - - ~ - - 
[159] LC-MS/MS Y - - - - + - - + + x + - - - - - - - - + - ~ 
[156] AA N - + - - - x - + + x + - - - - - - - - + - ~ 
[156] LC-MS/MS Y - + - - - - - + + x + - - - - - - - ~ ~ - - 
[156] LC-FLD Y - + - - - - - + ~ x ~ - - - - - - - + + - + 
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[156] LC-MS Y - + - - - - - + ~ x ~ - - + - - - ~ + + - + 
[120] LC-MS/MS N + + - ~ ~ x - + + x + + + + + + ~ + ~ ~ - - 
[120] LC-MS N + + - ~ ~ x - + + x + + + + - + ~ + + + - + 
[120] LC-MS/MS Y + + - ~ ~ - - + + X + - - - - - - - - - - -
[94] LC-MS/MS Y + + + + ~ + + + + + + - + + - + - ~ + + - + 
[83] LC-MS/MS§ Y + + + + ~ + + + + + + - p p - p - p + + - + 
[82] LC-FLD Y + + ~ + + - ~ ~ + + + + - - + - + ~ - + + + 
[82] LC-MS/MS Y + + ~ + - - - + ~ x ~ - - - - - - - ~ ~ - - 
[77] LC-MS/MS N + + + + + x + + + + + - + - + - + ~ + + - + 
[122] LC-MS Y + + + + - - - + + ~ + + + + - + - + + - - ~ 
[99] LC-MS/MS Y + + + + - - - + + x + - - - - - - - - + - ~ 
[133] LC-FLD Y + + ~ + ~ + + + ~ - ~ - + + - - - ~ ~ - - - 
[121] CE-UV X + + ~ + ~ x + + + + + + + + - + + + + - ~ ~ 
[162] LC-MS Y - - + - ~ - - + + ~ + - - - - - + ~ - ~ - - 
[147] LC-FLD^ Y + + + + + + + + + x + - + - + - + + p p p p 
[79] LC-MS/MS N + + + + + x + + + + + + + + + + + + + + + + 
[96] LC-FLD Y + - - - + + + + - - - + + + - ~ + + + + - + 
[144] LC-FLD Y + ~ + + - - - ~ + ~ ~ - - + - - ~ ~ + + - + 
[144] LC-MS/MS Y + ~ + + - - - - + x ~ - - - - - - - ~ ~ - - 
[97] LC-MS/MS Y ~ - + - ~ - - + + x + - + - + + - ~ + + + + 
[93] LC-MS/MS N + + + + + x + + + + + + + + + + + + + + - + 
[93] LC-MS/MS Y + + + + + + + + + + + + + + + + + + + + - + 
[93] LC-FLD Y + + + + + + + + + + + + + + + + + + + + + + 
[145] LC-MS/MS Y + - - - ~ + ~ + + + + + + + + + + + + + + + 
[143] LC-MS/MS Y ~ + + ~ - - - ~ ~ - ~ - - + + - + ~ ~ ~ + ~ 
[135] LC-MS/MS Y + + - + ~ - - + + + + + + + + + + + + + - + 
[105] LC-MS/MS N + + + + + x + + + + + + + + + + + + + - ~ ~ 
[153] ELISA X + + + + + x + + + + + + + + + - + + x x x x 
[153] LC-MS/MS# N + + + + + x + + + + + p p p p p p p p p p p 
[146] LC-MS/MS Y + + + + - - - - - - - - - - - - - - - - - - 
[100] LC-MS/MS Y + - + ~ + + + + + + + + + + + + + + + + + + 
[164] LC-MS/MS§ Y + + - ~ p p p + ~ x + - - - - - - - + + - + 
[149] LC-MS/MS Y + + ~ + ~ ~ ~ + ~ - ~ - - - - - + ~ - - - - 
[174] LC-FLD Y + ~ + + + + + + + + + + + - + - - ~ - - + ~ 
[174] LC-MS/MS Y + ~ + + + + + + + - ~ + + - + - - ~ - - + ~ 
[98] LC-MS/MS Y + + + + ~ - ~ + ~ + ~ + - - - - - - + + - + 
[142] LC-MS/MS% Y ~ p p + p p p p p p p p p p p p p p + ~ - ~ 
* Limit of detection (LOD)/Limit of quantification (LOQ)* Limit of detection (LOD)/Limit of quantification (LOQ)
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1 + + + + + [98, 100, 102, 135, 145] 
2 + + + + - [83, 94, 97, 164] 
3 - n.a. + + n.a. [76-79, 93, 147, 148] 
4 - + - + n.a. [111] 
5 + - n.a. n.a. n.a. [33, 36, 96, 121, 122, 125, 133, 153, 
157, 162] 
6 n.a. + n.a. - n.a. [34, 35, 82, 99, 105, 107, 120, 142-144, 
146, 149, 156, 158, 159, 163, 174] 
*Group numbers indicate:
1: BMAA detected by highly selective method, identification and quantification correctly reported
2: BMAA detected by highly selective method, identification correctly reported, but quantification
insufficiently reported
3: No BMAA detected by sensitive method, identification correctly reported
4: No BMAA detected by insensitive method, identification correctly reported
5: BMAA reported but no highly selective method used
6: BMAA identification by highly selective insufficiently reported
n.a.: not applicable.
*Group numbers indicate:
1: BMA  det cted by hig ly selective method, identification and qu tification correctly reported
2: BMA  detected by highly sel ctive method, i entification correctly repo ted, but quantification insufficiently 
reported
3: No BMAA det cted by sen itive m thod, identification correctly reported
4: No BMAA det cted by inse itive method, identification correctly eported
5: BMA  reported but no hig ly selective method use
6: BMA  identification by highly selectiv  insufficiently reported
n.a.: not applicable.
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CHAPTER 6
TrAns GenerATionAl effecTs 
of BMAA on DaphNia magNa
This chapter has been published as: Trans generational effects of the neurotoxin BMAA on 
the aquatic grazer Daphnia magna. Faassen, E.J., García-Altares, M., Mendes e Mello, M. 
and Lürling, M., 2015. Aquatic Toxicology 168, 98-107.
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ABSTRACT
β-N-Methylamino-L-alanine (BMAA) is a neurotoxin that is suspected to play a role in the 
neurological diseases amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s 
disease. BMAA has been detected in phytoplankton and globally, the main exposure routes 
for humans to BMAA are through direct contact with phytoplankton infested waters and 
consumption of BMAA contaminated fish and invertebrates. As BMAA can be transferred 
from mothers to offspring in mammals, BMAA exposure is expected to have trans 
generational effects. The aim of our study was to determine whether maternal exposure 
to BMAA affects offspring fitness in zooplankton. We performed a multi-generational life 
history experiment and a multi-generational uptake experiment with the water flea Daphnia 
magna as a model species. In both experiments, offspring from non-exposed and exposed 
mothers were raised in clean and BMAA containing medium. Direct exposure to 110 µg/l 
BMAA reduced survival, somatic growth, reproduction and population growth. Maternal 
exposure did not affect D. magna fitness: animals from exposed mothers that were raised 
in clean medium had a higher mortality and produced lighter neonates than the controls, 
but this did not result in lower population growth rates. No evidence for adaptation was 
found, instead, multi-generation exposure to BMAA had a negative effect: animals that 
were exposed during two generations had a lower brood viability and neonate weight than 
animals born from unexposed mothers, but raised in BMAA containing medium. Maternal 
transfer of BMAA was observed, but BMAA concentrations in neonates raised in BMAA 
containing medium were similar for animals born from exposed and unexposed mothers. 
Our results indicate that zooplankton might be an important vector for the transfer of BMAA 
along the pelagic food chain, but whether BMAA plays a role in preventing zooplankton 
from controlling cyanobacterial blooms needs further investigation.
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6.1 INTRODUCTION
The neurotoxin β-N-methylamino-L-alanine (BMAA) is suspected to play a role in the 
neurological diseases amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s 
disease [37, 46, 59, 69]. BMAA was discovered on the island of Guam in seeds of the cycad 
Cycas micronesica [31], which were used as food by the native Chamorro people [138]. Since 
there was a long latency period between exposure and onset of the disease, BMAA was 
considered to be a slow toxin [175]. It was suggested that this latency period was caused by 
the presence of a ‘toxic reservoir’, in which BMAA was stored in a protein-associated form 
and was slowly released in its free form [70]. Recent studies indeed indicate that BMAA 
can either associate with, or be incorporated into proteins [65, 90, 141, 176], although this 
association might in some cases be superficial [91]. BMAA can be maternally transferred 
as shown for mice, either directly [177] or trough milk during lactation [178]. If BMAA can 
reside inside the body for a longer period of time and can be transferred to offspring, it 
is likely that BMAA exposure can have trans generational effects. However, the effect of 
maternal exposure on offspring fitness has not been studied yet.
Globally, the main human exposure routes to BMAA are via the aquatic ecosystem, like 
through direct contact with phytoplankton infested waters and consumption of BMAA 
contaminated fish, shellfish and other invertebrates [58]. BMAA has been detected in natural 
phytoplankton communities (e.g. [83, 102]) and in laboratory cultured cyanobacterial and 
diatom isolates [94, 98]. Although reported values vary widely, BMAA concentrations in 
phytoplankton (when present) are expected to lie in the ng/g dry weight (DW) to low µg/g 
DW range [58]. In addition, BMAA has been found in animals used for human consumption, 
such as crabs, oysters, mussels and fish (e.g. [83, 100, 145]), in concentrations similar to 
those for phytoplankton [58].
To test whether trans generational effects of BMAA exposure occur, animals with short 
generation times can best be used. The water flea Daphnia magna reproduces fast and 
asexually, and is easy to culture. Moreover, D. magna is naturally exposed to BMAA, as it 
can feed on BMAA containing phytoplankton species such as cyanobacteria and diatoms. 
It may therefore be a vector for BMAA transport along the pelagic food chain, and as such 
contribute to human BMAA exposure through fish consumption. Indeed, BMAA has been 
found in natural zooplankton populations at concentrations below 0.1 µg/g DW [83] and 
in experimentally exposed zooplankton [129]. Finally, herbivore zooplankton species, such 
as D. magna, play an important ecological role in freshwater systems. Under favourable 
circumstances, like low predation pressure, they can control phytoplankton abundance 
and contribute to a clear water system [8]. They transfer energy from primary producers 
to higher trophic levels and are therefore key species in many aquatic food chains [8]. 
Changes in Daphnia fitness may therefore result in altered phytoplankton composition and 
abundance, as well as in food web changes.
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BMAA in dissolved form is not acutely lethal to D. magna, but exposure to concentrations 
of 10 - 100 µg/l increased size at first reproduction and decreased population growth 
rate in a previous study [129]. Moreover, BMAA was detected in offspring from exposed 
D. magna mothers [129]. We therefore expect that BMAA exposure of D. magna mothers 
might affect their offspring’s fitness. As shown for the cyanobacterial toxin microcystin-LR, 
such trans generational effects can both enhance or decrease offspring fitness. In one study, 
cyanobacterial extracts and microcystin-LR reduced survival and delayed maturity in offspring 
from exposed mothers [179]. However, in some cases Daphnia can adapt to cyanobacterial 
exposure, as shown in another study [180]. In case adaptation occurs, offspring from 
exposed mothers can have an increased fitness when exposed to cyanobacteria compared 
to offspring from unexposed mothers [181]. This increased fitness might be caused by 
microcystin-LR induced maternal transfer of detoxification enzyme activation, which results 
in higher offspring survival under exposed conditions [182]. As shown for D. carinata, this 
maternally transferred inducible tolerance is clone specific, and could come at the expense 
of reduced fitness under unexposed conditions [183].
Current toxicological studies focus on direct effects of BMAA exposure. Given the expected 
trans generational effects of BMAA exposure, multi-generation studies are also needed. The 
aim of our study is to determine whether maternal exposure to BMAA affects offspring 
fitness in D. magna, a key species in aquatic systems that has the potential to transfer BMAA 
from phytoplankton to human food. We hypothesize that maternal exposure to BMAA 
negatively affects their offspring’s population growth rates and that D. magna does not 
adapt to BMAA exposure. To test these hypotheses, we performed a life history experiment 
with offspring born from unexposed and exposed mothers, that were raised in either clean 
or BMAA containing medium. We furthermore performed an uptake experiment to see 
whether BMAA could be maternally transferred. 
6.2 METHODS
6.2.1 Daphnia magna maintenance and pre-culture
Daphnia magna Straus used in our experiments was isolated from the Dutch lake Zwemlust 
in 1999 and was maintained in the laboratory as described earlier [129]. Both experiments 
were performed with neonates from a new isofemale lineage [129]. The life history 
experiment was performed in 2010 and the BMAA uptake experiment was performed in 
2015.
6.2.2 Life history experiment
Neonates (less than 24 hours old) were placed individually in glass tubes and were either 
placed in clean medium (n=12, control treatment, C), or received medium with a BMAA 
concentration of ~110 µg/l (n=12, BMAA treatment, B). The first two broods of this F0 
generation animals were immediately removed from the tubes. Neonates of the third broods 
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(generation F1, less than 24 hours old) from different mothers were individually transferred 
to new glass tubes. One or two neonates of each mother were transferred to clean medium, 
another one or two to BMAA containing medium (Figure 6.1). This resulted in the following 
treatments: transfer from clean medium to clean medium (n=11, control-control treatment, 
CC), from clean medium to BMAA containing medium (n=11, control-BMAA treatment, 
CB), from BMAA containing to clean medium (n=9, BMAA-control treatment, BC) and from 
BMAA containing to BMAA containing medium (n=10, BMAA-BMAA treatment, BB). These 
F1 animals were kept until they produced their third brood; all broods (the F2 generation) 
were immediately removed from the tubes. Survival, somatic growth, reproduction and 
population growth of the F1 generation, and presence of BMAA in the animals from the F1 
and F2 generation were endpoints for this experiment.
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Figure 6.1. Setup of the life istory experiment.
All glass tubes used in this experiment contained 100 ml of RT medium [184] and the green 
algae Scenedesmus obliquus SAG 276/3a at ~5 mg C/l. In the treatments where animals 
were exposed to BMAA, BMAA (L-BMAA hydrochloride, Sigma-Aldrich) was added to the 
medium at a nominal concentration of ~110 µg/l. BMAA stocks were prepared weekly, and 
the nominal concentration in the medium ranged between 104 and 117 µg/l due to different 
stock concentrations. F0 animals were transferred to new tubes with clean medium, food and 
BMAA (if appropriate) every two days, F1 animals were transferred daily. The experiment 
was performed at 22 °C and a light-dark regime of 18-6 hours at 7.4 µmol photons/m2 s in an 
incubator (Gallenkamp) without shaking.
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Every two days (F0 animals), and nearly every day (F1 animals), survival, number of living 
and dead neonates and body length were recorded. Body length was measured under 
a dissecting microscope and was defined as the distance from the most posterior point 
on the eye to the base of the junction of the tail spine with the carapace. After animals 
were removed from the experiment (neonates immediately after they were born, adults 
at the end of the experiment), they were thoroughly rinsed and placed in clean medium 
for a few hours. Animals were subsequently placed in small aluminium cups for dry weight 
determination. All adults were pooled per treatment. For neonates from F0 adults, 3 to 
4 broods per treatment (all belonging to the same brood number) were combined. The 
neonates from F1 adults were pooled per brood. The animals were dried overnight at 50 
°C before weighing on a MC5 microbalance (Sartorius). At the start of the experiment, 
body length and dry weight of 24 F0 neonates that were not used in the experiment were 
determined as a representative of t=0.
6.2.3 BMAA uptake experiment
The setup of the BMAA uptake experiment was similar to that of the life history experiment, 
except that the animals were not kept individually, but with 20 individuals in one jar to 
obtain enough biomass for the BMAA analysis. Twenty neonates (less than 24 hours old) 
were placed in glass jars and were either placed in clean medium (n=3, control treatment, 
c), or received medium with a nominal BMAA concentration of 78 µg/l (n=3, BMAA 
treatment, b). The animals were fed daily, and the first two broods of this F0 generation 
animals were immediately removed from the jars, as were the dead animals. When the eggs 
from the third brood of the F0 animals were deposited in the brood sac, the F1 mothers were 
transferred to the new exposure conditions. Half of these animals were transferred to clean 
medium, the other half to BMAA containing medium. This resulted in similar treatments 
as in the life history experiment: control-control treatment (cc), control-BMAA treatment 
(cb), BMAA-control treatment (bc) and BMAA-BMAA treatment (bb, all n=3). After half of 
the F0 mothers had produced their third brood, 20 F1 neonates were randomly selected and 
were used for the second part of the experiment. The other neonates (F1) and the adults 
(F0) were removed from the jars. In the second part of the experiment, the 20 selected F1 
neonates were kept in the treatment in which they were born, until they produced their 
third brood. All broods (F2) were immediately removed from the jars. Survival, total number 
of offspring, brood mortality and concentration of BMAA in the animals were endpoints for 
this experiment.
All glass jars used in this experiment contained 800 ml of RT medium. Animals were 
transferred to new jars with medium and BMAA (if appropriate) at each pregnancy and 
after giving birth. The medium of the jars in which the animals were kept up to their first 
pregnancy was refreshed every three days. The animals were fed with S. obliquus SAG 
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276/3a, an amount corresponding to a food concentration of ~5 mg C/l was added daily. 
The experiment was performed in the dark at 20 °C in an incubator without shaking. 
Every day, survival and number of living and dead neonates were recorded. After living 
animals were removed from the experiment, they were thoroughly rinsed and placed in 
a beaker containing 100 ml of clean medium with ~5 mg C/l of S. obliquus for three hours. 
After these three hours, they were rinsed again and stored at -20 °C in Eppendorf tubes. 
Animals were pooled per replicate and brood: for each jar, the adults were pooled, as were 
the first broods, the second broods and the third broods.
6.2.4 BMAA analysis
The dried D. magna samples from the life history experiment were removed from the 
aluminium cups and were prepared and analysed for BMAA by LC-MS/MS as in [129]. In 
short, dried samples were hydrolysed in 6 N HCl vapour for 20 hours at 105 °C in a hydrolysis 
workstation (Eldex). After drying, these samples were reconstituted in 300 µL acetonitrile/
water/formic acid (v/v 65:35:0.1) and transferred to a vial for analysis. Analysis was 
performed on an Agilent 1200 LC and 6410 MS/MS. These analyses were performed before 
we developed our method with internal standard [93] and the BMAA content of the samples 
from the life history experiment could therefore not be quantified. BMAA concentrations in 
the medium were not determined, as medium was refreshed daily and BMAA was expected 
to be stable from previous test results.
Daphnia samples from the uptake experiment were analysed according to [93] with slight 
modifications. Before analysis, samples from the uptake experiment were lyophilized and 
homogenized with a plastic stick. Depending on the available amount of sample material, 
0.2 up to 1.1 mg (less than 0.2 mg for some brood samples) was transferred to a small glass 
tube and 40 µl of a 2 mg/l D
3
BMAA (D
3
BMAA hydrochloride, Novakits) solution in 20 mM HCl 
was added. After the samples were dried under vacuum, 30 µl 6 N HCl was added to each 
sample and after flushing with nitrogen gas, liquid hydrolysis was performed for 17.5 hours 
under vacuum in a hydrolysis workstation at 105 °C. After hydrolysis, samples were dried 
under vacuum and reconstituted in 1 ml of acetonitrile/water/formic acid (v/v 67:33:0.1) 
and filtered in a tube with a 0.2 µm cellulose acetate filter (Grace Davison Discovery Science) 
for 5 minutes at 16000 * g. The filtrate was transferred to a vial, stored at 4 °C and analysed 
by LC-MS/MS within two weeks.
The medium from the uptake experiment was regularly sampled. These samples were 
filtered over a 0.2 µm cellulose acetate filter for 5 min at 16000 * g. 300 µl of the filtrate was 
transferred to a vial and 600 µl of acetonitrile with 0.15% formic acid (v:v) was added. The 
samples were stored at 4 °C awaiting analysis.
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LC-MS/MS analysis was performed according to [93] with slight modifications. Separation 
was performed on an Agilent 1260 LC, with a 2.1 x 150 mm, 5 µm ZIC-HILIC column (SeQuant, 
Sweden). Column temperature was 40 °C, injection volume 5 µl and flowrate 0.4 ml/min. 
The mobile phase consisted of acetonitrile with 0.1 % formic acid (v/v, eluent A) and water 
with 0.1% formic acid (v/v, eluent B). The elution program was 0–2 min: 95% A, 4 min: 
65% A, 8–17 min 55% A, 17–23 min 95% A, the first 4 and last 6 minutes were directed 
to waste. BMAA, D
3
BMAA, α,γ-diaminobutyric acid (DAB, DAB dihydrochloride, Sigma) and 
N-(2-aminoethyl) glycine (AEG, TCI) were detected on an Agilent 6460 MS/MS. Nitrogen was 
used as drying, sheath and collision gas and source settings were: drying gas temperature 
230 °C, drying gas flow 12 l/min, nebulizer pressure 40 psi, sheath gas temperature 250 °C, 
sheath gas flow 12 l/min, capillary voltage 2500 V, nozzle voltage 500 V. Fragmentor voltage 
was 50 V and both quadrupoles were operated in unit mode. The ESI source was operated 
in positive mode, and the following transitions were monitored in MRM for D
3
BMAA: m/z 
122.1 to 105.1 (4 V collision energy), 88.1 (8 V) and 76.2 (8 V). For BMAA, DAB and AEG, the 
following transitions were monitored: m/z 119.1 to 102.1 (BMAA, DAB, AEG, 4 V), 101.1 
(DAB, 4 V), 88.1 (BMAA, 8 V), 76.2 (BMAA, 8 V) and 74.2 (DAB, 4 V). For D
3
BMAA, the ratio 
between quantifier m/z 105.1 and qualifier m/z 88.1 was 27%, the ratio between m/z 105.1 
and m/z 76.2 was 43%. For BMAA the ratios between quantifier m/z 102.1 and qualifiers 
m/z 88.1 and 76.2 were 25%. For both compounds, a relative deviation from these ratios of 
20% was allowed. DAB and AEG were not quantified in this study, but only included in the 
analysis to exclude co-elution with BMAA. In the Daphnia samples, BMAA was quantified 
against an external calibration curve and corrected for D
3
BMAA recovery. Medium samples 
were not spiked with D
3
BMAA as there was no bias during workup and analysis (recovery 
102%, SD 1.6, n=3), these samples were directly quantified against the BMAA calibration 
curve.
LOD (based on signal to noise (S/N) ratio for all three transitions of at least 3) for BMAA 
was an injected amount of 34 fmol, LOQ (S/N ratio of the quantifier at least 10, S/N ratio of 
the two qualifiers at least 3) was 84 fmol. Recovery in D. magna samples was 108% (SD 16, 
n=72). Retention times of BMAA, D
3
BMAA (both 11.6 min) and DAB (12.5 min) were similar 
as in [93], no chromatograms are therefore shown in this manuscript. AEG was baseline 
separated from DAB at 13.8 min.
6.2.5 Data analysis
In the life history experiment, somatic growth was determined for each adult by fitting 
the equation 
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of the maximum growth rate (1/day).
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 [185]. Within treatment variability in r was 
estimated by the Jackknife t chnique [186].
Most statistics were performed on untransformed data in Sigmaplot 12.0, except for 
ANCOVAs, they were performed on untransformed data in SPSS 19. ANCOVAs were used to 
correct for the F1 size at birth during the life history experiment, and were only performed 
if the dependent variable met the criteria for normal distribution and homogeneity of 
variance, and if it was determined for each surviving individual.
6.3 RESULTS
In this section, the results of the second part of both experiments (F1 exposure) are discussed. 
Treatments from the life history experiment are indicated with uppercase abbreviations (i.e. 
CC, CB, BC and BB), treatments from the uptake experiment are indicated with lower case 
abbreviations (cc, cb, bc and bb). Life history results of the F0 exposure for both experiments 
are shown in Appendices A6.1 and A6.2.
6.3.1 Survival
In the life history experiment, at least 75% of the animals survived for each treatment (Figure 
6.2). Survival was highest (100%) in the controls (CC). Survival was approximately 80% in all 
treatments in which animals were directly or via the F0 generation exposed to BMAA (CB, BC 
and BB). When the neonates of treatment B were transferred to treatments BC and BB, 20% 
of the animals died within a day. After this first day of the F1 exposure, no further treatment 
related mortality occurred in treatments BC and BB. In the CB treatment, mortality only 
occurred in the first five days after transferral. In treatments CB, BC and BB, one animal was 
killed during handling, but these deaths are not included in the survival calculations.
In the uptake experiment, survival was 88% or higher in treatments cc, bc and bb. In treatment 
cb however, high mortality occurred at day three (survival percentages of 75%, 55% and 15% 
in the separate jars, respectively) and incidental mortality occurred at subsequent days, 
resulting in a 48% overall survival at the end of the experiment (Table 6.1).
6.3.2 Somatic growth
Animals that were directly exposed to BMAA (treatments CB and BB) were smaller at the 
end of the experiment than animals raised in clean medium (CC and BC, Figure 6.3). Initially, 
F1 animals originating from BMAA exposed mothers (BC and BB) were smaller than those 
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Figure 6.2. Survival of D. magna during the F1 life history experiment. Survival is corrected for 
death by handling of one animal in treatments CB, BC and BB. n varies from 11 (CC and CB) to 9 (BC).
Table 6.1. Life history parameters of F1 generation D. magna in the uptake experiment. F1 
animals from unexposed mothers were either kept in clean medium (cc) or exposed to BMAA (cb), F1 animals from 
BMAA exposed mothers were treated similarly (bc and bb). SD means standard deviation, homogeneous subsets are 
indicated with similar symbols and determined by pairwise comparison (Holm-Sidak method, significant at p < 0.05) 
when treatment effects were significant, n=3 for all treatments.
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Table 6.1. Life history parameters of F1 generation D. magna in the uptake experiment. F1 animals 
from unexposed mothers were either kept in clean medium (cc) or exposed to BMAA (cb), F1 animals 
from BMAA exposed mothers were treated similarly (bc and bb). SD means standard deviation, 
homogeneous subsets are indicated with similar symbols and determined by pairwise comparison 
(Holm-Sidak method, significant at p < 0.05) when treatment effects were significant, n=3 for all 
treatments. 
cc cb bc bb Statistical information 
Survival (%) Mean 88 48 95 91 Kruskal-Wallis ANOVA 
SD 5.8 31.7 0.2 6.1 H3 = 7.89, p = 0.055 
group a a a a 
Total neonates brood 1a Mean 92 43 145 145 One Way ANOVA 
SD 7.2 32.7 36.3 12.2 F3,8 = 11.25, p = 0.003 
group a,b b a a 
Total neonates brood 2a Mean 155 84 307 231 One Way ANOVA 
SD 20.8 63.7 109.0 104.2 F3,8 = 4.07, p = 0.05 
group a a a a 
Total neonates brood 3a Mean 265 111 323 309 One Way ANOVA 
SD 46.4 53.8 120.7 45.0 F3,8 = 5.22, p = 0.027 
group a,b b a a,b 
Mortality in broods (%) Mean 0.1 0.0 1.0 0.5 Kruskal-Wallis ANOVA 
SD 0.13 0.00 1.46 0.47 H3 = 6.75, p = 0.080 
group a a a a 
a Only living offspring are considered 
6.3.2 Somatic growth 
Animals that were directly exposed to BMAA (treatments CB and BB) were smaller at the end of the 
experiment than animals raised in clean medium (CC and BC, Figure 6.3). Initially, F1 animals 
originating from BMAA exposed mothers (BC and BB) were smaller than those from control mothers 
(CC and CB, Mann-Whitney rank sum test, U = 25.00, nC= 22, nB =15, p<0.001). However, BC animals 
had a similar length at the end of the experiment as the animals that were neither directly nor 
indirectly exposed to BMAA (CC). Likewise, although the CB animals were initially larger than the BB 
animals, their final length was the same (Figure 6.3, Table 6.2). The differences in growth rate 
occurred around day 4 (Figure 6.3). The maximum growth rate of CB animals was lower than that of 
the other animals (Table 6.2). When corrected for size at the start of the experiment, the effects of 
direct F1 exposure on final length (ANCOVA, F1,29=138.28, p < 0.001) and on maximum growth rate 
(ANCOVA, F1,29=13.57, p = 0.001) were still significant. 
a Only living offspring are considered
from control mothers (CC and CB, Mann-Whitney rank sum test, U = 25.00, nC= 22, nB =15, 
p<0.001). However, BC animals had a similar length at the end of the experiment as the 
animals tha  were neither ire tly nor indirectly exposed to BMAA (CC). Likewise, although 
the CB animals were initially larger than the BB animals, their final length was the same 
(Figure 6.3, Table 6.2). The differences in growth rate occurred around day 4 (Figure 6.3). 
The maximum growth rate of CB animals was lower than that of the other animals (Table 
6.2). When corrected for size at the start of the experiment, the effects of direct F1 exposure 
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on final length (ANCOVA, F1,29=138.28, p < 0.001) and on maximum growth rate (ANCOVA, 
F1,29=13.57, p = 0.001) were still significant.
Figure 6.3. Somatic growth of D. magna during the F1 life history experiment. Error bars 
represent standard deviations, n varies between 6 (BC, end of experiment) and 11 (CC).
6.3.3 Reproduction
In the life history experiment, animals raised in clean medium (treatments CC and BC) 
produced more living offspring (average 64, SD 12.4, n=17) than animals that were raised in 
BMAA containing medium (CB and BB, average 32, SD 10.7, n=15, Mann-Whitney rank sum 
test, U=13.00, p < 0.001). When corrected for size at the start of the experiment, the effect of 
direct F1 exposure on the number of living neonates in brood 1 was still significant (ANCOVA, 
F1,29= 56.43, p < 0.001).The number of living offspring produced was lowest in animals that 
were exposed to BMAA in the F0 and F1 generation (treatment BB, Figure 6.4, Table 6.2). 
Animals that were only exposed to BMAA in the F1 generation (treatment CB) also produced 
less living neonates than animals raised in clean medium, but this was only significant for 
the first brood. The second and third CB broods belonged both to the statistically defined 
subgroups of the CC and BC animals, as to the subgroup of the BB animals (Table 6.2).
Furthermore, animals that were directly exposed to BMAA produced dead offspring. In 
total, 11% of the CB neonates and 32% of the BB neonates were born dead (Table 6.2), and 
in the third BB brood, the number of neonates born dead was 73% (Figure 6.4).
BMAA exposure, either directly or indirectly, resulted in smaller neonates: BB neonates, for 
instance, weighed 40% less than CC neonates (Table 6.2). This effect was most pronounced 
in the third brood (One Way ANOVA, F
3,27
=12.76, p < 0.001, Figure 6.5).
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Table 6.2. Life history parameters of F1 generation D. magna and presence of BMAA in 
F1 and F2 generations in the life history experiment. In this experiment, F1 animals from unexposed 
mothers were either kept in clean medium (CC) or exposed to BMAA (CB), F1 animals from BMAA exposed mothers 
were treated similarly (BC and BB). SD means standard deviation; homogeneous subsets are indicated with similar 
symbols. d. means detected, n.d. means not detected.
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Table 6.2. Life history parameters of F1 generation D. magna and presence of BMAA in F1 and F2 
generations in the life history experiment. In this experiment, F1 animals from unexposed mothers 
were either kept in clean medium (CC) or exposed to BMAA (CB), F1 animals from BMAA exposed 
mothers were treated similarly (BC and BB). SD means standard deviation; homogeneous subsets are 
indicated with similar symbols. d. means detected, n.d. means not detected. 
CC CB BC BB Statistical information 
Survival (%) 100 80 75 78 
n 11 11 9 10 
Final length (mm) Mean 3.8 3.3 3.7 3.2 One Way ANOVA 
SD 0.09 0.11 0.11 0.15 F3,28 = 58.02, p < 0.001 
n 11 8 6 7 Pairwise comp. Holm-Sidak 
group a b a b significant if p < 0.05 
Maximum growth rate (1/day) Mean 0.31 0.20 0.32 0.28 One Way ANOVA 
SD 0.03 0.03 0.03 0.03 F3,28 = 12.76, p < 0.001 
n 11 8 6 7 Pairwise comp. Holm-Sidak 
group a b a a significant if p < 0.05 
Time of first reproduction (day) Mean 8.3 8.5 7.7 8.7 Kruskal-Wallis ANOVA  
SD 0.65 0.67 0.82 0.49 H3 = 7.87, p = 0.049 
n 11 8 6 7 Pairwise comparison Dunn 
group a a a a all comparisons p > 0.05 
Inter-clutch duration (day) Mean 3.4 3.4 3.4 3.9 a Kruskal-Wallis ANOVA 
SD 0.32 0.32 0.38 0.85 H3 = 3.72, p = 0.293 
n 11 8 6 6 
group a a a a 
Size first brood b Mean 16 6 12 9 One Way ANOVA 
SD 2.2 4.2 3.8 3.7 F3,28 = 13.73, p < 0.001 
n 11 8 6 7 Pairwise comp. Holm-Sidak 
group a b a,c b,c significant if p < 0.05 
Size second brood b Mean 24 16 26 14 Kruskal-Wallis ANOVA  
SD 6.5 7.0 4.9 8.5 H3 = 15.89, p = 0.001 
n 11 8 6 7 Pairwise comparison Dunn 
group a a,b a b significant if p < 0.05 
Size third brood b Mean 25 16 27 3 Kruskal-Wallis ANOVA  
SD 7.6 1.6 4.0 4.0 H3 = 20.14, p < 0.001 
n 11 8 6 6 Pairwise comparison Dunn 
group a a,b a b significant if p < 0.05 
Dry weight neonates (µg) Mean 6.8 5.1 4.6 4.1 One Way ANOVA 
SD 2.0 1.4 1.4 1.6 F3,90 = 12.66, p < 0.001 
n 33 24 18 19 Pairwise comp. Holm-Sidak 
group a b b b significant if p < 0.05 
Mortality in broods (%) Mean 0 11 0 32 Kruskal-Wallis ANOVA  
SD 0.0 15.7 0.0 22.9 H3 = 18.16, p < 0.001 
n 11 8 6 7 Pairwise comparison Dunn 
group a a,b a b significant if p < 0.05 
Population growth rate (1/day) Mean 0.34 0.26 0.33 0.27 One Way ANOVA 
SD 0.02 0.05 0.06 0.06 F3, 34 = 6.94, p < 0.001 
n 11 10 8 9 Pairwise comp. Holm-Sidak 
group a b a b significant if p < 0.05 
BMAA in adults (F1) n.d. d. d. d. 
BMAA in neonates (F2) n.d. d. d. d. 
a One animal only reproduced twice, b Only living offspring are considered a One animal only reproduced twice, b Only living offspring are considere
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Figure 6.5. Neonate dry weight of the third brood during F1 exposure in the life history 
experiment. Error bars represent standard deviations, n ranges from 6 (BC and BB) to 11 (CC). Letters indicate 
homogeneous groups (Holm-Sidak pairwise comparison, significant at p < 0.05).
In the uptake experiment, the cb animals produced the lowest total number of living 
offspring (Table 6.1). Brood mortality (0.0-1.0%) was similar for all treatments, and was 
lower than in the life history experiment (Table 6.1).
6.3.4 Population growth rate
Direct BMAA exposure (treatments CB and BB) decreased the population growth rate over 
20% compared to the animals raised in clean medium. This decrease was mainly caused 
by the small number of living offspring produced compared to the F1 animals in clean 
medium. F0 exposure to BMAA did not affect the fitness of the F1 animals kept in clean 
medium (treatment BC): despite the higher mortality of BC animals in the first five days, 
their population growth rate was similar to that of the CC animals (Table 6.2).
Figure 6.4. Number of living (solid fill) and dead (crossed fill) neonates of D. magna during 
F1 exposure in the life history experiment. Error bars represent the standard deviation of the total 
number of neonates per brood. n varies between 6 (BC and third brood BB) and 11 (CC).
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6.3.5 BMAA in animals
BMAA was detected in all samples of adults that had directly or indirectly been exposed to 
BMAA in the life history experiment. No BMAA was detected in the controls (CC adults and 
neonates). BMAA was also detected in most neonate samples of treatments CB, BC and 
BB (Table 6.2). Neonate samples in which no BMAA was detected mostly contained little 
biomass, due to small brood sizes and/or low neonate weight, and therefore likely dropped 
below the limit of detection.
In the uptake experiment, BMAA was detected in F0 adults that had been exposed to BMAA 
either during the first part of their lives (bc), during the last stage of their third pregnancy and 
directly after giving birth to the third brood (cb) or during their whole lives (bb), although not 
always in all three replicates (Table 6.3). Furthermore, most of the F1 neonates exposed to 
BMAA containing medium for less than 24 hours (cb and bb) contained detectable amounts 
of BMAA. BMAA was also found in the cb and bb F1 adults, albeit at lower concentrations 
than in the F1 neonates from the same jar (paired t-test, t4=2.85, p = 0.047). No BMAA was 
detected in bc F1 neonates, that were born in clean medium from BMAA exposed mothers. 
However, in one of the bc jars, BMAA was found in the F1 adults. Most F2 neonates born in 
BMAA containing medium had comparable BMAA concentrations (2.5 up to 5.6 µg/g DW). 
No BMAA was detected in any of the cc animals.
Table 6.3. Mean BMAA concentrations (µg/g DW) in positive samples, with standard 
deviations (SD) and number of positive samples (n) in the second part of the uptake 
experiment. F
0
 adults have spent one or two days in the conditions of the second part of the experiment, only to 
give birth to the F1 neonates. A part of these F1 neonates has been removed within 24 hours after birth (‘F1 neonates’ 
in table); the other part was kept under the experimental conditions and was removed from the experiment after 
giving birth to three broods (‘F1 adults’ in the table). F2 neonates are the offspring of these F1 adults and were 
removed within 24 hours after birth. All treatments were performed in triplicate, n.d. means not detected.
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medium from BMAA exposed mothers. However, in one of the bc jars, BMAA was found in the F1 
adults. Most F2 neonates born in BMAA containing medium had comparable BMAA concentrations 
(2.5 up to 5.6 µg/g DW). No BMAA was detected in any of the cc animals. 
Table 6.3. Mean BMAA concentrations (µg/g DW) in positive samples, with standard deviations 
(SD) and number of positive samples (n) in the second part of the uptake experiment. F0 adults 
have spent one or two days in the conditions of the second part of the experiment, only to give birth 
to the F1 neonates. A part of these F1 neonates has been removed within 24 hours after birth (‘F1 
neonates’ in table); the other part was kept under the experimental conditions and was removed 
from the experiment after giving birth to three broods (‘F1 adults’ in the table). F2 neonates are the 
offspring of these F1 adults and were removed within 24 hours after birth. All treatments were 
performed in triplicate, n.d. means not detected. 
cc cb bc bb 
mean SD n mean SD n mean SD n mean SD n 
F0 adults n.d. - - 45.5 19.88 3 15.37 - 1 8.6 - 2
F1 neonates n.d. - - 56.2 35.18 3 n.d. - - 15.1 - 2
F2 neonates brood 1 n.d. - - 5.6 - 1 n.d. - - 5.2 2.04 3 
F2 neonates brood 2 n.d. - - 3.5 - 1 n.d. - - 4.8 - 1
F2 neonates brood 3 n.d. - - 4.7 - 2 n.d. - - 2.5 - 2
F1 adults n.d. - - 7.8 9.96 3 4.5 - 1 3.4 1.16 3 
6.4 Discussion 
Below, trans generational effects of BMAA exposure on D. magna will be discussed. Most conclusions 
will be based on the outcomes of the life history experiment, as this experiment was best controlled 
in terms of food availability, crowding and BMAA exposure. Moreover, as the animals were followed 
individually, this experiment gives more information on reproductive output. The uptake experiment 
will mainly be used to determine uptake characteristics and to assess whether maternal transfer of 
BMAA occurs. 
Direct chronic BMAA exposure (approximately 110 µg/l) decreased D. magna maximum growth rate, 
body length, brood size, neonate weight and clutch viability. Direct exposure caused a 24% reduction 
of population growth compared to the control animals (compare treatments CB and CC, Table 6.2). 
This is in line with a previous 15 day exposure study, in which an exposure to 100 µg BMAA/l also 
reduced population growth rate (calculated over two broods), albeit to a lesser extent (9%, [129]). 
However, brood mortality and reduced body length were not observed in this earlier study. 
Maternal BMAA exposure seemed to have a slightly negative impact on offspring raised in clean 
medium (compare treatments BC and CC). BC animals had a higher mortality directly after transferral 
to clean medium, and produced broods with lower weight than the control animals. However, since 
the BC animals started to reproduce early, and produced as many living offspring as the control 
animals, their population growth rate was equal to that of the controls. BC neonates were born in 
BMAA containing medium and spent their first hours (less than 24) in it before they were transferred 
to clean medium. As D. magna can take up BMAA within 24 hours (Table 6.3, [187]), effects of 
neonate BMAA exposure cannot be ruled out in the life history experiment. 
6.4 DISCUSSION
Belo , ns generational effects of BMAA exposure on D. magna will be dis sed. Most 
conclusions will be based on the outcomes of the life history experiment, as this experiment 
was best controlled in terms of food availability, crowding and BMAA exposure. Moreover, 
as the animals were followed individually, this experiment gives more information on 
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reproductive output. The uptake experiment will mainly be used to determine uptake 
characteristics and to assess whether maternal transfer of BMAA occurs.
Direct chronic BMAA exposure (approximately 110 µg/l) decreased D. magna maximum 
growth rate, body length, brood size, neonate weight and clutch viability. Direct exposure 
caused a 24% reduction of population growth compared to the control animals (compare 
treatments CB and CC, Table 6.2). This is in line with a previous 15 day exposure study, in 
which an exposure to 100 µg BMAA/l also reduced population growth rate (calculated over 
two broods), albeit to a lesser extent (9%, [129]). However, brood mortality and reduced 
body length were not observed in this earlier study.
Maternal BMAA exposure seemed to have a slightly negative impact on offspring raised in 
clean medium (compare treatments BC and CC). BC animals had a higher mortality directly 
after transferral to clean medium, and produced broods with lower weight than the control 
animals. However, since the BC animals started to reproduce early, and produced as many 
living offspring as the control animals, their population growth rate was equal to that of the 
controls. BC neonates were born in BMAA containing medium and spent their first hours 
(less than 24) in it before they were transferred to clean medium. As D. magna can take up 
BMAA within 24 hours (Table 6.3, [187]), effects of neonate BMAA exposure cannot be ruled 
out in the life history experiment.
The F1 generation born from BMAA exposed F0 mothers did not adapt to BMAA exposure 
(compare treatments CB and BB). BB animals only performed better than CB animals in 
terms of maximum somatic growth rate. In contrast, multi-generation exposure negatively 
affected reproduction in BB animals. Although the population growth rate between CB 
and BB animals was the same, BB animals produced lighter neonates and had a higher 
brood mortality. These effects were most pronounced (and significant) for the third brood. 
Daphnia can develop an increased stress tolerance within a lifetime, and transfer this trait 
to its offspring (e.g. [181, 188]). The duration of the experiment was therefore long enough 
to demonstrate such rapid adaptation, if our clone would have been able of it. Our clone 
had been kept in the laboratory for 12 years at the time of the life history experiment, 
and might therefore have lost some of its ability to deal with cyanobacterial toxins. As 
adaptation to changing environments is clone specific in Daphnia, it is possible that other 
clones would react differently to multi-generational BMAA exposure. In line with adaptation 
to the cyanobacterial toxin microcystin, such adaptation would be expected mostly in clones 
exposed to BMAA containing phytoplankton [180].
In the uptake experiment, measured BMAA concentrations (average 27 µg/l, SD 24.4, n=38) 
varied and were lower than the nominal concentration of 78 µg/l. This means that under 
the experimental conditions, BMAA was not stable for a few days. This is in contrast with a 
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previous test, in which BMAA was stable for 96 hours in a jar containing RT medium but no 
Daphnia and food (20 °C, continuous light, relative SD 6.2%, n=12). The fact that the animals 
in the uptake experiment were exposed to lower and more variable BMAA concentrations 
than the animals in the life history experiment (in which medium was refreshed daily), might 
explain the lack of effect of BMAA exposure on survival, reproduction and brood mortality in 
the bb animals (Table 6.1) compared to the BB animals (Table 6.2).
The effects of direct BMAA exposure were strongest on juveniles (in both experiments, most 
treatment related mortality occurred within the first five days and somatic growth reduction 
was most pronounced before the first pregnancy in BMAA exposed animals, Figure 6.3) 
and on the number, viability and weight of the offspring (Table 6.2). Once animals started 
to reproduce, no more adult mortality occurred in the life history experiment, and somatic 
growth was similar between exposed and non-exposed adults (Figure 6.3). BMAA was 
detected in the neonates of directly and indirectly exposed mothers (Table 6.2), also in the 
neonates that were born in clean medium (F2 BC neonates, Table 6.2 and F1 bc adults, Table 
6.3). This means that BMAA was maternally transferred, and that in D. magna females, 
the internal BMAA concentration is lowered through reproduction. Similarly, in mice, the 
internal BMAA load in mothers is reduced when BMAA is transferred to their offspring via 
the placenta and lactation [177, 178].
Unfortunately, we could not determine BMAA concentrations in the life history experiment, 
our semi-quantitative results were too inaccurate as was shown from mass balances of F1 
neonates and their F2 offspring. Whether the concentrations determined in our previous 
Daphnia study, using the same method, were accurate cannot be tested [129]. The samples 
from the uptake experiment were analysed with our improved method, with which BMAA 
concentrations can accurately be determined.
BMAA was taken up by D. magna adults within two days, as the F0 animals raised in clean 
medium but transferred to BMAA containing medium only to give birth (cb) contained 
BMAA (Table 6.3). This is in line with the rapid (within 3 hours) BMAA uptake reported for 
this species [187]. The BMAA concentration in adults born and raised in BMAA containing 
medium was 7 times lower at the end of the experiment than when they were neonates, but 
as the animals increase about 40 times in weight during this period, this decrease is lower 
than is expected from dilution by growth alone, which indicates BMAA uptake during their 
lifetime. BMAA losses seemed to occur at a slower speed than initial uptake: some animals 
that had spent more than 20 (bc F1 adults) or 14 to 17 days in clean medium (BC F1 adults) 
still contained detectable amounts of BMAA.
At present, little is known about BMAA metabolism in vivo. In neonatal rats, in vivo protein 
association of BMAA has been suggested, but no BMAA was detected seven months after 
TRANS GENERATIONAL EFFECTS OF BMAA ON DAPHNIA MAGNA 119
6
exposure [176]. One study on BMAA exposed shellfish did not find evidence for BMAA 
catabolism, but the majority of the BMAA added to the aquaria could not be retrieved 
[189]. Similarly, BMAA was taken up by the macrophyte Ceratophyllum demersum, but 
during depuration, free and protein associated BMAA levels in the plant decreased, while 
there were no indications for catabolism or excretion [190]. This latter study suggests that 
BMAA was transformed in vivo into a form that was undetectable by the analytical methods 
employed. 
Although it is common to either look for ‘free’ (in an aqueous extract) and ‘protein-
associated’ BMAA (in the pellet created during extraction and released after acid hydrolysis), 
or for total BMAA (hydrolysis of the total sample), there is a possibility that BMAA is bound 
to small molecules in the supernatant that are not precipitated during extraction [92]. When 
only free and protein associated BMAA are analysed, this fraction will be overlooked. We 
do not know in which forms BMAA was present during our experiment, as we had too little 
sample material to look for different forms. Instead, we chose to hydrolyse the total sample, 
which is the safest way of recovering all forms in which BMAA can be present. However, we 
performed some preliminary tests to determine the fraction in which BMAA is present in 
exposed D. magna. For this, we extracted lyophilized, BMAA exposed D. magna with 0.1 N 
trichloroacetic acid to precipitate proteins, as in [93]. The extract was subsequently dried and 
hydrolysed in 6 N HCl as described above (section 6.2.4). We found BMAA in this hydrolysed 
extract, and when compared to the non-hydrolysed extract and total BMAA concentrations, 
it appeared that approximately 20% of the BMAA was present in the non-hydrolysed extract, 
and that (most of) the remaining 80% was found in the hydrolysed extract. This agrees with 
another recent BMAA uptake study in D. magna, in which no protein associated, but only 
free BMAA was detected after 24 hours of exposure (no hydrolysed extract was analysed) 
[187].
Our study suggests that zooplankton can be an important vector for BMAA transport 
through the pelagic food chain. BMAA was present in adults and neonates both after direct 
BMAA exposure and after maternal exposure. This implies that after a BMAA containing 
phytoplankton bloom has declined, BMAA might still be present in the zooplankton and may 
from there on be transferred to higher aquatic organisms. Indeed, BMAA has not only been 
detected in natural zooplankton at concentrations below 0.1 µg/g DW [83], but also in the 
pelagic fish species Atlantic herring (Clupea harengus, 0.01 µg/g DW or lower) that feeds on 
plankton and is sold for human consumption [83].
Finally, the role of BMAA in phytoplankton is unknown. One possible explanation is that it, 
like many other non-protein amino acids, acts as a grazer repellent [127, 191]. As shown in 
this study, BMAA indeed reduced D. magna fitness. Our experiment however merely served 
as a proof of principle, as the dissolved BMAA concentrations were higher than expected in 
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the field: no quantifiable dissolved BMAA concentrations have to our knowledge yet been 
reported for surface water. While zooplankton grazing can control phytoplankton abundance 
under certain conditions, cyanobacteria are generally poor food to zooplankton due to their 
hard-to-handle morphology, low nutritional value and the presence of toxic compounds 
[8]. As a consequence, cyanobacterial blooms are little constrained by zooplankton grazing. 
BMAA might be one of the many compounds that protect cyanobacteria from losses by 
grazing and that contribute to the ongoing expansion and intensification of harmful 
cyanobacterial blooms. The finding of BMAA in diatoms however questions whether BMAA 
indeed plays a substantial role in reducing Daphnia fitness in field situations: although BMAA 
has been found in diatoms [98], diatoms generally do not reduce Daphnia fitness [192, 193]. 
Diatoms can reduce fecundity in zooplankton, mainly copepods, but these effects are mostly 
attributed to oxylipins [193, 194] and not to BMAA. An experiment comparing the fitness 
of Daphnia fed with either non BMAA containing and BMAA containing diatoms could 
therefore provide more insight in field relevant effects of BMAA on Daphnia.
6.5 CONCLUSIONS
Direct BMAA exposure negatively affected D. magna fitness: it decreased survival, somatic 
growth, reproduction and subsequently, population growth rates. Although BMAA is 
maternally transferred, there was no maternal exposure effect on population growth, as 
neonates from exposed mothers that were raised in clean medium compensated for initial 
mortality and lower weight with earlier onset of reproduction. Two generation exposure 
reduced brood viability and neonate weight, which means that the clone used in this study 
did not adapt to BMAA exposure. We conclude that in our study, BMAA exposure had trans 
generational effects, and that these were most pronounced in animals that were exposed to 
BMAA during two generations. Our results indicate that zooplankton might be an important 
vector for the transfer of BMAA along the pelagic food chain, but whether BMAA plays 
a role in preventing zooplankton from controlling cyanobacterial blooms needs further 
investigation.
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APPendix A6.1
Table A6.1. Life history parameters of F0 generation D. magna kept in clean medium (C) or 
exposed to BMAA (B) during the life history experiment. SD means standard deviation. d. means 
detected, n.d. means not detected.
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Appendix A6.1 
Table A6. . if  istory parameters of F0 gen ration D. magn  kept in clean medium (C) or exp sed 
to BMAA (B) during the life history experiment. SD means standard deviation. d. means detected, 
n.d. means not detected.
C B Statistical information 
Survival (%) 92 83 
n 12 12 
Final length (mm) Mean 3.2 2.8 Independent samples t-test 
SD 0.07 0.15 t19 = 7.97, p < 0.001 
n 11 10 
Maximum growth rate (1/day) Mean 0.32 0.20 Independent samples t-test 
SD 0.05 0.06 t19 = 5.00, p < 0.001 
n 11 10 
Time of first reproduction (day) Mean 9.6 10.4 Mann-Whitney rank sum test 
SD 0.81 1.58 U = 41.50, p = 0.219 
n 11 10 
Inter-clutch duration (day) Mean 3.1 3.3a Mann-Whitney rank sum test 
SD 0.30 0.71 U = 28.00, p = 0.083 
n 11 8 
Size first brood b Mean 8 6 Independent samples t-test 
SD 2.4 3.0 t19 = 1.42, p = 0.173 
n 11 10 
Size second brood b Mean 10 6 Independent samples t-test 
SD 2.1 3.2 t18 = 3.01, p = 0.007 
n 11 9 
Size third brood b Mean 7 4 Mann-Whitney rank sum test 
SD 2.4 1.7 U = 13.50, p = 0.012 
n 11 8 
Dry weight neonates (µg) Mean 8.7 5.3 Independent samples t-test 
SD 1.7 1.3 t19 = 5.14, p < 0.001 
n 11 10 
Mortality in broods (%) Mean 0 7 Mann-Whitney rank sum test 
SD 0.0 11.5 U = 38.50, p = 0.064 
n 11 10 
Population growth rate (1/day) Mean 0.25 0.19 Independent samples t-test 
SD 0.03 0.05 t22 = 4.06, p < 0.001 
n 12 12 
BMAA in adults (F0) n.d. d. 
BMAA in neonates (F1) n.d. d. 
a One animal only reproduced once, another only twice, b Only living offspring are considered a One animal only reproduce  once, a other only twice, b Only living offspring are considered
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APPendix A6.2
Table A6.2: Life history parameters of F0 generation D. magna kept in clean medium (c) 
or exposed to BMAA (b) during the uptake experiment. SD means standard deviation, n=3 for all 
treatments.
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Table A6.2: Life history parameters of F0 generation D. magna kept in clean medium (c) or exposed 
to BMAA (b) during the uptake experiment. SD means standard deviation, n=3 for all treatments. 
c b Statistical information 
Survival (%) Mean 98 61 Independent samples t-test 
SD 3.2 8.7 t4 = 6.95, p = 0.002 
Total neonates brood 1a Mean 168 75 Independent samples t-test 
SD 37 29.7 t4 = 3.40, p = 0.027 
Total neonates brood 2a Mean 199 71 Independent samples t-test 
SD 69.1 23.5 t4 = 3.03, p = 0.039 
Mortality in broods (%) Mean 0.5 2.1 Independent samples t-test 
SD 0.22 3.61 t4 = -0.74, p = 0.499 
a Only living offspring are considered a Only living offspring are considered
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“Got a mind full of questions and a teacher in my soul
And so it goes“
Eddie Vedder, Guaranteed
CHAPTER 7
A collABorATive evAluATion of lc-Ms/Ms 
BAsed MeThods for BMAA AnAlysis
This chapter has been published as: A Collaborative Evaluation of LC-MS/MS Based Methods 
for BMAA Analysis: Soluble Bound BMAA Found To Be an Important Fraction. Faassen E. J., 
Antoniou M. G., Beekman-Lukassen W., Blahova L., Chernova E., Christophoridis C., Combes 
A., Edwards C., Fastner J., Harmsen J., Hiskia A., Ilag L. L., Kaloudis T., Lopicic S., Lürling M., 
Mazur-Marzec H., Meriluoto J., Porojan C., Viner-Mozzini Y. and Zguna N., 2016. Marine 
Drugs 14, 45.
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ABSTRACT
Exposure to β-N-methylamino-l-alanine (BMAA) might be linked to the incidence of 
amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease. Analytical 
chemistry plays a crucial role in determining human BMAA exposure and the associated 
health risk, but the performance of various analytical methods currently employed is 
rarely compared. A CYANOCOST initiated workshop was organized aimed at training 
scientists in BMAA analysis, creating mutual understanding and paving the way towards 
interlaboratory comparison exercises. During this workshop, we tested different methods 
(extraction followed by derivatisation and liquid chromatography coupled to tandem 
mass spectrometry (LC-MS/MS) analysis, or directly followed by LC-MS/MS analysis) 
for trueness and intermediate precision. We adapted three workup methods for the 
underivatised analysis of animal, brain and cyanobacterial samples. Based on recovery of 
the internal standard D
3
BMAA, the underivatised methods were accurate (mean recovery 
80%) and precise (mean relative standard deviation 10%), except for the cyanobacterium 
Leptolyngbya. However, total BMAA concentrations in the positive controls (cycad seeds) 
showed higher variation (relative standard deviation 21%–32%), implying that D
3
BMAA was 
not a good indicator for the release of BMAA from bound forms. Significant losses occurred 
during workup for the derivatised method, resulting in low recovery (<10%). Most BMAA 
was found in a trichloroacetic acid soluble, bound form and we recommend including this 
fraction during analysis.
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7.1 INTRODUCTION
The neurotoxin β-N-methylamino-l-alanine (BMAA) is suspected to play a role in the 
progressive neurological diseases amyotrophic lateral sclerosis, Alzheimer’s disease and 
Parkinson’s disease [37, 46, 59, 69]. Potential routes of human exposure to BMAA include 
contact with cyanobacteria infested surface waters and ingestion of BMAA containing 
food, such as fish and shellfish [58]. However, extensive research is needed to determine 
the precise role of BMAA in the aetiology of these diseases along with characterization of 
pathways of human exposure.
To assess the health risk associated with BMAA, routes of human exposure are being 
quantified. BMAA can be present in natural phytoplankton (e.g. [83, 98, 102]) and can be 
taken up by aquatic organisms such as zooplankton [129, 187, 195], bivalves [189] and 
macrophytes [196]. Indeed, BMAA has been found in natural zooplankton and shellfish 
samples [83, 100, 103]. Moreover, it has been detected in other organisms from higher 
levels of the aquatic food web [83], including fish intended for human consumption [83, 
197]. Reported BMAA concentrations in phytoplankton and higher aquatic organisms vary 
widely, and a substantial part of this variation can be attributed to the use of nonselective 
analytical methods [93]. BMAA concentrations in aquatic organisms seem to lie within the 
ng/g dry weight (DW) to µg/g DW range in studies using well described analytical techniques 
supported by performance data [58].
Analytical procedures (method selectivity and sensitivity, fraction analysed, quality control) 
play a critical role in assessing the putative link between BMAA and the abovementioned 
neurodegenerative diseases [75, 85], as well as in the quantification of human exposure 
pathways [58]. Over the past years, many different analytical methods have been developed 
and at present, methods using tandem mass spectrometry (MS/MS) detection following 
proper sample processing are considered most suitable [58, 93, 134]. LC-MS/MS is currently 
the most frequently applied technique for BMAA analysis and within this technique, diverse 
sample processing and separation methods are used [58].
In natural samples, BMAA can be present as a free molecule or in bound forms. “Free BMAA” 
is the fraction obtained by extraction with polar solvents such as 0.1 M trichloroacetic acid 
(TCA) (Figure 7.1). Bound forms of BMAA can either stay in solution (“soluble bound BMAA”) 
or precipitate during extraction (“precipitated bound BMAA”) and BMAA can be released 
from both bound forms by acid hydrolysis (Figure 7.1). The total BMAA content of a sample 
is usually obtained by hydrolysis of the total sample (Figure 7.1). The precursor(s) of soluble 
bound BMAA have not been elucidated yet, but recently it was suggested that in mussels, 
soluble bound BMAA might not be bound to a peptide or protein [89]. The precursor(s) of 
the precipitated bound BMAA fraction are also unknown. This fraction is commonly referred 
to as “protein associated” or “protein bound” [33, 35], but the association of BMAA with 
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proteins in natural samples still needs to be elucidated. In vitro, BMAA can be incorporated 
into proteins and can be associated to proteins through non-covalent bonding [65, 90], but 
in vivo experiments with bacteria do not show protein incorporation [91].
 
0.1 M TCA 
Precipitated 
bound 
BMAA 
Soluble 
bound 
BMAA 
Free 
BMAA 
Total soluble BMAA Total BMAA 
Figure 7.1. Terminology used in this manuscript for the different β-N-methylamino-l-
alanine (BMAA) fractions. Free and soluble bound BMAA are found in the trichloroacetic acid (TCA) extract. 
Precipitated bound BMAA is found in the pellet created during extraction. Total BMAA is the sum of all fractions.
Only few studies look at soluble bound BMAA in an isolated fraction (e.g., [89, 92, 103, 198]). 
In studies where total BMAA (i.e., hydrolysis of the total sample) is (also) determined, ignoring 
soluble bound BMAA does not lead to an underestimation of the total BMAA concentration. 
However, when only free and precipitated bound BMAA are analysed (e.g., [33, 36, 102] and 
more recently [187, 189, 190]) total BMAA concentrations might be underestimated, and 
the fate of BMAA in experimental systems might be difficult to assess. As an example, in a 
recent study on BMAA metabolism in the macrophyte Ceratophyllum demersum, in which 
only free and precipitated bound BMAA were analysed, detectable BMAA concentrations in 
the exposed plants dropped during depuration, while no BMAA was found in the depuration 
medium and BMAA catabolism did not seem to have occurred. This lead the authors to 
conclude that BMAA was likely covalently bound in a form undetectable by the analytical 
methods employed [190].
After extraction, BMAA can be analysed by LC-MS/MS without derivatisation. As BMAA is 
a small, polar molecule, hydrophilic interaction liquid chromatography (HILIC) is in these 
cases predominantly used for separation (e.g., [76, 79, 102, 103, 105]). BMAA can also be 
derivatised after extraction to obtain a larger, more hydrophobic molecule which is easily 
separated by reversed phase liquid chromatography. Commonly used derivatisation agents 
are 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC, e.g., [34, 97, 98]), propyl 
chloroformate (e.g., [91, 99]) and dansyl chloride [100, 101].
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As outlined above, analytical chemistry plays an essential role in BMAA risk assessment, but 
to date, method harmonisation and inter-laboratory comparison of methods have not yet 
been performed. During a workshop organized in Wageningen University under the auspices 
of the CYANOCOST network (COST Action ES 1105), analysts from different labs were trained 
in BMAA analysis and BMAA methods were discussed. By doing so, we aimed to create 
mutual understanding and to pave the way towards an inter-laboratory comparison exercise 
and ultimately towards method harmonisation. During this workshop, samples from four 
relevant matrices (cycad, animal, brain and cyanobacteria) were extracted with at least 
two different methods (one followed by derivatisation before LC-MS/MS analysis and one 
directly followed by LC-MS/MS analysis), and each workup was performed by two pairs 
of analysts. All samples were analysed by LC-MS/MS by one operator. The analysts were 
experienced in cyanotoxin analysis, were provided with detailed protocols and instructions 
and were intensively supported by the three trainers who had developed the methods used.
7.2 EXPERIMENTAL DESIGN
Three different sample types, animal samples (seafood and BMAA exposed Daphnia 
magna), brain tissue (unspiked and spiked with BMAA before workup) and cyanobacterial 
samples (Leptolyngbya PCC 73110 and a Dolichospermum dominated field sample), were 
prepared for underivatised and AQC derivatised LC-MS/MS analysis (detailed Materials and 
Methods are described in Appendices A7.1 (underivatised protocols) and A7.2 (derivatised 
protocol)). We selected sample preparation methods that were published, validated and 
developed by the trainers of the workshop (see [93] for underivatised analysis of animal 
and cyanobacterial samples, [199] for underivatised analysis in brain and [197] for AQC 
derivatised analysis of all sample types). Where needed, the extraction methods were 
adapted to the available equipment.
The sample preparations were performed by the workshop participants. An open call was 
distributed through the CYANOCOST network and the selection of participants was carried 
out jointly by CYANOCOST Working Group 3: “Cyanotoxin analysis” leaders and by the local 
organizers. Selection was largely based on the applicants’ experience with cyanotoxin analysis, 
and especially with LC-MS/MS analysis. During the workshop, the following measures were 
taken to minimize any variation caused by lack of training: Before starting the practical work, 
all participants attended lectures on the chemical properties of BMAA and on methods of 
BMAA analysis. All participants were given detailed documented protocols for the different 
extraction methods and were trained in the techniques and instrumentation used. Constant 
technical support was provided by three trainers who developed the sample preparation 
(Ilag/Zguna for protocol D, Combes for protocol B and Faassen for protocol A and C) and by 
laboratory technicians who had experience with the methods used. All LC-MS/MS analyses 
were performed on an Agilent 1260 LC coupled to an Agilent 6460 triple quadrupole mass 
spectrometer by one operator.
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The samples that were prepared for underivatised LC-MS/MS analysis were extracted with 
0.1 M TCA at ambient temperature to obtain free BMAA. Total BMAA was obtained by 
6 M HCl hydrolysis of the total sample. For the animal samples, total soluble BMAA was 
also determined by hydrolysing the dried 0.1 M TCA extract with 6 M HCl. This fraction 
was not determined for the other two sample types because we did not have brain and 
cyanobacterial samples with relatively high BMAA concentrations. The workup for the brain 
samples included an additional clean-up step by Oasis MCX solid phase extraction (SPE, 
Figure 7.2). 
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Figure 7.2. Sample preparation schemes for the analysis of underivatised BMAA in three 
different matrices: animal tissue other than brain (protocol A), brain tissue (protocol B) and cyanobacterial 
samples (protocol C). The workup for total BMAA is the same in method A and C. Workup for free BMAA in these 
protocols only differs in the point at which D
3
BMAA was added.
In all protocols, D
3
BMAA was added as internal standard, and blanks (workup without 
matrix, negative controls) and cycad seed sarcotesta (positive controls) were included. All 
samples and controls were prepared in triplicate by two pairs of analyst, resulting in six 
workups per sample (see Table A7.1.1 in Appendix A7.1).
We intended to use the derivatised protocol for total BMAA determination in all sample 
types. However, in agreement with a recent method evaluation in an independent laboratory 
[200], we obtained such a poor recovery with the derivatised protocol (Protocol D, recovery 
< 10%) that we did not use it for BMAA quantification. From this point on, the manuscript 
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therefore focuses on the underivatised protocols, and the results and discussion for the 
derivatised protocol can be found in Appendix A7.2.
7.3 RESULTS AND DISCUSSION
7.3.1 Trueness and precision
Trueness of protocols A, B and C, expressed as mean recovery of D
3
BMAA added before 
workup, were not all within the acceptable range of 70%–120% [201] (Table 7.1). Some 
fractions of the control samples gave a slightly lower recovery (between 59% and 69%) and 
D
3
BMAA recovery in Leptolyngbya was very low (7%–21%). Better recoveries (88%–100% 
for the free fraction and 56%–75% for the total samples) had previously been obtained for 
cyanobacterial lab strains extracted with the same protocol [93] and it is unclear what has 
caused the low recovery in this Leptolyngbya strain. In contrast to Leptolyngbya, D
3
BMAA 
recovery from the free fraction in Daphnia (141%) was too high. When the workup was 
repeated, D
3
BMAA recovery was well within the acceptable range (103%, SD 7.4, n = 3). 
Table 7.1. Trueness (mean D3BMAA recovery (%)) and intermediate precision (relative 
standard deviation of D3BMAA recovery, n = 6, results of both pairs combined), for samples 
prepared for underivatised analysis. Trueness outside the acceptable range is indicated with blue (<70%) 
and red (>120%). Precision exceeding the acceptable value (20) is indicated with red [201].
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In contrast to Leptolyngbya, D3BMAA recovery from the free fraction in Daphnia (141%) was too 
high. When the workup was repeated, D3BMAA recovery was well within the acceptable range 
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Table 7.1. Trueness (mean D3BMAA recovery (%)) and intermediate precision (relative standard 
deviation of D3BMAA recovery, n = 6, results of both pairs combined), for samples prepared for 
underivatised analysis. Trueness outside the acceptable range is indicated with blue (<70%) and red 
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Protocol Animal (A) Brain (B) Cyanobacteria (C) 
Fraction Free T.S. 1 Total Free Total Free Total 
Blank 85 (2.6) 65 (4.9) 81 (13.7) 78 (4.8) 72 (8.4) 100 (7.8) 59 (6.3) 
Cycad 93 (7.8) 64 (11.4) 86 (2.1)* 69 (7.5) 73 (2.5) 103 (8.5) 65 (4.3) 
Seafood 96 (6.6) 78 (7.9) 108 (6.7) - - - - 
Daphnia magna 141 (2.5) 75 (1.0) 110 (8.0) - - - - 
Brain unspiked - - - 77 (11.1) 84 (15.7) - - 
Brain spiked - - - 80 (6.0) 82 (9.0) - - 
Dolichospermum - - - - - 103 (7.4) 78 (2.3) 
Leptolyngbya - - - - - 21 (61.0) 7 (41.5) 
1 Total Soluble, * n = 5 
Intermediate precision (within-laboratory reproducibility, expressed as relative standard deviation of 
D3BMAA recovery) was below 10% for most, and below 20% for all samples except for Leptolyngbya 
(Table 7.1). The workup in protocol A and C was essentially the same for free BMAA and exactly the 
same for total BMAA, but the extractions were performed on different days. When the results of 
protocols A and C were combined, the precision was still within the acceptable range: 9.8% for 
D3BMAA recovery in the free fraction in blanks, 9.4% in the free fraction of cycads, 19.5% in the total 
fraction in blanks (all n = 12) and 15.1% in the total fraction of cycads (n = 11). 
In Table 7.1, trueness and intermediate precision were based on the recovery of D3BMAA that was 
added as a free compound, as no “bound” D3BMAA or BMAA is available. When intermediate 
precision is expressed as the relative standard deviation of the amount of BMAA found in the positive 
1 Total Soluble, * n = 5 
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for free BMAA and exactly the same for total BMAA, but the extractions were performed on 
different days. When the results of protocols A and C were combined, the precision was still 
within the acceptable range: 9.8% for D
3
BMAA recovery in the free fraction in blanks, 9.4% 
in the free fraction of cycads, 19.5% in the total fraction in blanks (all n = 12) and 15.1% in 
the total fr ction of cycads (  = 11).
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In Table 7.1, trueness and intermediate precision were based on the recovery of D
3
BMAA 
that was added as a free compound, as no “bound” D
3
BMAA or BMAA is available. When 
intermediate precision is expressed as the relative standard deviation of the amount of 
BMAA found in the positive control (cycad seed), which does contain bound forms of BMAA, 
it shows that in all three protocols, intermediate precision for total BMAA is greater than 
20% and that correction for D
3
BMAA recovery does not increase precision (Table 7.2). For 
total BMAA determination, D
3
BMAA recovery and the BMAA concentrations uncorrected 
for D
3
BMAA recovery were not correlated (Pearson product moment correlation, p = 0.15, 
n = 17, see Appendix A7.3), in contrast to the free fraction, where this correlation did 
exist (correlation coefficient 0.88, p < 0.001, n = 18, see Appendix A7.3). Assuming that 
the stability of (free) BMAA and D
3
BMAA is the same, this implies that during workup for 
total BMAA (and possibly also for soluble bound BMAA), small procedural variations have 
affected the release or formation of BMAA, but not, or to a lesser extent, its stability or 
signal suppression. This also suggests, that although each method seemed precise and 
accurate based on D
3
BMAA recovery, correction for D
3
BMAA recovery only results in 
accurate quantification of free BMAA and not in accurate quantification of bound forms. 
(Free) D
3
BMAA added before sample procession does therefore seem to be a good indicator 
for losses during extraction and changes in MS/MS signal due to matrix effects, but does 
not seem to accurately reflect the release or formation of bound BMAA in natural samples.
Table 7.2. Intermediate precision expressed as relative standard deviation of the BMAA 
concentration (µg/g DW) determined in cycad seed by underivatised analysis, data with 
and without correction for D3BMAA recovery are shown (n = 6, results of both pairs 
combined). Results exceeding the acceptable value (20, [201]) are indicated with red.
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Protocol Animal (A) Brain (B) Cyanobacteria (C) 
Fraction Free T. S. 1 Total Free Total Free Total 
uncorrected for D3BMAA 10.3 8.4 22.9* 13.5 31.4 18.5 20.5 
corrected for D3BMAA 10.4 13.6 23.9* 9.2 31.6 11.6 20.9 
1 Total Soluble, * n = 5 
7.4.2 BMAA in blanks and cycad samples 
No BMAA was detected in any of the blanks (negative controls). BMAA was detected in the cycad 
seed (positive controls), free BMAA concentrations averaged 8.8 µg/g DW (SD 1.8, n = 18), which is 
similar to the value previously determined in the same sample (10.7 µg/g DW, SD 2.9, n = 3 [93]). 
BMAA was found in the hydrolysed 0.1 M TCA extract (“total soluble BMAA” in Figure 7.3), and total 
soluble BMAA exceeded the total BMAA concentration (t-test total soluble vs. total BMAA, t21 = 
3.071, p = 0.006, n = 23, Figure 7.3). Although the average total BMAA concentration in the cycad 
seed as determined by all three protocols (75.2 µg/g DW, SD 33.1, n = 17) was consistent with 
previously reported values for this sample (75.0 µg/g DW, SD 10.8, n = 3, [93]), these values differed 
substantially between the protocols used in this study (Figure 7.3). This implies that the release of 
BMAA from precursor bound forms, for which the addition of free D3BMAA as an internal standard 
does not correct, is sensitive to slight variations in the workup procedure. In our study, hydrolysis 
was performed overnight and incubation times were not strictly controlled or registered. Although 
different hydrolysis procedures are currently applied by different labs [134], the effects of variations 
in hydrolysis conditions have not been systematically evaluated yet. Given the variation observed in 
the total BMAA determinations our study, this might be worth looking into. This work should be 
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33.1, n = 17) was consistent with previously reported values for this sample (75.0 µg/g DW, 
SD 10.8, n = 3, [93]), these values differed substantially between the protocols used in this 
study (Figure 7.3). This implies that the release of BMAA from precursor bound forms, for 
which the addition of free D
3
BMAA as an internal standard does not correct, is sensitive to 
slight variations in the workup procedure. In our study, hydrolysis was performed overnight 
and incubation times were not strictly controlled or registered. Although different hydrolysis 
procedures are currently applied by different labs [134], the effects of variations in hydrolysis 
conditions have not been systematically evaluated yet. Given the variation observed in the 
total BMAA determinations our study, this might be worth looking into. This work should 
be carried out with samples containing bound forms of BMAA, preferably matrix matched 
certified reference materials. Such materials are not available yet, but the recent finding of 
BMAA in commercially available mussel material [104] is promising. Until certified reference 
materials are available, samples that contain a relatively high concentration of bound BMAA, 
such as cycad seeds, can be used during method development and comparison.
Figure 7.3. BMAA concentrations in cycad seeds as determined by protocols A to C, results 
for both pairs are combined. Error bars represent standard deviations, n = 6, except for total BMAA 
determined by protocol A, where n = 5. “Total soluble BMAA” refers to the TCA soluble fraction, including free BMAA.
7.3.3 BMAA in brain tissue
No BMAA was detected in the unspiked brain samples. An additional set of brain samples 
was therefore spiked with BMAA before sample preparation. After TCA extraction, a BMAA 
concentration of 3.0 µg/g DW (SD 0.1, n = 6) was determined, which was exactly the spiked 
concentration. The BMAA concentration determined after hydrolysis of the total sample 
was 39.9 µg/g DW (SD 3.1, n = 6), which is very close to the spiked concentration of 40 µg/g 
DW. These findings support our assumption (see Section 7.3.1) that BMAA and D
3
BMAA 
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added before workup (i.e. the free compounds) behave similar in terms of stability and 
signal suppression, both during 0.1 N TCA extraction and during 6 M HCl hydrolysis.
7.3.4 BMAA in animal and cyanobacterial samples
No BMAA was detected in any of the cyanobacterial samples. The Leptolyngbya strain used 
in this study had been shown to contain BMAA at concentrations below 1 µg/g DW with AQC 
derivatised LC-MS/MS methods [97, 200], but no BMAA was detected in the same strain 
by underivatised LC-MS/MS analysis ([103], LOD 0.225 µg/g DW). We did not detect BMAA 
in this strain, but this might be attributed to the high LOD for this sample (estimated at 1 
µg/g DW for free BMAA and 20 µg/g DW for total BMAA, as opposed to 0.2 µg/g DW for 
free BMAA and 2.5 µg/g DW for total BMAA in Dolichospermum field samples), which was 
caused by low recovery in Leptolyngbya.
In seafood samples, free BMAA was detected in two replicates, of which one was quantifiable 
at a concentration of 0.3 µg/g DW. Highest BMAA concentrations were again found in the 
hydrolysed TCA extract (t-test total soluble vs. total BMAA, t10 = 2.330, p = 0.042, n = 12, 
Figure 7.4). The variation within each fraction was considerable: relative SD of 21.8 for 
soluble bound BMAA and 58.2 for total BMAA, where the relative SD of D
3
BMAA recovery 
was below 8% for both fractions (Table 7.1). It is most likely that this variation is caused by 
small variations during workup (as discussed in Sections 7.3.1 and 7.3.2) and possibly by 
sample heterogeneity, for both of which the addition of an internal standard cannot correct.
Figure 7.4. BMAA concentrations in seafood samples as determined by protocol A, results 
for both pairs are combined. Error bars represent standard deviations, n = 1 for free BMAA and n = 6 for each 
of the other two fractions. “Total soluble” refers to the TCA soluble fraction, including free BMAA.
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All Daphnia samples contained quantifiable amounts of free and total soluble BMAA (Figure 
7.5). Total soluble BMAA concentrations equalled total BMAA concentrations (with outlier 
included: Mann–Whitney rank sum test, U = 15, p = 0.699, n = 12; without outlier: t-test 
total soluble vs. total BMAA, t9 = 0.768, p = 0.462, n = 11, Figure 7.5). The variation observed 
in the total BMAA results may be due to sample heterogeneity along with differences in 
actual sample size (tissue weight) due to incomplete drying of the animals. Unexposed 
Daphnia and their food source Scenedesmus obliquus did not contain detectable amounts 
of BMAA [93, 195].
Figure 7.5. BMAA concentrations in BMAA exposed Daphnia as determined by protocol 
A, results for both pairs are combined. Error bars represent standard deviations, n = 6, except for total 
BMAA, where n = 5 and the sixth data point is presented as outlier. “Total soluble” refers to the TCA soluble fraction, 
including free BMAA.
7.3.5 BMAA fractions
Free BMAA was found in all cycad and Daphnia samples, and in two of the six seafood 
replicates. Although free BMAA can slowly be released from bound forms during extraction 
with dilute acid at low temperatures [89], we do not expect that this process has substantially 
added to the free BMAA concentration we found as our handling times during TCA extraction 
were short (less than one hour).
In the BMAA positive samples we analysed, total soluble BMAA concentrations (free and 
soluble bound BMAA, represented by the green bars in Figures 7.3–7.5) were relatively 
close to the total BMAA concentrations (blue bars in same figures). The tested samples are 
therefore not expected to contain a high percentage of precipitated bound BMAA. However, 
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a direct comparative analysis of free, soluble bound and precipitated bound BMAA is needed 
to definitively answer this question.
The form in which soluble bound BMAA was present in the hydrolysed extract is unclear, 
because from our experiment we can only derive that it was TCA soluble and that it was 
bound to a precursor. Whether it is the same low molecular weight, non-protein/peptide 
precursor as found in mussels [89] is unknown. Further work is needed to identify the 
structure(s) of this precursor, and to optimize its extraction, as milder methods than the 6 
M HCl liquid hydrolysis used in this study have been shown to release soluble bound BMAA 
in mussels [89].
We detected soluble bound BMAA in all three BMAA positive samples (cycad, seafood and 
exposed Daphnia). Although a limited number of studies have determined this fraction so 
far, soluble bound BMAA seems to occur in a diversity of organisms: cycad seeds (this study 
and [92]), periphyton [198], plankton [98, 198], and bivalves [89, 103, 198]. It is therefore 
recommended to include soluble bound BMAA in future studies, for instance by hydrolysing 
the total sample (e.g. [93, 100, 197]), or by releasing it from the dried extract [89, 98, 103, 
198]. When only free and precipitated bound BMAA are determined, the soluble bound 
fraction can be overlooked, potentially resulting in a substantial underestimation of the total 
sample’s BMAA content.
7.4 CONCLUSIONS AND OUTLOOK
The three LC-MS/MS based protocols we tested to analyse underivatised BMAA in animal 
tissue, brain tissue and cyanobacterial samples were generally accurate and precise in terms 
of D
3
BMAA recovery, as well as for free BMAA determination in the positive control (cycad 
seeds). However, total BMAA determination in cycad seeds was less precise (intermediate 
precision ranging from 20% to 32%). We suspect that small variations during workup have 
influenced the liberation or formation of BMAA from bound forms, for which the addition 
of free D
3
BMAA as internal standard could not correct. Given the observed variation in total 
BMAA concentrations in cycad seeds, we recommend optimization of the workup for soluble 
bound and total BMAA, which should be performed with samples containing bound BMAA.
The majority of the BMAA detected in the positive samples (cycad seeds, seafood and 
Daphnia) was present in a bound form in the TCA extract. This fraction was released by 
liquid phase acid hydrolysis, but additional work is needed to identify the structure of its 
precursor(s) and to optimize its extraction. When only free and precipitated bound BMAA 
are determined, this fraction will be overlooked. Until its structure has been elucidated and 
extraction has been optimized, we recommend to include soluble bound BMAA either by 
determining total BMAA or by hydrolysing (part of) the extract used for free BMAA analysis.
A COLLABORATIVE EVALUATION OF LC-MS/MS BASED METHODS FOR BMAA ANALYSIS 137
7
During the workshop, scientists from 12 different research groups were provided with the 
knowledge and skills to develop appropriate BMAA methods in their own laboratories. 
Furthermore, mutual understanding was created by an open discussion on the pros and 
cons of different analytical techniques and by evaluation of the conflicting data in BMAA 
literature. This common starting point will facilitate the performance of interlaboratory 
comparison exercises, which are needed to progress BMAA research [58].
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APPendix A7.1 
deTAiled MeThods underivATised ProTocols
A7.1.1 Experimental design
Table A7.1.1. Experimental design. Extraction for underivatised LC-MS/MS analysis was carried out by two 
pairs of analysts (1 to 6) for animal tissue (protocol A), brain tissue (B) and cyanobacterial samples (C). Extraction for 
derivatised LC-MS/MS analysis was similar for all sample types (D) and was also carried out by two pairs of analysts.
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Appendix A7.1 Detailed methods underivatised protocols 
A7.1.1 Experimental design 
Table A7.1.1. Experimental design. Extraction for underivatised LC-MS/MS analysis was carried out 
by two pairs of analysts (1 to 6) for animal tissue (protocol A), brain tissue (B) and cyanobacterial 
samples (C). Extraction for derivatised LC-MS/MS analysis was similar for all sample types (D) and was 
also carried out by two pairs of analysts. 
Protocol A A A B B C C D 
BMAA fraction free ‘t.s.’1 total free total free total total 
Blank (neg. control) 5,6 5,6 1,2 1,2 3,4 3,4 5,6 1,3 
Cycad seed (pos. control) 5,6 5,6 1,2 1,2 3,4 3,4 5,6 2,4 
Seafood 5,6 5,6 1,2 - - - - 3,4 
Daphnia magna 5,6 5,6 1,2 - - - - 3,4 
Brain unspiked - - - 1,2 3,4 - - 5,6 
Brain spiked - - - 1,2 3,4 - - 5,6 
Dolichospermum - - - - - 3,4 5,6 1,2 
Leptolyngbya - - - - - 3,4 5,6 1,2 
1 t.s.: total soluble BMAA
A7.1.2 Sample origin and storage 
The positive control sample consisted of the sarcotesta of Cycas micronesica (Hill) seed, which was 
kindly provided by Chad Husby, Montgomery Botanical Centre, Miami, US. The seed was freeze 
dried, homogenized by mortar and pestle and stored at −20 °C. The seafood sample was a mixture of 
crabmeat and Asari clam (Venerupis philippinarum), kindly provided by Stephanie Christensen, 
University of Hawaii, US. The samples were mixed to obtain enough biomass for all analyses. 
Crabmeat was purchased at a seafood market in Louisiana (US) and shipped to Hawaii frozen on dry 
ice. It was stored at −80 °C until freeze drying. The freeze dried sample was hand ground with mortar 
and pestle, and stored in the dark at room temperature. The Asari clam was purchased from a 
seafood market at Nijiya market, Hawaii, US and prepared and stored the same way as the crabmeat. 
Daphnia magna (Strauss) was isolated from the Dutch lake Zwemlust in 1999, it was maintained in 
jars containing RT medium [184] and fed with the green algae Scenedesmus obliquus SAG 276/3a. 
Prior to the experiment, the animals were kept under similar conditions, but BMAA (L-BMAA 
hydrochloride, Sigma) was added to the jars. The animals were exposed to a nominal concentration 
of 78 µg/L for approximately two weeks. After exposure, animals were rinsed with water, freeze 
dried and homogenized with a plastic stick. The brain sample was kindly provided by Lonneke 
IJsseldijk, Utrecht University, The Netherlands and by Mardik Leopold, IMARES, The Netherlands. It 
was taken from a stranded male harbour porpoise (Phocoena phocoena, 33.3 kg, 134 cm), found in 
Callantsoog (The Netherlands) on 16–06–2008. The animal was still relative fresh (DCC 2), had slightly 
lost weight (NCC 3) and had probably died of pneumonia. The corpse was kept at −20 °C until 
dissection and the whole brain was then stored at the same temperature. Before the start of the 
experiment, the brain was freeze dried and homogenized in a food processor. The Dolichospermum 
dominated scum sample was collected from a Dutch lake in 2008 and was stored at −20 °C after 
freeze drying. The lab strain Leptolyngbya PCC 73110 was kindly provided by Birgitta Bergman, 
Stockholm University, Sweden and was grown at 20 °C on BG11 growth medium [165]. After 
1 t.s.: total soluble BMAA
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was kindly provide  by Lonneke IJsseldijk, Utrecht University, The Netherlands and by 
Mardik Leopold, IMARES, The Netherlands. It was taken from a stranded male harbour 
porpoise (Phocoena phocoena, 33.3 kg, 134 cm), found in Callantsoog (The Netherlands) 
on 16–06–2008. The animal was still relative fresh (DCC 2), had slightly lost weight (NCC 3) 
and had probably died of pneumonia. The corpse was kept at −20 °C until dissection and the 
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whole brain was then stored at the same temperature. Before the start of the experiment, 
the brain was freeze dried and homogenized in a food processor. The Dolichospermum 
dominated scum sample was collected from a Dutch lake in 2008 and was stored at −20 °C 
after freeze drying. The lab strain Leptolyngbya PCC 73110 was kindly provided by Birgitta 
Bergman, Stockholm University, Sweden and was grown at 20 °C on BG11 growth medium 
[165]. After collection by centrifugation and freeze drying, the samples were stored at −20 
°C. Samples were prepared and analysed as described in the sections below.
A7.1.3 Protocol A
The protocol used for extraction of animal samples followed by underivatised LC-MS/MS 
analysis was adapted from a method developed and validated for the underivatised analysis 
of cyanobacterial samples [93]. Main adaptations are that the total soluble BMAA fraction 
was included, and that analysis was performed on a more recent LC-MS/MS system, with 
enhanced sensitivity.
For the extraction of free BMAA and the TCA soluble fraction released by hydrolysis (the 
‘total soluble fraction’), 8 mg of cycad and 10 mg of Daphnia and seafood was used. Samples 
were extracted by addition of 600 µl 0.1 M TCA, vortexed and left for 10 min at room 
temperature. Following a further vortex, samples were centrifuged for 5 min at 16000× g and 
the supernatant was transferred to an Eppendorf tube with a 0.2 µm cellulose acetate filter 
(Grace Davison Discovery Science, Columbia, USA) and centrifuged for 5 min at 16000× g. 
TCA (600 µL) was then added to the pellet, and after vortexing, centrifugation and filtration 
as described above, both extracts were combined. For the analysis of free BMAA, 20 µL of a 
2 mg/L D
3
BMAA (D
3
BMAA hydrochloride, Novakits, Nantes, France) solution was added to 
600 µl of the pooled extract. The extract was subsequently dried in a speedvac (SPD121P, 
Thermo Scientific Savant, Asheville, USA) and reconstituted in 500 µL water/acetonitrile/
formic acid (v/v 33:67:0.1).
For the analysis of the total soluble fraction, 120 µL of the pooled extract was transferred 
to a small glass tube, and 40 µL of the 2 mg/L D
3
BMAA solution was added. This extract was 
freeze-dried, and 30 µL 6 M HCl was added to the dry sample. After flushing the sample with 
nitrogen, it was hydrolysed overnight under vacuum at 105 °C in a hydrolysis workstation 
(Eldex). After hydrolysis, the samples were dried under vacuum, dissolved in 1000 µL water/
acetonitrile/formic acid (v/v 33:67:0.1) and filtrated over a 0.2 µm cellulose acetate filter.
Total BMAA was determined in 0.8 mg of cycad seeds and 1 mg of the Daphnia and seafood 
samples. An aliquot of the same D
3
BMAA solution (40 µL) was added and the sample 
was dried under vacuum. Samples were hydrolysed by addition of 6 M HCl (30 µL) and 
reconstituted as described above for the total soluble fraction.
140 A COLLABORATIVE EVALUATION OF LC-MS/MS BASED METHODS FOR BMAA ANALYSIS
A7.1.4 Protocol B
The protocol used for brain samples followed by underivatised LC-MS/MS analysis was 
adapted from a method developed and validated for the underivatised analysis of free 
BMAA in brain tissue [199]. Main adaptations to this published method are that we included 
a method for total BMAA, that we started with freeze dried samples instead of with samples 
that were only frozen and thawed and that we therefore adapted the first extraction steps 
for free BMAA, and that the LC-MS/MS analysis was performed according to [195] on the 
same LC-MS/MS system as used for the other analyses in this experiment.
Free BMAA was determined in 8 mg of cycad seed, and 20 mg of harbour porpoise brain. 
Each pair analysed three unspiked brain samples, three other samples were spiked with 60 
ng l-BMAA directly after weighing. An aliquot (40 µL) of the 2 mg/L D
3
BMAA solution and 
3 mL 0.1 M TCA were added, and the samples were vortexed. BMAA was extracted in an 
ultrasonic bath (Branson 3510, Danbury, USA) at room temperature for 10 min, after which 
the sample tubes were centrifuged for 10 min at 3500× g. The supernatant was transferred 
to a clean glass tube, and solid phase extraction (SPE) was performed using MCX, 60 mg, 3 
mL cartridges (Oasis, Etten-Leur, The Netherlands). Cartridges were conditioned with 2 mL 
of methanol, followed by 1 mL of water with formic acid (pH = 3). Sample (3 mL) was then 
loaded onto the cartridges, which were subsequently washed with 1 mL cyclohexane. After 
drying the cartridges with nitrogen gas, 1 mL 0.1 M HCl and 2 mL methanol were added. 
The samples were then eluted with 3 mL methanol with NH
4
OH (freshly prepared by adding 
6.6% of a 25% NH
4
OH solution to 93.4% of methanol (v/v)). After drying in the speedvac, 
the samples were reconstituted in 1000 µL of water/acetonitrile/formic acid and filtered as 
described above.
Total BMAA was determined in 0.8 mg of cycad seeds and in 1 mg of brain samples. Directly 
after weighing, three replicate brain samples for each pair were spiked with 40 ng l-BMAA. 
An aliquot (40 µL) of the 2 mg/L D
3
BMAA solution was added to all samples, and after 
drying, hydrolysis was performed as described in Section A7.1.3. After hydrolysis, dried 
samples were quantitatively transferred to new tubes using 0.1 M TCA, final volume was 3 
mL. Samples were subsequently cleaned up by SPE and reconstituted as described above.
A7.1.5 Protocol C
The protocol used for cyanobacterial samples followed by underivatised LC-MS/MS analysis 
was described and validated previously [93], but for this experiment, a more updated LC-
MS/MS system was used [195].
Free BMAA was determined in 4 mg of cycad seeds and 5 mg of cyanobacterial samples. 
To each sample, 20 µL of a 2 mg/L D
3
BMAA solution was added. Samples were extracted 
as described for the animal samples, but only 300 µL of 0.1 M TCA was used during both 
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extraction steps, instead of 600 µL. After extraction and filtration, the complete extract 
was dried in a speedvac, and reconstituted in 500 µL water/acetonitrile/formic acid (v/v 
33:67:0.1).
Total BMAA determination was the same as described for the animal samples (protocol A, 
Section A7.1.3), the amount of cycad samples used was 0.8 mg, and 1 mg was used for the 
cyanobacterial samples.
A7.1.6 LC-MS/MS analysis
LC-MS/MS analyses were performed on an Agilent 1260 LC coupled to an Agilent 6460 triple 
quadrupole mass spectrometer. The method for underivatised analysis is described in [195]. 
Separation was performed with a 2.1 × 150 mm, 5 µm ZIC-HILIC column (SeQuant, Solna, 
Sweden). Column temperature was 40 °C, injection volume 5 µL and flowrate 0.4 mL/min. 
The mobile phase consisted of acetonitrile with 0.1 % formic acid (v/v, eluent A) and water 
with 0.1% formic acid (v/v, eluent B). The elution program was 0–2 min: 95% A, 4 min: 65% 
A, 8–17 min 55% A, 17–23 min 95% A, with linear decreases between the steps. During 
the first 4 and last 6 minutes the flow was directed to waste. Nitrogen was used as drying, 
sheath and collision gas and source settings were: drying gas temperature 230 °C, drying gas 
flow 12 L/min, nebulizer pressure 40 psi, sheath gas temperature 250 °C, sheath gas flow 
12 L/min, capillary voltage 2500 V, nozzle voltage 500 V. Both quadrupoles were operated 
in unit mode and the ESI source was operated in positive mode. MS/MS settings, and 
precursor to product ion transitions monitored in multiple reaction monitoring (MRM) for 
BMAA, D
3
BMAA, α,γ-diaminobutyric acid (DAB, DAB dihydrochloride, Sigma, Zwijndrecht, 
The Netherlands) and N-(2-aminoethyl) glycine (AEG, TCI) are shown in Table A7.1.2.
Table A7.1.2. MS/MS settings and MRM transitions for underivatised analysis.
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drying gas temperature 230 °C, drying gas flow 12 L/min, nebulizer pressure 40 psi, sheath gas 
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Table A7.1.2. MS/MS settings and MRM transitions for underivatised analysis. 
Compound Precursor F1 Quant2 CE3 Qual4 CE Ratio5 Qual CE Ratio 
m/z V m/z V m/z V % m/z V % 
D3BMAA 122.1 50 105.1 4 88.1 8 27 76.2 8 43 
BMAA 119.1 50 102.1 4 88.1 8 25 76.2 8 25 
DAB 119.1 50 101.1 4 74.2 4 - - - - 
AEG 119.1 50 102.1 4 - - - - - - 
1 Fragmentor voltage, 2 Quantifier ion, 3 Collision energy, 4 Qualifier ion, 5 Ratio between areas of 
qualifier and quantifier ion 
BMAA was identified based on retention time compared to D3BMAA in the same sample, and by the 
ratios between quantifier and qualifiers which had to be within a 20% relative range of the same 
ratios in the calibration standards. DAB and AEG were not quantified in this study, but only included 
in the analysis to ensure that there was no co-elution with BMAA (Figure A7.1.1). BMAA was 
quantified against an external calibration curve and each sample was corrected for D3BMAA 
recovery. LOD (based on signal to noise (S/N) ratio for all three transitions of at least 3 in a calibration 
standard) for BMAA was an injected amount of 84 fmol (2 µg/L), LOQ (S/N ratio of the quantifier at 
least 10, S/N ratio of the two qualifiers at least 3) was 208 fmol (5 µg/L). Response was linear (R2 = 
0.995) within the concentration range of 5 µg/L to 100 µg/L. 
1 Fragmentor voltage, 2 Quantifier ion, 3 Collisi n energy, 4 Qualifier ion, 5 Ratio between areas of qu lifier and 
quantifi r io
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range of the same ratios in the calibration standards. DAB and AEG were not quantified in 
this study, but only included in the analysis to ensure that there was no co-elution with 
BMAA (Figure A7.1.1). BMAA was quantified against an external calibration curve and each 
sample was corrected for D
3
BMAA recovery. LOD (based on signal to noise (S/N) ratio for all 
three transitions of at least 3 in a calibration standard) for BMAA was an injected amount of 
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84 fmol (2 µg/L), LOQ (S/N ratio of the quantifier at least 10, S/N ratio of the two qualifiers 
at least 3) was 208 fmol (5 µg/L). Response was linear (R2 = 0.995) within the concentration 
range of 5 µg/L to 100 µg/L.
Figure A7.1.1. Chromatograms of underivatised LC-MS/MS analysis of a calibration 
standard (left panels) and the total soluble BMAA fraction of a Daphnia sample (right 
panels). Quantifiers are indicated by bold lines, qualifiers are indicated by normal lines. The calibration standard 
contains 50 µg/L of D
3
BMAA, BMAA, DAB and AEG.
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APPendix A7.2. MeThods And resulTs of 
The derivATised ProTocol (ProTocol d)
A7.2.1 Main steps workup
The protocol used for derivatised LC-MS/MS analysis was adapted from a previously 
published and validated method [197]. This protocol was used on all sample types for 
the determination of total BMAA. The samples were extracted with aqueous methanol, 
hydrolysed, cleaned up by chloroform extraction and Isolute HCX-3 SPE, derivatised and 
concentrated before LC-MS/MS analysis (Figure A7.2.1).
 
Sample 
dried 
extract 
total dried 
hydrol. 
cleaned 
hydrol. 
hydrolysis 
drying 
drying 
reconstitution 
derivatization 
D3BMAA methanol/water 
extraction 
drying 
chloroform 
extraction 
Isolute HCX-3 
SPE 
deriv. 
hydrol. 
drying 
reconstitution 
a b c d e 
Figure A7.2.1. Sample preparation scheme for the analysis of derivatised BMAA (protocol 
D). The main steps are indicated by letters a to e.
A7.2.2 Detailed protocol
Total BMAA was determined in 0.5 mg of cycad seed, Daphnia and seafood sample, 2 mg of 
cyanobacterial and brain samples was used. Directly after weighing, 80 ng of l-BMAA was 
added to half of the brain samples. To all samples, 6 µL of a 100 µg/L D
3
BMAA solution was 
added. Samples were subsequently extracted for 10 min in 500 µL 80% methanol in water 
(v/v) in an ultrasonic bath at room temperature. The samples were then dried down in a 
speedvac, and transferred to glass vials using 150 µL of 6 M HCl. The vials were closed and 
the samples were hydrolysed overnight in an oven at 110 °C. After hydrolysis, 300 µL of water 
was added to the vials, and the samples were filtered for 5 min at 16000× g over a 0.2 µm 
cellulose acetate filter. After drying in a speedvac, the samples were reconstituted in 550 µL 
water, and 1000 µL of chloroform was added. After manually shaking for 5 min, the samples 
were centrifuged for 3 min at 16000× g and 500 µL of the aqueous layer was transferred to a 
new Eppendorf tube. Water plus 0.2% formic acid (500 µL) was added and the samples were 
cleaned up by SPE. HCX-3 cartridges (100 mg, Isolute, Uppsala, Sweden) were conditioned 
with 1 mL of methanol and 1 mL of water with 0.1% formic acid. Samples (1 mL) were loaded, 
washed with 1 mL of water plus 0.1% formic acid (pH 2.7) and 1 mL of methanol. Samples 
were eluted by the addition of 2× 800 µL of NH
4
OH in methanol (prepared by adding 2.6% 
of a 25% NH
4
OH solution to 97.4% of methanol (v/v)). The eluates were dried in a speedvac 
and reconstituted in 20 µL 20mM HCl. Samples were then derivatised by adding 60 µL of 
borate buffer and 20 µL of AQC (Waters) derivatisation reagent. The derivatised samples 
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were again dried in a speedvac, and reconstituted in 30 µL of a water/acetonitrile solution 
(95:5 v/v). Samples were stored at −20 °C before analysis.
As the UPLC method used for the analysis of derivatised samples [197] could not be 
reproduced on our LC system, we adapted the method for derivatised BMAA analysis as 
described in [93] to the used LC-MS/MS system to ensure separation of AEG from DAB 
and BMAA. Chromatography was performed on a Zorbax Eclipse AAA 4.6 × 75 mm, 3.5 µm 
column (Agilent, Waldbronn, Germany) with the same mobile phases as for the underivatised 
analysis. The following gradient was applied: 0 min 1% A; 4 min 2% A; 8 min 5% A; 24 min 
10% A; 26–30 min 50% A; 30–42 min 1% A with linear increases between the steps. During 
the first 6 and the last 12 min of each run, the flow was directed to waste. Flow rate was 
1 mL/min, injection volume 10 µL and column temperature 40 °C. Source settings were: 
drying gas temperature 300 °C, drying gas flow 5 L/min, nebulizer pressure 45 psi, sheath 
gas temperature 400 °C, sheath gas flow 11 L/min, capillary voltage 2500 V, nozzle voltage 
500 V. Both quadrupoles were operated in unit mode, and the ESI source was operated in 
positive mode. MS/MS settings and transitions monitored in MRM for D
3
BMAA, BMAA, DAB 
and AEG are shown in Table A7.2.1.
Table A7.2.1. MS/MS settings and MRM transitions for derivatised analysis.
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Compound Precursor F1 Quant2 CE3 Qual4 CE Ratio5 Qual CE Ratio 
m/z V m/z V m/z V % m/z V % 
D3BMAA 462 134 171 35 145 16 12 122 16 27 
BMAA 459 143 171 32 258 25 3 119 16 28 
DAB 459 134 171 32 315 12 - - - - 
AEG 459 134 171 32 214 35 - - - - 
1 Fragmentor voltage, 2 Quantifier ion, 3 Collision energy, 4 Qualifier ion, 5 Ratio between areas of 
qualifier and quantifier ion 
BMAA was identified based on retention time compared to D3BMAA in the same sample, and by the 
ratios between quantifier and qualifiers which had to be within a 20% relative range of the same 
ratios in the calibration standards. DAB and AEG were not quantified in this study, but only included 
in the analysis to ensure that there was no co-elution with BMAA (Figure A7.2.2). BMAA was 
quantified against an external calibration curve and each sample was corrected for D3BMAA 
recovery. Calibration standards were prepared in 20mM HCl, derivatised in the same way as the 
samples, and subsequently dried down and dissolved in water/acetonitrile as described above. For 
BMAA, LOD and LOQ were similar: an amount of 45 fmol on column (corresponding to a 
concentration of 1 µg/L before derivatization and concentration). Response was linear (R2 = 0.995) 
within the concentration range of 1 µg/L to 100 µg/L. 
A7.2.3 D3BMAA recovery 
D3BMAA recovery was below 10% in all samples analysed with protocol D which is consistent with a 
recent independent evaluation of a similar protocol [200]. The majority of the analyte is lost during 
SPE: when during method development a D3BMAA solution was subjected to SPE, without matrix or 
previous extraction, and the eluate was derivatised directly after drying (step c and d in Figure 
A7.2.1), recovery was 37% (SD 7.9, n = 3). When this test was repeated with inclusion of the final 
concentration step (step e in Figure A7.2.1), no extra losses occurred (recovery 34%, SD 9.0, n=3). In 
addition to losses during SPE, strong signal suppression has been reported for this method [200]. 
Because of the low recovery achieved, it was not possible to determine BMAA concentrations in 
samples using this protocol. 
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A7.2.3 D3BMAA recovery
D
3
BMAA recovery was below 10% in all samples analysed with protocol D which is consistent 
with a recent independent evaluation of a similar protocol [200]. The majority of the analyte 
is lost during SPE: when during method development a D
3
BMAA solution was subjected to 
SPE, without matrix or previous extraction, and the eluate was derivatised directly after 
drying (step c and d in Figure A7.2.1), recovery was 37% (SD 7.9, n = 3). When this test was 
repeated with inclusion of the final concentration step (step e in Figure A7.2.1), no extra 
losses occurred (recovery 34%, SD 9.0, n=3). In addition to losses during SPE, strong signal 
suppression has been reported for this method [200]. Because of the low recovery achieved, 
it was not possible to determine BMAA concentrations in samples using this protocol.
A recovery of 63.3% has been reported for a similar method where the final concentration 
step was omitted, combined with alternative chromatography and MS/MS detection [135]. 
However, this value does not cover full recovery, as it is based on the ratio between a spike 
added before workup and a spike added before derivatisation. Losses that occur during and 
after derivatisation (like signal suppression) were therefore not taken into account. As the 
optimum sample protein to derivatisation reagent ratio (0.005 to 0.25 µg protein/µL before 
derivatisation [124]) is greatly exceeded in this method, it is necessary to determine the 
efficiency of derivatisation.
The D
3
BMAA recovery of the protocol used in our study was low, but this is not inherent 
to AQC based LC-MS/MS methods as in our case, a substantial part of the D
3
BMAA got lost 
during workup. If coupled to appropriate workup protocols, AQC based methods can give 
good recoveries, values ranging from 61% to 99% have been reported for AQC derivatised 
LC-MS/MS analysis of BMAA (e.g. [93, 145, 149]).
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Figure A7.2.2. Chromatogram of derivatised LC-MS/MS analysis of a calibration standard 
containing 500 µg/L of D3BMAA, BMAA, DAB and AEG. Quantifiers for D3BMAA and BMAA are 
indicated by bold lines, qualifiers are indicated by normal lines.
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APPendix A7.3. 
relATion d3BMAA recovery – 
uncorrecTed BMAA concenTrATion 
Figure A7.3. Relation between D3BMAA recovery and the BMAA concentration determined 
in cycad seeds by underivatised LC-MS/MS analysis, uncorrected for D3BMAA recovery. The 
upper panel shows free BMAA, the lower panel shows total soluble BMAA and total BMAA.
“Ah, (it’s) all about chemistry
Won’t you show me everything you know?”
Semisonic, Chemistry
CHAPTER 8
sTAndArd oPerATinG Procedure: exTrAcTion 
And lc-Ms/Ms AnAlysis of underivATised BMAA
This chapter will be published as: SOP 22  Extraction and LC-MS/MS analysis of underivatised 
BMAA. E. J. Faassen. In: Handbook of Cyanobacterial  Monitoring and Cyanotoxin Analysis, 
2016. Edited by Meriluoto J., Spoof, L. and Codd, G.A. John Wiley & Sons, Chichester, UK.
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8.1 INTRODUCTION
Liquid chromatography coupled to tandem mass-spectrometry detection (LC-MS/MS) 
is a suitable, commonly used technique for the quantification of the neurotoxin β-N-
methylamino-L-alanine (BMAA) in cyanobacteria [58]. BMAA can either be derivatised 
before analysis, for instance with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) 
[34, 97], propyl chloroformate [99] and dansyl chloride [100], or it can be analysed without 
pre-column derivatisation [76, 102].
In LC-MS/MS analysis, BMAA should be properly separated from isobaric compounds 
such as α,γ-diaminobutyric acid (DAB), N-(2-aminoethyl) glycine (AEG) and β-amino-N-
methylalanine (BAMA) [97, 104]. Furthermore, attention should be paid to the form in which 
BMAA can be present in natural samples: either free, bound in a fraction that precipitates 
with proteins or bound in a (0.1 M trichloroacetic acid, TCA) soluble fraction.
The extraction methods used in this SOP (0.1 M TCA extraction and liquid 6 M HCl hydrolysis) 
are commonly used in BMAA research. However, it is possible that method details like 
incubation times and conditions will still be optimized. Furthermore, the precursors of the 
bound BMAA fractions are still unknown and therefore, more effective extraction methods 
for bound BMAA could be developed [89]. It is therefore recommended to check recent 
literature before setting up an analytical method for BMAA. 
8.2 EXPERIMENTAL
8.2.1 Materials
•	 Ultrapure water, e.g. with a Qpod (Millipore) 
•	 Acetonitrile at least of HPLC grade 
•	 Hydrochloric acid, trichloroacetic acid and formic acid of analytical grade
•	 Teflon forceps
•	 Glass Pasteur pipettes
•	 2 mL plastic tubes (e.g. from Eppendorf)
•	 2 mL spin filter tubes with 0.2 µm cellulose acetate filter
•	 Small glass tubes for hydrolysis (6 x 50 mm, when hydrolysis workstation is used)
•	 HPLC/UHPLC glass vials
•	 Calibration standards of BMAA, DAB, AEG and deuterium labelled BMAA as an internal 
standard (D
3
BMAA), all standards are commercially available.
8.2.2 Special equipment
•	 Freeze-dryer
•	 Speedvac
•	 Microcentrifuge
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•	 Hydrolysis workstation (e.g. Eldex), alternatively, samples can be hydrolysed in a stove, 
in glass vials with screw caps (in which case samples are analysed under atmospheric 
conditions, the steps describing nitrogen flushing and application of vacuum can be 
skipped).
•	 HPLC or UPLC coupled to a triple quadrupole mass spectrometer 
•	 Integration software
8.2.3 Solutions 
•	 1 M trichloroacetic acid (TCA)
•	 6 M hydrochloric acid (HCl)
•	 20 mM HCl
•	 67% acetonitrile/33% water/0.1% formic acid solution (v/v/v)
•	 D
3
BMAA spike solution in 20 mM HCl. The concentration of the spike solution and the 
volume of spiking solution added during sample processing depend on the method LOD. 
In this SOP, a concentration of 1 μg/ml is used. When the spiking volumes described in 
section 8.2.5 are used, this results in a concentration of 40 ng/ml in the solution to be 
analysed (if 100% recovery would be achieved).
8.2.4. LC-mobile phase
•	 Mobile phase A: Acetonitrile with 0.1% formic acid (v/v)
•	 Mobile phase B: Water with 0.1% formic acid (v/v)
8.2.5 General procedure
In sections 8.2.5.1 and 8.2.5.2, the extraction of free BMAA, total 0.1 M TCA-dissolved 
BMAA (including the soluble bound fraction) and total BMAA in cyanobacterial samples is 
described step to step. The amount of bound BMAA present in the precipitated fraction can 
be determined by subtracting the amounts of free and dissolved bound BMAA from the 
total amount in the sample. But preferably, this fraction is directly determined, as described 
in section 8.2.5.3 (see Figure 8.1).
For all extraction methods, it is recommended to include blank samples (no matrix) 
and positive controls (e.g. cycad seeds, Cycas micronesica (Hill)). Hydrolysis of sample 
material collected on GF/C filters with the methods described below results in very low 
recovery, cyanobacterial samples are therefore better concentrated in other ways, e.g. by 
centrifugation. Furthermore, all extractions should be performed under acidic conditions to 
ensure BMAA stability.
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8.2.5.1 Total BMAA
a) Freeze dry samples to disrupt the cell walls.
b) Weigh 1 mg into a small glass tube.
c) Add D
3
BMAA spike (40 µL).
d) Dry the sample under vacuum in the hydrolysis workstation.
e) Add 30 µL 6 M HCl to each glass tube. After HCl addition, use Teflon forceps to 
handle the tubes.
f) Flush sample three times with nitrogen in the hydrolysis workstation, apply 
vacuum between flushing steps.
g) Apply a vacuum of approximately 0.7 mbar, without drying down the acid.
h) Hydrolyse the sample for 20 hours at 105 °C.
i) After hydrolysis, dry the samples under vacuum in the hydrolysis workstation.
j) Add 500 µL 67% acetonitrile/33% water/0.1% formic acid to each sample.
k) Vortex until sample has detached from the glass (use pipette tip if needed) and 
transfer suspension to spin filter tube with glass Pasteur pipette.
l) Centrifuge sample for 5 minutes at maximum speed in a micro centrifuge.
m) Transfer filtrate to a glass vial.
n) Add again 500 µL 67% acetonitrile/33% water/0.1% formic acid to each sample 
tube.
o) Vortex and transfer suspension to same spin filter tube.
p) Centrifuge again for 5 minutes at maximum speed.
q) Transfer filtrate to the same vial, mix and close the vial.
 
Sample 
extract 
free 
total 0.1 M 
TCA soluble 
(incl. bound) 
total 
hydrolysed 
extract 
hydrolysed 
sample 
hydrolysis 
drying 
reconstitution 
D3BMAA TCA extraction 
pellet 
0.1 M TCA 
precipitated, 
bound 
hydrolysed 
pellet 
Sample Sample 
BMAA fraction 
drying 
reconstitution 
hydrolysis 
TCA extraction 
D3BMAA 
D3BMAA 
hydrolysis 
Figure 8.1. Sample preparation scheme for the extraction of different BMAA fractions. 
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8.2.5.2 Free BMAA and total 0.1 M TCA-soluble BMAA
a) Freeze dry samples to disrupt the cell walls.
b) Weigh 12.5 mg into a plastic 2 ml tube.
c) Add 50 µL of D
3
BMAA spike solution
d) Add 600 µL of 0.1 M TCA.
e) Vortex for 1 minute and leave for 10 minutes at room temperature.
f) Vortex again for 1 minute and centrifuge for 5 minutes at maximum speed.
g) Transfer supernatant to a spin filter tube.
h) Centrifuge the spin filter tube for 5 minutes at maximum speed.
i) Transfer filtrate to a new plastic 2 ml tube.
j) Add again 600 µL of 0.1 M TCA to the sample.
k) Vortex for 1 minute and centrifuge for 5 minutes at maximum speed.
l) Transfer the second supernatant to the same spin filter tube.
m) Centrifuge the spin filter tube again for 5 minutes at maximum speed.
n) Transfer the second filtrate to the same tube as the first filtrate (total volume 1250 
µL)
o) Vortex and split the extract in two fractions:
Free BMAA:
p) Transfer 500 µL of the extract to a new plastic 2 ml tube.
q) Dry these samples down in speedvac.
r) Add 500 µL of a 67% acetonitrile/33% water/0.1% formic acid solution to each 
tube.
s) Vortex for 2 minutes and transfer samples to HPLC/UHPLC vials for analysis.
Total soluble BMAA:
t) Transfer 500 µL of the extract to a small glass tube for hydrolysis.
u) Put the samples in the freezer until they are completely frozen and subsequently 
freeze dry them (overnight).
v) Perform hydrolysis and reconstitute as described for total BMAA (steps 8.2.5.1.e to 
8.2.5.1.q ) but use 2 times 250 µL of 67% acetonitrile/33% water/0.1% formic acid 
(final volume in HPLC/UHPLC vial is 500 µL).
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8.2.5.3 Bound BMAA in the precipitate
Bound BMAA in the pellet created during 0.1 M TCA extraction can best be determined by 
extracting another 1 mg of lyophilized sample as described in the following steps.
a) Freeze dry samples to disrupt the cell walls.
b) Weigh 1 mg into a plastic 2 ml tube.
c) Add 150 µL of 0.1 M TCA.
d) Vortex for 1 minute and leave for 10 minutes at room temperature.
e) Vortex again for 1 minute and centrifuge for 5 minutes at maximum speed.
f) Discard the supernatant.
g) Add again 150 µL of 0.1 M TCA to the sample.
h) Vortex for 1 minute and centrifuge for 5 minutes at maximum speed.
i) Discard the supernatant.
j) Transfer the pellet to small glass tube for hydrolysis, use 20 mM HCl to make sure 
all material is transferred.
k) Add 40 µL D
3
BMAA spike.
l) Dry the sample under vacuum in the hydrolysis workstation.
m) Perform hydrolysis and reconstitute as described for total BMAA (steps 8.2.5.1.e 
to 8.2.5.1.q).
Alternatively, the pellet created during the extraction for free and total 0.1 M TCA soluble 
BMAA (8.2.5.2) can be transferred to small glass tubes, dried and hydrolysed as described 
in steps 8.2.5.1.d to 8.2.5.1.q. In this case, a portion of the pellet equivalent to 1 mg of dry 
weight should be used and D
3
BMAA should be added to the pellet after it was transferred 
to the tube for hydrolysis.
8.2.6. Chromatography
Underivatised BMAA can effectively be separated from DAB and AEG by hydrophilic 
liquid interaction chromatography (HILIC). For HPLC equipment, chromatography can be 
performed on a 2.1 × 150 mm, 5 µm ZIC-HILIC column (SeQuant, Sweden) at 40 °C. Use an 
injection volume of 5 µl and a flow rate of 0.4 ml min-1. Mobile phases are acetonitrile with 
0.1 % formic acid (eluent A) and water with 0.1% formic acid (eluent B). Use the following 
elution program [93]:
•	 0–2 min: 95% A
•	 4 min: 65% A
•	 8–17 min 55% A
•	 17–23 min 95% A (equilibration)
with linear decreases between the time steps and directing the flow to waste during the first 
4 and last 6 minutes. Chromatograms of a calibration standard and a cycad seed sarcotesta 
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extracted for free BMAA are shown in Figure 8.2. Separation from isobaric compounds other 
than DAB and AEG is not described in this SOP, but see [104] for more information.
For LC systems operated at higher pressure, similar columns, but with smaller particle 
diameter can be used, and the elution program should be adjusted accordingly.
Tips for HILIC chromatography:
i. The solution used for dissolving the samples and calibration standards should have 
a low water content to ensure good retention.
ii. Elute under acidic conditions to ensure BMAA is positively charged and will be well 
retained on the column.
iii. Using a relatively high percentage of water at the end of each run and a sufficient 
equilibration time before the next injection ensures retention time stability.
8.2.7 Detection by MS/MS
Settings of the tandem mass spectrometer should be optimized for the specific equipment 
used, commercially available standards can be used for this. For detection and quantification 
of BMAA, electrospray ionisation (ESI) in positive mode is usually employed. The transitions 
that should be monitored in multiple reaction mode are displayed in Table 8.1. Preferably, 
two qualifiers are used for BMAA identification. For reliable identification, it is recommended 
to set the resolution of both mass filters as narrow as possible.
Table 8.1. MS/MS transitions for the analysis of underivatised D3BMAA, BMAA, DAB and 
AEG.
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 m/z a m/z m/z m/z 
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AEG 119.1 102.1 - - 
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For BMAA identification, the following criteria should be met for each sample: 
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ii. The signal to noise ratio of all product ions should be at least 3.
iii. The ratio between m/z 102.1 and m/z 88.1 should not deviate more than 20% from 
the ratio between the same ions in the BMAA calibration standards.
iv. The ratio between m/z 102.1 and m/z 76.2 should not deviate more than 20% from 
the ratio between the same ions in the BMAA calibration standards.
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Figure 8.2. Chromatograms of a 50 ng/mL BMAA, D3BMAA, DAB and AEG standard (panel 
a and c) and a cycad seed sarcotesta (Cycas micronesica), extracted for free BMAA as 
positive control (8.1 mg used, concentration determined at 11.4 µg/g) and spiked with 
D3BMAA at 80 ng/mL (panel b and d). Quantifiers are indicated by bold lines, qualifiers are indicated 
by normal lines. Chromatography was performed as described in Section 8.2.6 on an Agilent 1260 LC. Compounds 
were detected on an Agilent 6460 triple quadrupole mass spectrometer with the following settings: drying gas 
temperature 230 °C, sheath gas temperature 250 °C, drying gas flow and sheath gas flow 12 l/min, nebulizer pressure 
40 psi, capillary voltage 2500 V, nozzle voltage 500 V. Both quadrupoles were operated in unit mode. Fragmentor 
voltage was 50 V, collision energy was 4 V for the transitions m/z 122.1 to 105.1 and m/z 119.1 to 102.1, 101.1 and 
74.2 and was 8 V for all other transitions.
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8.3 QUANTIFICATION
For BMAA quantification, a calibration curve containing BMAA and D
3
BMAA should be 
constructed. The solvent should be the same as the one used for the samples (e.g. a 67% 
acetonitrile/33% water/0.1% formic acid solution). Also add DAB and AEG standards to the 
calibration curve, either for semi-quantification of these compounds, or to make sure that 
no co-elution with BMAA has taken place. As an example, a dilution series of 0, 0.5, 1, 5, 10, 
50 and 100 µg/L could be used, in which each standard contains the reported concentration 
of each analysed compound (BMAA, D
3
BMAA, DAB and AEG).
The LC-MS/MS worklist should start and end with calibration standards, as well as after a 
fixed number of injected samples (e.g. 10), a set of calibration standards should be analysed 
In this way, it is possible to correct for changes in signal intensity that might occur during the 
run. Include vials with only solvent to check for signal carry over.  
Quantify BMAA by determining the BMAA and D
3
BMAA concentration of each sample against 
the external calibration curves (signal to noise ratio should be at least 10 for the quantifier 
ions). Next, calculate D
3
BMAA recovery for each sample, and correct the determined BMAA 
concentration for this value. Finally, correct for the exact amount of sample used, the final 
volume in which the extract was dissolved before analysis, and in case of free and total 0.1 
M TCA-soluble BMAA, the fraction of the extract used; 500/1250 μl/μl (steps 8.2.5.2.p and 
8.2.5.2.t) (Equation 8.1).
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[𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵]𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 = [𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵]𝑠𝑠𝑎𝑎𝑠𝑠𝑠𝑠𝑎𝑎𝑠𝑠𝑠𝑠𝑎𝑎 ×
[𝐷𝐷3𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵]𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒
[𝐷𝐷3𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵]𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑒𝑒𝑒𝑒
×
𝑉𝑉𝑖𝑖𝑎𝑎 𝑣𝑣𝑖𝑖𝑎𝑎𝑎𝑎
𝑊𝑊𝑎𝑎𝑎𝑎𝑠𝑠𝑒𝑒𝑎𝑎𝑒𝑒
×
𝑉𝑉𝑒𝑒𝑡𝑡𝑒𝑒𝑎𝑎𝑎𝑎 𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑎𝑎𝑒𝑒𝑒𝑒
𝑉𝑉𝑢𝑢𝑎𝑎𝑒𝑒𝑒𝑒 𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑎𝑎𝑒𝑒𝑒𝑒
 Equation 8.1 
 
In which [BMAA]sample is expressed as µg/g, [BMAA]analysed, [D3BMAA]expected and [D3BMAA]analysed as 
ng/mL, Vin vial as mL, Wsample as mg and Vtotal extract and Vused extract as µL. 
 
  
    
 Equation 8.1
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3
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3
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 s mg and Vtotal extract and Vused extract as µL.
“.... that I do not think that I know what I do not know.”
Plato, Apology
CHAPTER 9
synThesis
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Below, the main findings of this thesis will be integrated and discussed.
9.1 BMAA ANALYSIS
Most of the discrepancy in reported BMAA concentrations is caused by the different 
ways in which BMAA analysis is performed (Chapters 3 and 5). Generally, highest BMAA 
concentrations are found by methods using optical detection for quantification (Chapter 5). 
As shown in this thesis, these methods lack selectivity for BMAA, and risk misidentification 
and overestimation of BMAA concentrations (Chapter 3). It is therefore recommended to 
use more selective techniques like tandem mass spectrometry for BMAA quantification 
(Chapter 3, [134]), and at present, LC-MS/MS is the most applied technique (Chapter 
5). A diversity of derivatisation techniques can be used in combination with LC-MS/MS 
analysis of BMAA (e.g. Chapter 3, [100, 145]) and the performance of underivatised LC-
MS/MS methods can be good as well (e.g. Chapters 3 and 7, [103, 199]). If each method 
is properly applied, there seems to be no scientific support for the suggestion that AQC 
derivatised LC-MS/MS analysis would lead to false positives [77], but neither for the claims 
that underivatised LC-MS/MS methods will greatly underestimate BMAA concentrations 
[88] or that these methods simply are inferior to AQC derivatised LC-MS/MS methods [84]. 
LC-MS/MS methods are still improving: isotope dilution is more and more used for 
quantification (e.g. [76, 93, 103, 135]), and is now easier to perform as D
3
BMAA has 
become commercially available. In addition, possible interferences of structural isomers 
are investigated [97, 104], and new methods of separation are explored [104, 202], as are 
alternative derivatisation techniques [203].
During sample workup, it is important that the different forms in which BMAA can be 
present are considered (see Figure 1.4). The recent attention for soluble bound BMAA in 
cycad seeds (Chapter 7 and [92]), periphyton [198], plankton [98, 198], and bivalves [89, 
103, 198] calls for revision of the relatively common extraction strategy of determining free 
BMAA in the aqueous extract and precipitated bound (“protein associated”) BMAA in the 
hydrolysed pellet (e.g. Chapter 2 and [33, 35, 187, 189, 190, 204]). When only free and 
precipitated bound BMAA are determined, the soluble bound fraction will be overlooked. 
As long as the structure(s) of soluble bound BMAA are unknown and its extraction is not 
yet optimised, this problem can be overcome by either hydrolysing the aqueous extract to 
include total soluble BMAA as an isolated fraction, or to hydrolyse all of the sample for total 
BMAA analysis (Chapter 9). In addition, it should be checked whether “free” BMAA is not 
(partly) formed during 0.1 M TCA extraction, as extraction with another dilute acid (20 mM 
HCl at 5 °C) resulted in a slow release of free BMAA from soluble bound forms in mussels 
[89]. Similarly, more free BMAA was found in 0.1 M TCA Skeletonema marinoi extracts 
incubated for 48 hours at 4 °C than in similar extracts incubated for 24 hours under the same 
conditions [200], which might be attributed to the same process. The robustness of 6 M HCl 
hydrolysis should also be investigated, as within-laboratory reproducibility of total BMAA in 
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cycad seed sarcotestas was much lower than within-laboratory reproducibility of free BMAA 
in the same samples (Chapter 7). This finding points at a limitation of using isotope dilution 
for quantification of total BMAA, as the addition of free D
3
BMAA before hydrolysis did not 
seem to accurately correct for the release of BMAA from bound forms (Chapter 7).
No standardized method for BMAA analysis is at present available, and inter-laboratory 
comparison studies are required to compare method performance (Chapter 5). The 
availability of certified reference materials would facilitate such studies, but no reference 
material has been developed for BMAA yet.
While LC-MS/MS based methods are recommended for their sensitivity and selectivity, 
these techniques require expensive equipment, specialised operators and in some cases 
a rather extensive sample preparation. A faster and cheaper method could therefore be 
useful for screening purposes, so that the number of samples for LC-MS/MS analysis can 
be reduced. In microcystin research, ELISA kits are frequently used for fast and sensitive 
analyses (e.g.,  [205-207]) and in 2012, an ELISA for BMAA detection became commercially 
available. However, this assay showed high cross reactivity in a diversity of sample types, 
and should be further developed before application (Chapter 4).
9.2 REPORTING
In addition to the use of inappropriate analytical techniques, poor reporting of analytical 
results and selective discussion of scientific literature has further created confusion in 
BMAA research (Chapter 5). One major problem is that for many studies, the identification 
of BMAA by selective analytical methods cannot be verified because chromatograms are 
not presented, are incomplete or contain errors. In addition, some studies create a biased 
view by only citing studies in which BMAA was detected. Finally, the interpretation of BMAA 
literature was hindered by unclear or unsupported conclusions in some key articles and 
lack of a critical evaluation of the presented work (Chapter 5). To progress BMAA research 
in aquatic systems, it is therefore crucial that the use of appropriate methods is combined 
with correct and complete description of research. This includes an extensive and correct 
description of methods and results, with special attention to recovery data, quantification 
procedure and identification. Furthermore, the work should be critically evaluated and 
should be put it in its scientific context. The validity of published studies lacking information 
on BMAA identification could be checked if the analytical results would be disclosed, e.g. by 
deposition in openly available data repositories. Alternatively, comparative analyses could 
be performed if the sample material used in these studies would be made available. 
9.3 PRESENCE OF BMAA IN AQUATIC SYSTEMS
What is really known about the presence of BMAA in aquatic ecosystems, based on studies 
that used appropriate analytical techniques and that correctly presented their work, is that 
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BMAA can indeed be present in phytoplankton and higher organisms, likely at µg/g DW 
concentrations or lower (Chapter 5). More work still needs to be done to identify the BMAA 
producers in aquatic systems. The detection of BMAA in axenic phytoplankton cultures 
would give a good indication of whether BMAA is indeed produced by phytoplankton or by 
their associated bacteria. So far, BMAA has been found in axenic cultures of cyanobacteria 
[94] and diatoms [98], but independent confirmation of these findings is required. 
Dinoflagellates have also been suggested to produce BMAA [208], but this hypothesis needs 
to be tested on axenic cultures. Identification of the genes responsible for BMAA synthesis 
would greatly assist in assigning BMAA production to specific species or strains, but work in 
this area is still premature.
Interestingly, BMAA has only once been found in cyanobacteria or cyanobacteria dominated 
samples analysed by underivatised LC-MS/MS (Chapter 2), while it has more frequently 
been found in cyanobacteria dominated samples analysed by derivatised LC-MS/MS (e.g. 
[83, 94, 101, 135, 164]). As shown in Chapter 2, free BMAA was detected in nine out of 21 
cyanobacterial field samples from Dutch urban waters, and the highest concentration found 
was 42 µg/g DW. When an additional set of 52 similar samples was recently analysed for 
total BMAA following the protocol described in Chapter 7, no BMAA was detected in 48 
samples (Table 9.1), and putative BMAA peaks were observed in 4 samples (LOD total BMAA 
approximately 2.5 µg/g DW). Subsequent analysis of these four samples for free, total 
soluble and total BMAA (extracted as described in Chapter 9, and analysed as described 
in Chapter 7), resulted in BMAA detection below quantifiable levels in the only benthic 
sample, which was dominated by cyanobacteria and diatoms (Figure 9.1), and quantification 
of 0.6 µg/g DW of total soluble BMAA in a cyanobacteria dominated pelagic sample (Figure 
9.1, Table 9.2). These findings are quite in agreement with other studies that did not detect 
BMAA in cyanobacterial samples by underivatised LC-MS/MS analysis (e.g. [76, 77, 79, 103, 
198]) and also with the detection of BMAA in diatoms by underivatised LC-MS/MS analysis 
(e.g. [198]). However, the number of positive samples and the BMAA concentration found 
in this recent study are lower than reported in Chapter 2 and it is unclear why the result of 
these two studies differ this much.
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Figure 9.1. Light microscopy images of BMAA containing samples ‘Stroombroek’ (A) and 
‘Leusden’ (B, Table 9.2). Credit: Miquel Lürling.
Table 9.1. Properties of 47 scum samples and one Azolla sample, analysed for total BMAA 
as described in Chapter 7, in which no BMAA was detected. Samples were lyophilised after 
collection and were stored at -20 °C before extraction. n.d. means not determined.
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Table 9.1. Properties of 47 scum samples and one Azolla sample, analysed for total BMAA as 
described in Chapter 7, in which no BMAA was detected. Samples were lyophilised after collection 
and were stored at -20 °C before extraction. n.d. means not determined. 
Location 
Sampling 
date 
Dominant 
species1 Location 
Sampling 
date 
Dominant 
species1 
Boxtel 25-07-2013 Ma, Mw Eindhoven 22-08-2013 Df, Dp, Ma 
Ede 13-08-2012 PLa De Meern 17-08-2009 Ma, Dp, Msp 
Someren 14-08-2012 Wn, Df Almere 24-08-2009 Ma, Msp, AZf, Dc 
Ursem 07-09-2009 Ma Tilburg 28-08-2013 Ma, Msp, Wn 
Ede 23-08-2013 Df Beek en Donk 16-07-2010 PLa, Dl, Ma 
Breda 21-07-2010 AZf Barendrecht 09-09-2009 Ma, Mf, AZf 
Tilburg 06-08-2009 Ds, Dc Kralingen 25-10-2012 Msp, Dsp 
Tilburg 27-08-2013 n.d. Middelrode 19-08-2013 Ma, Wn, Mw 
Someren 16-07-2010 Ma, Mf Budel 15-08-2008 Ds, Dc, PLa, AZsp 
Huizen 03-07-2009 n.d. Boxtel 11-09-2010 Wn, Mw, Ma 
Tilburg 22-07-2009 n.d. Beek en Donk 02-08-2011 AZsp, Ma, Dsp 
Breda 27-08-2013 n.d. Wageningen 20-08-2009 Dsp 
Someren 16-07-2010 Ma St. Oedenrode 03-06-2011 Wn, Ma, Mf 
Enclave 27-08-2013 n.d. Prinsenbeek 21-04-2009 AZf 
Voordorp 31-08-2009 Msp, Wn Valkenswaard 02-08-2011 Df 
Borculo 15-02-2008 Pr St. Oedenrode 30-09-2011 Mf, Ma, Wn, Dp 
Son 02-08-2011 Dp St. Oedenrode 15-07-2010 Df, Dp, Euglena 
Lelystad 24-08-2009 Ma Bergen op Zoom 06-08-2009 Dc, Ma, Mf, Wn 
Nijkerk 23-09-2009 Ma, Df Budel 22-08-2013 Dc, Ds, Df, Ma, Mf, AZsp 
Houten 09-09-2009 Dsp Bergen op Zoom 27-08-2013 n.d. 
Kardinge 15-09-2009 Msp, Dl St. Oedenrode 05-08-2008 Dc, AZg, Ma, Ssp, ATsp, Lsp, Csp 
Wageningen 19-11-2013 Azolla Rotterdam 09-09-2009 Ma, AZf, Dsp 
Wageningen 22-07-2010 Ma Valkenswaard 22-08-2013 Ds 
Amsterdam 31-08-2009 Ma Amersfoort 24-08-2009 AZf, Mb, Ma, Mw, Dp, Df 
1 Species abbreviations: ATsp: Aphanothece sp.; AZf: Aphanizomenon flos-aquae; AZg: 
Aphanizomenon gracile; AZsp, Aphanizomenon sp.; Csp: Chroococcus sp.; Dc: Dolichospermum 
circinalis; Df: Dolichospermum flos-aquae; Dl: Dolichospermum lemmermannii; Dp: Dolichospermum 
planktonicum; Ds: Dolichospermum spiroides; Dsp: Dolichospermum sp.; Lsp: Limnothrix sp.; Ma: 
Microcystis aeruginosa; Mb: Microcystis botrys; Mf: Microcystis flos-aquae; Msp: Microcystis sp.; 
Mw: Microcystis wesenbergii; Osp: Oscillatoria sp.; PHsp: Phormidium sp.; PLa: Planktothrix agardhii; 
PLr: Planktothrix rubescens; Ssp: Snowella sp; Wn: Woronichinia naegeliana 
 
  
1 Species abbreviations: ATsp: Aphanothece sp.; AZf: Aphanizomenon flos-aquae; AZg: Aphanizomenon gracile; 
AZs , Aphanizomenon sp.; Csp: Chroococcus sp.; Dc: Dolichospermum ircinalis; Df: Dolichospermum flos-aquae; 
Dl: Dolichospermum lemmermannii; Dp: Dolichospermum planktonicu ; Ds: Dolichospermum spiroides; Dsp: 
Dolichospermum sp.; Lsp: Limnothrix sp.; Ma: Microcystis aeruginosa; Mb: Microcystis botrys; Mf: Microcystis 
flos-aquae; Msp: Microcystis sp.; Mw: Microcystis wesenbergii; Osp: Oscillatoria sp.; PHsp: Phormidium sp.; PLa: 
Planktothrix agardhii; PLr: Planktothrix rubescens; Ssp: Snowella sp; Wn: Woronichinia naegeliana
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Table 9.2. Three cyanobacterial scums and a benthic sample analysed for free, total 
soluble and total BMAA as described in Chapters 7 and 9. n.d. means below limit of detection (LOD), 
n.q. means below limit of quantification (LOQ). Species codes are explained below Table 9.1.
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Tabl  .2. Three cyanobacterial scum  and a benthic sample analysed for free, total soluble and 
total BMAA as described in Chapters 7 and 9. n.d. means below limit of det ction (LOD), n.q. means 
below limit of quantification (LOQ). Species codes are explained below Table 9.1. 
 Sampling  BMAA (µg/g DW) 
Location date Dominant species Free1 T.s.2 Total3 
Nieuwkoop 13-08-2009 Wn, Ma, Dp, Ds n.d. n.d. n.d. 
Soest 23-09-2009 Ma n.d. n.d. n.d. 
Stroombroek 11-06-2013 PHsp, Osp, Dsp, diatoms4 n.d. n.d. n.q. 
Leusden 10-08-2009 Pa, Dc, Df, Ma n.d. 0.6 n.q. 
1 LOD 0.2 µg/g DW, LOQ 0.5 µg/g DW; 2 Total soluble, LOD 0.2 µg/g DW, LOQ 0.6 µg/g DW; 
3 LOD 2.5 µg/g DW, LOQ 6.2 µg/g DW; 4 Benthic sample 
 
How BMAA production is influenced by environmental conditions is unknown. The experimental 
setup of one study on BMAA production by cyanobacteria [99] is flawed (Chapter 5), and in another 
study, no BMAA was detected in the tested cyanobacterial strains [209]. In field situations, the 
phytoplankton BMAA content was reported to be negatively correlated with the dissolved inorganic 
nitrogen concentration, but no evidence of correct BMAA identification is provided for this study 
[210]. 
 
BMAA has been found in different trophic levels in the aquatic food web, ranging from 
phytoplankton to fish (e.g. [83, 100, 145, 197]). Assuming that BMAA is produced by phytoplankton 
and/or benthic algae, this means that BMAA can be taken up by higher organisms and that it can be 
transported through the food web. Indeed, zooplankton, mussels and macrophytes can rapidly take 
up dissolved BMAA [129, 187, 189, 190]. Moreover, BMAA can be maternally transferred (Chapter 6) 
and it can stay within the body for a longer period of time, as shown for the zooplankter D. magna 
that still contained detectable amounts of BMAA 20 days after exposure (Chapter 6). In most uptake 
studies so far, organisms have been exposed to dissolved, free BMAA. As BMAA is an endotoxin, 
exposure studies with BMAA-containing food (e.g. phytoplankton in zooplankton and bivalve studies, 
zooplankton in fish studies) are required, to determine whether BMAA is as efficiently taken up from 
ingested biological matrix as from growth medium. For the cyanobacterial toxin microcystin for 
instance, ingestion of cyanobacterial cells enhanced toxin uptake in Daphnia, because an unknown 
cell compound disrupted Daphnia’s gut epithelium [211]. Another reason to perform exposure 
studies with BMAA-containing food, is that BMAA can be present in different forms in the food 
source, and that the bioavailability of these distinct forms may differ. D. magna has been exposed to 
cyanobacteria reportedly containing free and precipitated bound BMAA, but after 2 weeks of 
exposure, neither free nor precipitated bound BMAA could be detected in the Daphnia tissue [187]. 
In another study, Mediterranean mussels (Mytilus galloprovincialis) have been exposed to 
cyanobacteria which reportedly contained traces of BMAA. In this system, BMAA uptake through 
ingestion of cyanobacteria was described [212], but for both studies it is unclear whether BMAA 
identification has been performed correctly. 
 
The fate of BMAA in exposed aquatic organisms has rarely been studied. In a study where bivalves 
were exposed to dissolved BMAA, most BMAA was present in the organisms in a free form. However,  
the majority of the isotopically labelled BMAA added to the aquaria could not be retrieved after 48 
hours [189]. This could either be attributed to instability of BMAA in the exposure media, as 
observed in Chapter 6, or to the transformation of free BMAA to forms undetectable by the 
1 LOD 0.2 µg/g DW, LOQ 0.5 µg/g DW; 2 Total soluble, LOD 0.2 µg/g DW, LOQ 0.6 µg/g DW;
3 LOD 2.5 µg/  DW, LOQ 6.2 µg/g DW; 4 Benthic sample
How BMAA production is influenced by environmental conditions is unknown. The 
experimental setup of one study on BMAA production by cyanobacteria [99] is flawed 
(Chapter 5), and in another study, no BMAA was detected in the tested cyanobacterial strains 
[209]. In field situations, the phytoplankton BMAA content was reported to be negatively 
correlated with the dissolved inorganic nitrogen concentration, but no evidence of correct 
BMAA identification is provided for this study [210].
BMAA has been found in different trophic levels in the aquatic food web, ranging from 
phytoplankton to fish (e.g. [83, 100, 145, 197]). Assuming that BMAA is produced by 
phytoplankton and/or benthic algae, this means that BMAA can be taken up by higher 
organisms and that it can be transported through the food web. Indeed, zooplankton, mussels 
and macrophytes can rapidly take up dissolved BMAA [129, 187, 189, 190]. Moreover, BMAA 
can be maternally transferred (Chapter 6) and it can stay within the body for a longer period 
of time, as shown for the zooplankter D. magna that still contained detectable amounts of 
BMAA 20 days after exposure (Chapter 6). In most uptake studies so far, org nisms have 
been xposed to dissolved, free BMAA. As BMAA is an endotoxin, exposure studies with 
BMAA-containing food (e.g. phytoplankton in zooplankton and bivalve studies, zooplankton 
in fish studies) are required, to determine whether BMAA is as efficiently taken up from 
ingested biological matrix as from growth medium. For the cyanobacterial toxin microcystin 
for instance, ingestion of cyanobacterial cells enhanced toxin uptake in Daphnia, because 
an unknown cell compound disrupted Daphnia’s gut epithelium [211]. Another reason 
to perform exposure studies with BMAA-containing food, is that BMAA can be present 
in different forms in the food source, and that the bioavailability of these distinct forms 
may differ. D. magna has been exposed to cyano acteria reportedly containing free and 
precipitated bound BMAA, but after 2 weeks of exposure, neither free nor precipitated 
bound BMAA could be detected in the Daphnia tissue [187]. In another study, Mediterranean 
mussels (Mytilus galloprovincialis) have been exposed to cyanobacteria which reportedly 
contained traces of BMAA. In this system, BMAA uptake through ingestion of cyanobacteria 
was described [212], but for both studies it is unclear whether BMAA identification has been 
performed correctly.
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The fate of BMAA in exposed aquatic organisms has rarely been studied. In a study where 
bivalves were exposed to dissolved BMAA, most BMAA was present in the organisms in a 
free form. However, the majority of the isotopically labelled BMAA added to the aquaria 
could not be retrieved after 48 hours [189]. This could either be attributed to instability 
of BMAA in the exposure media, as observed in Chapter 6, or to the transformation of 
free BMAA to forms undetectable by the analytical methods used (which only determined 
free and precipitated bound BMAA), such as soluble bound BMAA. In an experiment with 
similar setup, but using the macrophyte Ceratophyllum demersum as a model species, 
free BMAA was the most abundant fraction, and both free and precipitated bound BMAA 
concentrations in the plant dropped during depuration, while no BMAA could be found 
in the depuration medium [190]. Also in this study, it would have been interesting to see 
whether the formation of soluble bound BMAA was responsible for the observed decrease 
in free and precipitated bound BMAA, but this fraction was not analysed. Finally, in D. 
magna exposed to dissolved BMAA, only free BMAA was found in one study ([187], free and 
precipitated bound BMAA were analysed), while in Chapter 7, soluble bound BMAA (77% 
of total BMAA) was more abundant in D. magna tissue than free BMAA (23%; free, soluble 
bound and total BMAA were analysed).
9.4 BMAA TOXICITY TO AQUATIC ORGANISMS
As discussed above, BMAA can be present in aquatic systems at different trophic levels, which 
implies that different groups of aquatic animals are exposed to BMAA. The effect of BMAA 
on aquatic organisms was first studied on zebrafish larvae (Danio rerio). In the presence of 
bicarbonate, exposure to 5 µg/l dissolved BMAA caused an increase in pericardial oedema, 
premature hatching and clonus like convulsions (the latter were also observed without the 
presence of bicarbonate). Exposure levels of 50 µg/l (either with or without bicarbonate) 
caused spine deformations [168]. The protist Nassula sorex showed increased mortality 
when exposed to dissolved BMAA for 72 hours (LC
50
 5000 µg/l), and exposure of the brine 
shrimp Artemia salina resulted in the loss of phototactic response at a concentration of 500 
µg/l [167]. Exposure of Daphnia magna to dissolved BMAA resulted in reduced mobility 
(EC
50
 after 48 hours at 40 µg/l), decreased brood viability, smaller adults, lighter offspring 
and decreased population growth (nominal concentration 100 – 110 µg/l, [129] and Chapter 
6). In D. magna, two generation BMAA exposure lead to higher brood mortality and lower 
neonate weight than single generation exposure (Chapter 6, nominal concentration 110 
µg/l). Interestingly, cyanobacteria can also be negatively affected by BMAA exposure, 
exposure to 2400 µg/l reduced nitrogen fixation in Nostoc [164], and exposure to 500 µg/l 
reduced the growth rate of Synechocystis [213].
In vitro, BMAA can cause oxidative stress [59]. In tests on aquatic species, antioxidant and 
biotransformation enzyme activity changed in response to BMAA exposure, however, the 
effect varied between species, exposure times and exposure conditions. In D. magna that 
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were exposed to 100 µg/l dissolved BMAA for 24 h, the activity of the antioxidant enzymes 
superoxide dismutase and catalase was reduced, as well as of the biotransformation 
enzyme glutathione S-transferase [187]. Exposure of the same species to concentrations 
up to 1000 µg/l however did not change the animal’s oxidative status, as indicated 
by hydrogen peroxide concentrations and the thiobarbituric acid reactive substances 
assay, which was used to indicate lipid peroxidation [187]. Exposure of the macrophyte 
Ceratophyllum demersum to dissolved BMAA in the concentration range of 0.5 to 1.0 µg/l 
reduced the activity of antioxidant enzymes and glutathione S-transferase, but in this study, 
the antioxidant concentration in the plant was increased at an exposure to 50 µg/l BMAA 
[214]. The macrophytes Lomariopsis lineata, Fontinalis antipyretica, Riccia fluitans and 
Taxiphyllum barbieri all responded to BMAA exposure with changes in their antioxidant and 
biotransformation enzyme activities, but these effects differed in direction and magnitude 
between the species and the exposure times (1 to 7d) and concentrations used (10 to 100 
µg/l) [215]. Similarly, only two out of four bivalve species exposed to BMAA responded 
in terms of antioxidant and biotransformation enzyme activity, but again variable results 
were obtained for different exposure times (24 h to 7 d) and concentrations (10 to 500 
µg/l) [216]. The mechanism behind these responses still needs to be clarified, and it is also 
not yet known to which extent BMAA-induced disturbance of the oxidative status of cells 
contributes to the above summarized effect on animal and population level.
In all ecotoxicological studies performed so far, the aquatic organisms were exposed to 
relatively high concentrations of dissolved BMAA, and most studies used relatively short 
(within one generation) exposure times. These tests are valuable for a first screening 
of effects, and to investigate toxicity mechanisms. For a better estimation of the 
environmentally relevant toxicological effects of BMAA exposure however, these tests should 
be complemented with approaches closer to the environmental conditions experienced 
by the test organisms, such as a more realistic mode of exposure, exposure to multiple 
stressors and increased exposure time.
BMAA is an endotoxin, and reports on free BMAA in surface waters are rare [217]. Exposure 
to BMAA containing food (either naturally contaminated or artificially exposed) may lead 
to different effects than exposure to dissolved BMAA; for instance, uptake may differ when 
BMAA is present in food (e.g. [211]) and test organisms may change their feeding behaviour, 
and therefore regulate the amount of toxin ingested, when exposed to toxin containing food 
[218]. Also, BMAA can be present in different forms in natural food (see section 9.1) and it 
is still unknown how these forms are taken up and metabolised.
Moreover, under field conditions, aquatic organisms are simultaneously exposed to multiple 
stressors. For instance, representatives of BMAA-containing phytoplankton groups (diatoms, 
cyanobacteria) can produce a wide range of known and unidentified toxic compounds [13, 
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128]. The combined toxicity of BMAA and other algal compounds should therefore be 
assessed. Combinations of purified BMAA and other known purified phycotoxins, preferably 
those that could co-occur in a phytoplankton community, can be used for this. BMAA and 
domoic acid would be a particularly interesting combination, as both compounds cause 
excitotoxicity and can be present in diatoms. In the only study so far that tested the combined 
effect of BMAA and microcystin-LR exposure on a filamentous alga [219], BMAA seemed 
to be better taken up in the presence of microcystin-LR, but it is unclear whether BMAA 
identification has been correctly performed. The activity of glutathione S-transferase and 
catalase was higher in the algae that were simultaneously exposed to both toxins than in the 
algae that were exposed to each toxin alone [219]. To include the effect of unknown algal 
components present in food, zooplankton or bivalves could be exposed to BMAA-containing 
phytoplankton strains, with non BMAA containing strains of the same species serving as 
a control. These type of experiments have already been performed for other phycotoxins 
[220, 221], and the challenge in this case would be to find enough closely related strains 
which differ in their BMAA content.
Finally, chronic exposure tests and the inclusion of more sensitive endpoints such as 
behavioural changes may provide ecologically relevant information. As shown in Chapter 
6, two-generation exposure of D. magna to dissolved BMAA had a slightly more negative 
effect on reproduction than single generation exposure, although this did not result in lower 
population growth rates.
9.5 OUTLOOK
The main question in BMAA research is to what extent BMAA constitutes a human health 
risk. To answer this question, the relation between BMAA exposure and the onset of the 
neurodegenerative diseases ALS, PD and AD should be established. And although much 
work is performed to answer this question, additional evidence is still needed (Section 1.3). 
In addition to the studies on the neurotoxicity of BMAA, exposure pathways are quantified. 
In recent studies, BMAA is consistently found in human food such as fish, mussels and crabs 
at µg/g (dry or wet weight) levels or lower [83, 145, 197, 198, 222, 223] and the consumption 
of aquatic organisms therefore seems to be an important human exposure route for BMAA. 
Whether cycads and aquatic organisms are the only sources of human BMAA exposure is 
unclear, as the presence of BMAA in (cycad unrelated) terrestrial food and ecosystems has 
not been studied. As we are still unaware of how widespread the production of BMAA really 
is, screening of terrestrial food items might be prudent, as its structural isomer DAB has 
been found in tomato (unpublished data) and broccoli [94].
Under future conditions, such as climate change and increased eutrophication, cyanobacteria 
are expected to become more dominant in freshwater lakes [224, 225]. Also in marine 
systems, the phytoplankton composition is expected to change [226], although it is at present 
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not possible to accurately predict the future situation [227]. How these future changes in 
phytoplankton biomass and composition affect the occurrence of BMAA in aquatic systems 
is unknown. The total amount of toxin present in a system depends on the abundance of 
toxin producing species, and the amount of toxin produced by these species under given 
environmental conditions. Of these two, the abundance of toxin producing species is the 
most important factor, as strain specific biomass can vary orders of magnitude within a 
season. The within strain environmental modulation of BMAA production is still unknown, 
but based on the variation observed in the production of (other) cyanobacterial toxins [150, 
228-231], it is expected to make only a small contribution to the total variation.
In conclusion, many questions regarding human exposure to BMAA and the possible health 
risks associated with it still require an answer. Given the possible severe implications of 
BMAA exposure, research on the BMAA-neurodegenerative diseases hypothesis needs to 
be continued. In future research, care should be taken that sound analytical methods are 
used, and that the research is correctly reported and critically evaluated. In addition, a more 
constructive discussion and better cooperation between different researchers is required to 
progress this field.
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Eutrophication is a major water quality issue and in many aquatic systems, it leads to the 
proliferation of toxic phytoplankton species. The neurotoxin β-N-methylamino-L-alanine 
(BMAA) is one of the compounds that can be present in phytoplankton. BMAA has been 
suggested to play a role in the neurodegenerative diseases Alzheimer’s disease, Parkinson’s 
disease and amyotrophic lateral sclerosis, although this hypothesis still needs to be 
confirmed. It is expected that the main human exposure pathways to BMAA are through 
direct contact with BMAA containing phytoplankton and through ingestion of BMAA 
contaminated food, such as fish and shellfish. However, reports on the occurrence of BMAA 
in aquatic systems have been conflicting and the cause of these reported differences was 
heavily debated. The use of different analytical methods seems to play a crucial role in the 
observed discrepancies, but initially, there was little consensus on which method produced 
most reliable results. The objectives of the work presented in this thesis therefore were 
to find out what has caused the differences in published results on BMAA concentrations, 
and to identify and produce reliable data on the presence of BMAA in aquatic systems. 
In addition, I aimed to determine the effect of BMAA exposure on a key species in many 
freshwater ecosystems, the grazer Daphnia magna.
The performances of different analytical techniques were compared, and LC-MS/MS analysis, 
either preceded by derivatisation or not, was found to produce most reliable results. LC-FLD 
and ELISA should not be used for BMAA analysis, as both methods risk misidentifying BMAA 
or overestimating its concentrations due to their low selectivity. When reviewing literature 
on the presence of BMAA in aquatic systems, it was found that the observed discrepancies 
in results could be explained by the use of unselective analytical methods in some studies, 
and by severe reporting deficiencies in others. When only studies that used appropriate 
analytical techniques and that correctly reported their work were taken into account, it 
was shown that BMAA could be present in phytoplankton and higher aquatic organisms, in 
concentrations of µg/g dry weight or lower. These results are in agreement with our findings 
of BMAA in cyanobacterial scums from Dutch urban waters. In a 2008 screening, BMAA was 
found to be present in 9 out of 21 analysed cyanobacterial scums, at concentrations ranging 
from 4 to 42 µg/g dry weight. When this screening was repeated 8 years later with 52 similar 
samples, BMAA was detected below the quantification limit in one sample and quantified in 
another sample at 0.6 µg/g dry weight. 
In order to perform the work presented in this thesis, sensitive and selective analytical 
methods, mostly based on LC-MS/MS analysis without derivatisation, were developed. 
This resulted in a standard operating procedure for the underivatised LC-MS/MS analysis 
of BMAA in cyanobacteria. Also, a CYANOCOST initiated workshop was given, in which a 
group of scientists from 17 independent laboratories evaluated LC-MS/MS based methods 
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in different matrices. A bound BMAA from found in the supernatant was the most abundant 
fraction in the positive samples that were tested: cycad seed, seafood and exposed D. magna. 
In addition, it was found that the deuterated internal standard used for quantification was 
not a good indicator for the release of BMAA from bound forms, resulting in unprecise 
quantification of total BMAA.
BMAA was found to reduce survival, somatic growth, reproduction and population growth 
in D. magna. Animals did not adapt to BMAA exposure: exposed animals born from exposed 
mothers had a lower brood viability and neonate weight than animals exposed to BMAA, 
but born from unexposed mothers. In addition, D. magna was shown to take up BMAA 
from the growth medium and to transfer it to its offspring. D. magna therefore might be 
an important vector for BMAA transfer along the pelagic food chain, but whether BMAA 
plays a role in preventing zooplankton from controlling cyanobacterial blooms needs further 
investigation.
Although BMAA research has much progressed between the start of this thesis’ work and 
its completion, some important questions still require an answer. Most urgently, it should 
be determined whether BMAA is indeed involved in the neurological diseases mentioned 
above, and if so, which doses trigger the onset of these diseases. Human exposure pathways 
should then be more systematically quantified, and it might be prudent to investigate if the 
occurrence of BMAA is restricted to aquatic systems, or whether sources from terrestrial 
systems contribute to BMAA exposure as well.
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